FromID,ToID,Relation_value,Relation_type,Relation_Context_ClinicalPhase,FromType,ToType
2917,25441,phosphodiesterase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
11220,25441,phosphodiesterase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25442,25441,phosphodiesterase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7016,25441,phosphodiesterase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
11127,25441,phosphodiesterase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
13052,25443,benzodiazepine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25444,25443,benzodiazepine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
11220,25445,phosphodiesterase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7016,25445,phosphodiesterase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
12386,25446,tachykinin antagonist,MoA,Preclinical,Gene,Chemical_Compound
6912,25447,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7999,25447,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13702,25448,retinoid receptor ligand,MoA,Preclinical,Gene,Chemical_Compound
25449,25450,purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
2701,25451,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5102,25451,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25433,25452,dopamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25453,25454,purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25455,25456,nicotinic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25457,25458,adrenergic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
13904,25458,adrenergic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25459,25458,adrenergic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
11394,25460,AKT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12829,25460,AKT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5683,25460,AKT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6103,25461,transient receptor potential channel antagonist,MoA,Preclinical,Gene,Chemical_Compound
25462,25463,sodium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
25453,25464,purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25453,25465,purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25466,25467,acetylcholine receptor allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
25468,25467,acetylcholine receptor allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
25455,25467,acetylcholine receptor allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
25462,25469,sodium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
6312,25470,diacylglycerol O acyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4093,25471,stearoyl-CoA desaturase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10521,25472,transient receptor potential channel antagonist,MoA,Preclinical,Gene,Chemical_Compound
7954,25473,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25474,25473,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25475,25473,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25476,25473,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25477,25473,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25478,25473,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25479,25473,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25432,25473,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25435,25473,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25436,25473,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25438,25473,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
6992,25473,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25480,25473,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25481,25473,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25482,25483,GABA receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
25484,25483,GABA receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
15687,25483,GABA receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
25486,25487,metalloproteinase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25488,25489,gonadotropin releasing factor hormone receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
6423,25490,sphingosine kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12953,25496,histamine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25497,25496,histamine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25498,25496,histamine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25499,25500,platelet activating factor receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25501,25502,calcium channel blocker,MoA,Phase 2,Gene,Chemical_Compound
25503,25502,calcium channel blocker,MoA,Phase 2,Gene,Chemical_Compound
25504,25502,calcium channel blocker,MoA,Phase 2,Gene,Chemical_Compound
10232,25505,adenosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25433,25506,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
4988,25507,BCL inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
15946,25507,BCL inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
13433,25507,BCL inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
7675,25508,tubulin polymerization inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25509,25510,estrogen receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
14114,25511,retinoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
7653,25512,PAR agonist,MoA,Preclinical,Gene,Chemical_Compound
9912,25513,PARP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6394,25514,retinoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
14114,25514,retinoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
5098,25515,PDGFR tyrosine kinase receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25516,25515,PDGFR tyrosine kinase receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25517,25515,PDGFR tyrosine kinase receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7305,25515,PDGFR tyrosine kinase receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12215,25515,PDGFR tyrosine kinase receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25518,25519,urotensin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
6722,25522,PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
12010,25522,PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25539,25543,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25546,25547,polarization inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7246,25572,lipoxygenase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25573,25572,lipoxygenase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15788,25580,cholesterol inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25581,25580,cholesterol inhibitor,MoA,Phase 3,Gene,Chemical_Compound
2432,25586,gamma glutamyltransferase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25593,25594,orexin receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25595,25594,orexin receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25596,25597,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
15208,25597,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9483,25598,HDAC inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
9854,25598,HDAC inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
5097,25598,HDAC inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
15412,25598,HDAC inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
11559,25598,HDAC inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
2655,25600,aldose reductase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
2655,25602,TGF beta receptor inhibitor,MoA,Phase 3,Gene,Chemical_Compound
6908,25602,TGF beta receptor inhibitor,MoA,Phase 3,Gene,Chemical_Compound
3741,25602,TGF beta receptor inhibitor,MoA,Phase 3,Gene,Chemical_Compound
5568,25602,TGF beta receptor inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25603,25602,TGF beta receptor inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25604,25605,CC chemokine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
14114,25606,retinoid receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
6578,25606,retinoid receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25435,25607,serotonin receptor agonist|serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25438,25607,serotonin receptor agonist|serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
9676,25608,protein synthesis stimulant,MoA,Preclinical,Gene,Chemical_Compound
5809,25608,protein synthesis stimulant,MoA,Preclinical,Gene,Chemical_Compound
4516,25608,protein synthesis stimulant,MoA,Preclinical,Gene,Chemical_Compound
7061,25608,protein synthesis stimulant,MoA,Preclinical,Gene,Chemical_Compound
13184,25608,protein synthesis stimulant,MoA,Preclinical,Gene,Chemical_Compound
10173,25608,protein synthesis stimulant,MoA,Preclinical,Gene,Chemical_Compound
3999,25612,adenosine receptor agonist,MoA,Launched,Gene,Chemical_Compound
12691,25612,adenosine receptor agonist,MoA,Launched,Gene,Chemical_Compound
2954,25612,adenosine receptor agonist,MoA,Launched,Gene,Chemical_Compound
4380,25612,adenosine receptor agonist,MoA,Launched,Gene,Chemical_Compound
10232,25612,adenosine receptor agonist,MoA,Launched,Gene,Chemical_Compound
11112,25612,adenosine receptor agonist,MoA,Launched,Gene,Chemical_Compound
25613,25612,adenosine receptor agonist,MoA,Launched,Gene,Chemical_Compound
8804,25612,adenosine receptor agonist,MoA,Launched,Gene,Chemical_Compound
11220,25612,adenosine receptor agonist,MoA,Launched,Gene,Chemical_Compound
7016,25612,adenosine receptor agonist,MoA,Launched,Gene,Chemical_Compound
2589,25612,adenosine receptor agonist,MoA,Launched,Gene,Chemical_Compound
13837,25612,adenosine receptor agonist,MoA,Launched,Gene,Chemical_Compound
7448,25612,adenosine receptor agonist,MoA,Launched,Gene,Chemical_Compound
12547,25612,adenosine receptor agonist,MoA,Launched,Gene,Chemical_Compound
12125,25612,adenosine receptor agonist,MoA,Launched,Gene,Chemical_Compound
10738,25612,adenosine receptor agonist,MoA,Launched,Gene,Chemical_Compound
5507,25614,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25615,25614,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25616,25614,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
14267,25614,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25563,25614,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
2767,25614,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
13117,25614,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
10671,25614,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
12552,25614,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
3999,25614,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
12691,25614,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
2954,25614,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
12032,25614,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
3775,25614,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25617,25614,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
4380,25614,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25618,25614,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25619,25614,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
15043,25614,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
11394,25614,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
11243,25614,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25620,25614,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
3359,25614,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
13172,25614,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25621,25614,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
11314,25614,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
5996,25614,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
12775,25614,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25622,25614,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
10621,25614,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
6876,25614,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
4094,25614,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25623,25614,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25624,25614,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25625,25614,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25626,25614,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25627,25614,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
13837,25614,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25628,25614,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25629,25614,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
14629,25614,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
13686,25614,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
3987,25614,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
10738,25614,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
10891,25614,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25632,25633,solute carrier family member inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14803,25634,adiponectin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
13308,25634,adiponectin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25635,25636,opioid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25431,25637,dopamine receptor antagonist|serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25435,25637,dopamine receptor antagonist|serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
7246,25639,11-beta hydroxysteroid dehydrogenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25573,25639,11-beta hydroxysteroid dehydrogenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25539,25640,glutamate receptor negative allosteric modulator,MoA,Phase 2,Gene,Chemical_Compound
25539,25641,glutamate receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
12820,25642,EGFR inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
13503,25642,EGFR inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
11113,25642,EGFR inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25643,25642,EGFR inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25644,25642,EGFR inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25596,25642,EGFR inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25431,25645,dopamine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
11306,25647,estrogen receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25509,25647,estrogen receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25648,25647,estrogen receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
8006,25647,estrogen receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
15338,25647,estrogen receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25649,25647,estrogen receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25650,25647,estrogen receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25651,25647,estrogen receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
3903,25652,sortilin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11540,25653,insulin growth factor receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13667,25654,PARP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12820,25655,EGFR inhibitor|JAK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11513,25655,EGFR inhibitor|JAK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5688,25655,EGFR inhibitor|JAK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8140,25656,tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8661,25657,isocitrate dehydrogenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6606,25658,isocitrate dehydrogenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11374,25659,cell cycle inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25428,25660,nitric oxide synthase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25661,25660,nitric oxide synthase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25662,25660,nitric oxide synthase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25630,25660,nitric oxide synthase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25536,25660,nitric oxide synthase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25565,25660,nitric oxide synthase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
6489,25660,nitric oxide synthase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
6489,25663,imidazoline receptor ligand,MoA,Preclinical,Gene,Chemical_Compound
9880,25664,retinoid receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
14770,25664,retinoid receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25585,25664,retinoid receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
6394,25665,retinoid receptor agonist,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25669,25670,free fatty acid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
13904,25671,adrenergic receptor ligand,MoA,Preclinical,Gene,Chemical_Compound
25672,25673,prostanoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25674,25673,prostanoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
9689,25673,prostanoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7233,25673,prostanoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
2852,25675,core binding factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3987,25676,tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25431,25677,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25432,25677,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25433,25677,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
14836,25678,SIRT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25679,25680,lipoxygenase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
4362,25681,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8464,25683,apoptosis stimulant|STAT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25684,25685,serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
15365,25686,gonadotropin releasing factor hormone receptor antagonist,MoA,Launched,Gene,Chemical_Compound
4128,25696,aldehyde dehydrogenase activator,MoA,Preclinical,Gene,Chemical_Compound
12902,25697,topoisomerase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
9645,25700,phosphatidylglycerophosphatase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13256,25712,Aurora kinase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
10521,25715,cytokine production inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6103,25715,cytokine production inhibitor,MoA,Phase 2,Gene,Chemical_Compound
10521,25720,TRPV agonist,MoA,Preclinical,Gene,Chemical_Compound
25593,25722,orexin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25595,25722,orexin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
8299,25724,anticancer agent,MoA,Preclinical,Gene,Chemical_Compound
25480,25726,serotonin receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25727,25728,protease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
6512,25731,cytochrome P450 inhibitor|HMGCR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11142,25732,omega 3 fatty acid stimulant,MoA,Phase 3,Gene,Chemical_Compound
12233,25732,omega 3 fatty acid stimulant,MoA,Phase 3,Gene,Chemical_Compound
6336,25732,omega 3 fatty acid stimulant,MoA,Phase 3,Gene,Chemical_Compound
25733,25732,omega 3 fatty acid stimulant,MoA,Phase 3,Gene,Chemical_Compound
25669,25732,omega 3 fatty acid stimulant,MoA,Phase 3,Gene,Chemical_Compound
25549,25732,omega 3 fatty acid stimulant,MoA,Phase 3,Gene,Chemical_Compound
12709,25732,omega 3 fatty acid stimulant,MoA,Phase 3,Gene,Chemical_Compound
6103,25732,omega 3 fatty acid stimulant,MoA,Phase 3,Gene,Chemical_Compound
25498,25734,histamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25498,25735,histamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25437,25736,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25737,25736,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25738,25736,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25438,25736,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
6992,25736,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25439,25736,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25739,25736,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25482,25740,benzodiazepine receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
2655,25747,aldose reductase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25438,25748,serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25468,25749,nicotinic receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25750,25749,nicotinic receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25596,25751,MET inhibitor|VEGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
10658,25751,MET inhibitor|VEGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
15208,25751,MET inhibitor|VEGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
4142,25754,HSP inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15211,25758,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
8140,25758,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5572,25758,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5957,25758,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
3218,25758,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5091,25758,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
13863,25758,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11612,25758,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12820,25758,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25603,25758,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
10974,25759,glycine transporter inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25760,25761,cannabinoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25762,25761,cannabinoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25679,25763,lipoxygenase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25760,25764,cannabinoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25765,25764,cannabinoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25766,25764,cannabinoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25760,25767,cannabinoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25762,25767,cannabinoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25766,25767,cannabinoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25760,25768,cyclooxygenase inhibitor|FAAH inhibitor|TRPV antagonist,MoA,Preclinical,Gene,Chemical_Compound
25762,25768,cyclooxygenase inhibitor|FAAH inhibitor|TRPV antagonist,MoA,Preclinical,Gene,Chemical_Compound
25769,25768,cyclooxygenase inhibitor|FAAH inhibitor|TRPV antagonist,MoA,Preclinical,Gene,Chemical_Compound
6103,25768,cyclooxygenase inhibitor|FAAH inhibitor|TRPV antagonist,MoA,Preclinical,Gene,Chemical_Compound
6394,25770,retinoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25760,25771,cannabinoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25762,25771,cannabinoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25536,25772,potassium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
25778,25779,CC chemokine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25604,25780,CC chemokine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25778,25780,CC chemokine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25716,25783,xanthine oxidase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15628,25784,PERK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10658,25785,tyrosine kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9899,25786,MDM inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12010,25787,PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
10658,25788,MET inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25789,25790,CC chemokine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
6103,25791,TRPV antagonist,MoA,Phase 1,Gene,Chemical_Compound
25792,25793,MAP kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
15860,25793,MAP kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
6521,25793,MAP kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
4362,25793,MAP kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25733,25794,free fatty acid receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
5572,25795,CDK inhibitor|FLT3 inhibitor,MoA,Phase 1,Gene,Chemical_Compound
3218,25795,CDK inhibitor|FLT3 inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25516,25795,CDK inhibitor|FLT3 inhibitor,MoA,Phase 1,Gene,Chemical_Compound
6103,25796,TRPV antagonist,MoA,Preclinical,Gene,Chemical_Compound
12010,25797,PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
10658,25798,MET inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13256,25799,Aurora kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8198,25799,Aurora kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25800,25799,Aurora kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9947,25801,protein arginine N-methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25802,25803,adrenergic receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
6933,25804,monoamine oxidase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25805,25804,monoamine oxidase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25805,25818,dopamine receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25684,25818,dopamine receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
2655,25825,nitric oxide synthase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25826,25825,nitric oxide synthase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
5739,25825,nitric oxide synthase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25826,25827,nitric oxide synthase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10808,25830,dihydrofolate reductase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
9726,25830,dihydrofolate reductase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
15211,25831,CDK inhibitor|tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8140,25831,CDK inhibitor|tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5957,25831,CDK inhibitor|tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25611,25834,inosine monophosphate dehydrogenase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
13065,25834,inosine monophosphate dehydrogenase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25826,25835,cyclin D inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25805,25841,serotonin transporter (SERT) inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25842,25841,serotonin transporter (SERT) inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25684,25841,serotonin transporter (SERT) inhibitor,MoA,Phase 3,Gene,Chemical_Compound
2589,25863,Pim kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25864,25865,glutamate receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
12902,25867,topoisomerase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7990,25867,topoisomerase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25536,25873,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25874,25875,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25536,25875,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25876,25877,glutamate receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25874,25877,glutamate receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
15461,25877,glutamate receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25878,25877,glutamate receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25497,25885,histamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25517,25887,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RAD51 inhibitor|RET tyrosine kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
10658,25887,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RAD51 inhibitor|RET tyrosine kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11931,25888,caspase activator,MoA,Phase 2,Gene,Chemical_Compound
25889,25890,cannabinoid receptor agonist|lipoxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25760,25890,cannabinoid receptor agonist|lipoxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25762,25890,cannabinoid receptor agonist|lipoxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5987,25891,tropomyosin receptor kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25892,25893,cholesteryl ester transfer protein inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25896,25897,growth hormone secretagogue receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25501,25898,cannabinoid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25503,25898,cannabinoid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25504,25898,cannabinoid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25760,25898,cannabinoid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25762,25898,cannabinoid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
6267,25898,cannabinoid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25765,25898,cannabinoid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25766,25898,cannabinoid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25899,25898,cannabinoid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
8285,25898,cannabinoid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25900,25898,cannabinoid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25901,25898,cannabinoid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
6103,25898,cannabinoid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
7205,25903,androgen receptor modulator,MoA,Phase 1,Gene,Chemical_Compound
25904,25905,tumor necrosis factor production inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5939,25905,tumor necrosis factor production inhibitor,MoA,Phase 2,Gene,Chemical_Compound
13835,25905,tumor necrosis factor production inhibitor,MoA,Phase 2,Gene,Chemical_Compound
3290,25905,tumor necrosis factor production inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25882,25905,tumor necrosis factor production inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25906,25907,protein synthesis inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25431,25908,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
25876,25908,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
25874,25908,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
15461,25908,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
25878,25908,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
25438,25908,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
25457,25910,lipid peroxidase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25911,25912,DNA synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25913,25912,DNA synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8519,25912,DNA synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3534,25912,DNA synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8676,25912,DNA synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3469,25912,DNA synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14831,25912,DNA synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9285,25912,DNA synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4016,25912,DNA synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9441,25912,DNA synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3152,25912,DNA synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8971,25912,DNA synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9205,25912,DNA synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25596,25914,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Launched,Gene,Chemical_Compound
12215,25914,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Launched,Gene,Chemical_Compound
25436,25915,serotonin receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25610,25916,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
9010,25917,neuropeptide receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25918,25919,corticotropin releasing factor receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
2946,25921,CDC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11599,25922,ATP synthase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10521,25923,transient receptor potential channel antagonist,MoA,Preclinical,Gene,Chemical_Compound
13913,25924,apolipoprotein expression enhancer,MoA,Phase 3,Gene,Chemical_Compound
25499,25925,platelet activating factor receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
4501,25926,RET tyrosine kinase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25596,25926,RET tyrosine kinase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25517,25926,RET tyrosine kinase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
4084,25926,RET tyrosine kinase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7205,25927,androgen receptor antagonist|anti-inflammatory agent,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25517,25928,KIT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8464,25928,KIT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25929,25930,glucose dependent insulinotropic receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25929,25931,glucose dependent insulinotropic receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
14146,25932,sigma receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
11394,25933,AKT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3526,25933,AKT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12280,25933,AKT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2655,25934,casein kinase inhibitor|cell proliferation inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7205,25934,casein kinase inhibitor|cell proliferation inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3218,25934,casein kinase inhibitor|cell proliferation inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25935,25934,casein kinase inhibitor|cell proliferation inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25824,25934,casein kinase inhibitor|cell proliferation inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3061,25934,casein kinase inhibitor|cell proliferation inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3470,25934,casein kinase inhibitor|cell proliferation inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5166,25937,NADPH oxidase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7295,25938,carboxylesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7143,25938,carboxylesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8459,25939,p53 activator,MoA,Phase 3,Gene,Chemical_Compound
5811,25941,matrix metalloprotease inhibitor|tumor necrosis factor production inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25942,25941,matrix metalloprotease inhibitor|tumor necrosis factor production inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25943,25941,matrix metalloprotease inhibitor|tumor necrosis factor production inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25486,25941,matrix metalloprotease inhibitor|tumor necrosis factor production inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25536,25947,glutamate receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
11020,25948,krüppel-like factor expression enhancer,MoA,Phase 1,Gene,Chemical_Compound
6115,25949,serine/threonine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25950,25951,phosphoinositide dependent kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25952,25951,phosphoinositide dependent kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9822,25951,phosphoinositide dependent kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11243,25954,ALK tyrosine kinase receptor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12820,25954,ALK tyrosine kinase receptor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25477,25955,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7999,25956,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7236,25957,monocarboxylate transporter inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4121,25957,monocarboxylate transporter inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5210,25958,phosphoinositide dependent kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9483,25959,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
10798,25960,cytochrome P450 inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25961,25960,cytochrome P450 inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25962,25960,cytochrome P450 inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25963,25960,cytochrome P450 inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8281,25960,cytochrome P450 inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25651,25960,cytochrome P450 inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7742,25960,cytochrome P450 inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7423,25960,cytochrome P450 inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25964,25960,cytochrome P450 inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25966,25967,melanin inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
25425,25968,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25427,25968,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25428,25968,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
4939,25969,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14630,25969,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14717,25970,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5572,25970,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5732,25971,thrombin inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25477,25972,acetylcholine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25476,25973,acetylcholine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25477,25973,acetylcholine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25478,25973,acetylcholine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25479,25973,acetylcholine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25476,25974,acetylcholine receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25477,25974,acetylcholine receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25478,25974,acetylcholine receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25479,25974,acetylcholine receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
3238,25977,farnesyltransferase inhibitor,MoA,Launched,Gene,Chemical_Compound
13835,25977,farnesyltransferase inhibitor,MoA,Launched,Gene,Chemical_Compound
2917,25979,phosphodiesterase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
3526,25981,AKT inhibitor,MoA,Phase 1,Gene,Chemical_Compound
15101,25982,kinesin-like spindle protein inhibitor,MoA,Phase 1,Gene,Chemical_Compound
13503,25983,EGFR inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
25549,25990,astrocyte modulating agent,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
25991,25990,astrocyte modulating agent,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
15441,25992,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25929,25993,glucose dependent insulinotropic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
13539,25994,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25995,25996,SHIP2 phosphatase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25733,25997,free fatty acid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
12112,25998,interleukin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25730,25999,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9550,26000,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25730,26000,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14630,26001,MEK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15556,26001,MEK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26002,26003,potassium channel blocker,MoA,Phase 1,Gene,Chemical_Compound
26004,26003,potassium channel blocker,MoA,Phase 1,Gene,Chemical_Compound
12919,26003,potassium channel blocker,MoA,Phase 1,Gene,Chemical_Compound
25549,26005,cyclooxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7205,26006,androgen receptor enhancer,MoA,Phase 2,Gene,Chemical_Compound
14084,26007,calcineurin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25603,26011,apoptosis stimulant,MoA,Preclinical,Gene,Chemical_Compound
25756,26012,opioid receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
10974,26013,glycine transporter inhibitor,MoA,Phase 1,Gene,Chemical_Compound
11243,26018,ALK tyrosine kinase receptor inhibitor,MoA,Phase 1,Gene,Chemical_Compound
12820,26019,EGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
13503,26019,EGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
12953,26020,histamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
5315,26020,histamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25839,26020,histamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25826,26021,nitric oxide synthase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26022,26021,nitric oxide synthase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25438,26023,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
15211,26024,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
8140,26024,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5572,26024,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5957,26024,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
3218,26024,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11612,26024,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
13256,26025,Aurora kinase inhibitor|JAK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
8198,26025,Aurora kinase inhibitor|JAK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11513,26025,Aurora kinase inhibitor|JAK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5688,26025,Aurora kinase inhibitor|JAK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12448,26025,Aurora kinase inhibitor|JAK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
13201,26025,Aurora kinase inhibitor|JAK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9689,26027,cyclooxygenase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11513,26030,JAK inhibitor|STAT inhibitor,MoA,Phase 2,Gene,Chemical_Compound
8464,26030,JAK inhibitor|STAT inhibitor,MoA,Phase 2,Gene,Chemical_Compound
2917,26031,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11220,26031,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25442,26031,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7016,26031,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
8410,26032,integrin antagonist,MoA,Phase 2,Gene,Chemical_Compound
6480,26032,integrin antagonist,MoA,Phase 2,Gene,Chemical_Compound
15018,26032,integrin antagonist,MoA,Phase 2,Gene,Chemical_Compound
13803,26032,integrin antagonist,MoA,Phase 2,Gene,Chemical_Compound
8240,26039,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
5086,26040,endothelin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25476,26042,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25477,26042,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25478,26042,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25479,26042,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
9193,26042,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
11394,26043,protein kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
3526,26043,protein kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
12280,26043,protein kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
13539,26043,protein kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9815,26043,protein kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
3241,26043,protein kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
4142,26044,HSP inhibitor,MoA,Phase 2,Gene,Chemical_Compound
3526,26045,AKT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7999,26045,AKT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12829,26045,AKT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5683,26045,AKT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13256,26047,Aurora kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15091,26049,autotaxin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12820,26050,protein tyrosine kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
13503,26050,protein tyrosine kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
12386,26051,tachykinin antagonist,MoA,Phase 2,Gene,Chemical_Compound
8427,26052,gamma secretase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7143,26054,ACAT inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26057,26058,angiotensin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25520,26059,Bruton's tyrosine kinase (BTK) inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6404,26059,Bruton's tyrosine kinase (BTK) inhibitor,MoA,Phase 2,Gene,Chemical_Compound
13065,26060,inosine monophosphate dehydrogenase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11579,26060,inosine monophosphate dehydrogenase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11931,26065,caspase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25453,26066,purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26067,26068,hedgehog pathway inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8931,26069,RAF inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5363,26069,RAF inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12953,26071,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
10548,26072,purine antagonist,MoA,Preclinical,Gene,Chemical_Compound
25549,26074,cyclooxygenase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
6912,26079,glycogen synthase kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7999,26079,glycogen synthase kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
2589,26080,Pim kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26081,26080,Pim kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
2981,26080,Pim kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
3984,26082,purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25468,26083,acetylcholine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25750,26083,acetylcholine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
3018,26084,JAK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
11513,26084,JAK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5688,26084,JAK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26085,26086,CRTH receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
7553,26087,mTOR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7999,26088,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8369,26089,IKK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11243,26090,ALK tyrosine kinase receptor inhibitor|insulin growth factor receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11540,26090,ALK tyrosine kinase receptor inhibitor|insulin growth factor receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7205,26091,androgen receptor modulator,MoA,Phase 1,Gene,Chemical_Compound
12820,26092,EGFR inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
6821,26093,beta-secretase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7236,26094,monocarboxylate transporter inhibitor,MoA,Phase 1,Gene,Chemical_Compound
6312,26095,diacylglycerol kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26096,26097,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
26098,26097,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
4313,26097,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
26099,26097,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
26100,26097,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
8893,26097,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
26101,26097,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
6181,26097,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
15531,26097,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
26102,26097,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
6267,26097,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
2983,26097,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
26103,26097,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
7644,26097,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
26104,26097,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
26105,26097,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
14443,26097,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
26106,26097,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25765,26097,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
26107,26097,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25536,26097,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
11055,26097,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
4116,26097,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
14073,26097,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
14881,26097,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25538,26097,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
4560,26097,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
9727,26097,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
6621,26097,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
26108,26097,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
26109,26097,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
8037,26097,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
26110,26097,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
10974,26097,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
5125,26111,FGFR inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
25643,26111,FGFR inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
25644,26111,FGFR inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
26112,26111,FGFR inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
11540,26111,FGFR inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
25596,26111,FGFR inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
26113,26114,CC chemokine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
11394,26115,AKT inhibitor,MoA,Phase 3,Gene,Chemical_Compound
3526,26115,AKT inhibitor,MoA,Phase 3,Gene,Chemical_Compound
12280,26115,AKT inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25839,26116,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
4111,26117,XIAP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26118,26117,XIAP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8257,26117,XIAP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9550,26119,PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
6722,26119,PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
12010,26119,PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25730,26119,PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
15729,26120,ATR kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25536,26121,glutamate receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
3637,26122,pyruvate dehydrogenase kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
6312,26123,diacylglycerol O acyltransferase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7430,26124,CHK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8245,26124,CHK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7553,26125,mTOR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
6722,26126,PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
12010,26126,PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
13138,26127,MEK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9550,26128,PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
12010,26128,PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
12820,26129,EGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
13503,26129,EGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26130,26129,EGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25539,26131,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
11306,26132,estrogen receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
26133,26134,elastase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26139,26140,RAGE receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
26004,26145,potassium channel blocker,MoA,Phase 3,Gene,Chemical_Compound
15699,26148,SRC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12918,26150,DYRK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15729,26151,ATR kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7553,26151,ATR kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8595,26152,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12820,26153,EGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11513,26154,JAK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11086,26155,polynucleotide kinase/phosphatase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26156,26157,ICAM1 expression inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25554,26157,ICAM1 expression inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25457,26158,adrenergic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
9550,26159,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25453,26160,purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25429,26161,dopamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
6312,26162,diacylglycerol O acyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10054,26166,PPAR receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
10671,26167,Bcr-Abl kinase inhibitor|LYN tyrosine kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5733,26167,Bcr-Abl kinase inhibitor|LYN tyrosine kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
13693,26167,Bcr-Abl kinase inhibitor|LYN tyrosine kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25730,26168,phosphoinositide dependent kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25679,26169,lipoxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6756,26169,lipoxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7345,26169,lipoxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26170,26169,lipoxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25555,26169,lipoxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25882,26169,lipoxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25716,26169,lipoxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7815,26172,DNA polymerase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
10054,26173,insulin sensitizer|PPAR receptor partial agonist,MoA,Phase 3,Gene,Chemical_Compound
5790,26174,cathepsin inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9387,26177,BAX activator,MoA,Preclinical,Gene,Chemical_Compound
26178,26179,nociceptin/orphanin FQ receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
12902,26180,topoisomerase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
13256,26181,Aurora kinase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
8198,26181,Aurora kinase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
8198,26182,Aurora kinase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
25826,26183,nuclear factor erythroid derived|like (NRF2) activator,MoA,Phase 1,Gene,Chemical_Compound
10054,26183,nuclear factor erythroid derived|like (NRF2) activator,MoA,Phase 1,Gene,Chemical_Compound
10054,26184,nuclear factor erythroid derived|like (NRF2) activator,MoA,Phase 3,Gene,Chemical_Compound
8464,26184,nuclear factor erythroid derived|like (NRF2) activator,MoA,Phase 3,Gene,Chemical_Compound
25539,26186,glutamate receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
26187,26188,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
12001,26188,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25568,26188,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
5977,26188,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
3434,26188,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26189,26188,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25498,26190,histamine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
9387,26191,cytochrome C release inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15452,26192,L-type calcium channel activator,MoA,Preclinical,Gene,Chemical_Compound
3757,26193,NFkB pathway inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10881,26194,NFkB pathway inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26195,26196,guanylyl cyclase activator,MoA,Preclinical,Gene,Chemical_Compound
26197,26196,guanylyl cyclase activator,MoA,Preclinical,Gene,Chemical_Compound
7954,26198,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25610,26198,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
9723,26198,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25611,26198,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26199,26200,phosphodiesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26201,26202,SYK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7815,26203,hypoxia inducible factor inhibitor,MoA,Phase 1,Gene,Chemical_Compound
13965,26205,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9019,26206,urokinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6103,26207,TRPV antagonist,MoA,Preclinical,Gene,Chemical_Compound
3502,26208,complement inhibitor|serine protease inhibitor,MoA,Phase 1,Gene,Chemical_Compound
14146,26209,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
14146,26210,sigma receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25457,26211,adrenergic receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
8427,26215,gamma secretase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25480,26221,serotonin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
26076,26221,serotonin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
14558,26222,AMPK inhibitor,MoA,Launched,Gene,Chemical_Compound
6512,26227,gluconeogenesis inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25810,26241,sodium channel blocker,MoA,Phase 2,Gene,Chemical_Compound
25812,26241,sodium channel blocker,MoA,Phase 2,Gene,Chemical_Compound
25813,26241,sodium channel blocker,MoA,Phase 2,Gene,Chemical_Compound
25814,26241,sodium channel blocker,MoA,Phase 2,Gene,Chemical_Compound
25815,26241,sodium channel blocker,MoA,Phase 2,Gene,Chemical_Compound
25816,26241,sodium channel blocker,MoA,Phase 2,Gene,Chemical_Compound
12709,26241,sodium channel blocker,MoA,Phase 2,Gene,Chemical_Compound
25630,26250,cholinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26251,26252,CCK receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
26253,26252,CCK receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
11747,26260,LDL receptor activator,MoA,Launched,Gene,Chemical_Compound
25904,26261,interleukin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25882,26261,interleukin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7538,26262,beta amyloid synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25482,26263,benzodiazepine receptor ligand,MoA,Launched,Gene,Chemical_Compound
25532,26263,benzodiazepine receptor ligand,MoA,Launched,Gene,Chemical_Compound
3434,26264,apoptosis stimulant,MoA,Launched,Gene,Chemical_Compound
25486,26264,apoptosis stimulant,MoA,Launched,Gene,Chemical_Compound
25635,26265,opioid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25756,26265,opioid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25757,26265,opioid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7553,26266,protein synthesis stimulant,MoA,Launched,Gene,Chemical_Compound
15859,26268,topoisomerase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26277,26278,GLP receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
26280,26281,apoptosis stimulant|NFkB pathway inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
7553,26284,PI3K inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
9550,26284,PI3K inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
6722,26284,PI3K inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25730,26284,PI3K inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
26285,26286,ATPase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26287,26288,ribosomal protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8352,26288,ribosomal protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15242,26288,ribosomal protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12448,26288,ribosomal protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15441,26289,PLK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
14549,26289,PLK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26290,26289,PLK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15249,26289,PLK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9010,26291,JNK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13256,26292,Aurora kinase inhibitor|MEK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8198,26292,Aurora kinase inhibitor|MEK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25800,26292,Aurora kinase inhibitor|MEK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
14630,26292,Aurora kinase inhibitor|MEK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
15556,26292,Aurora kinase inhibitor|MEK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26293,26294,calcitonin antagonist,MoA,Phase 2,Gene,Chemical_Compound
3638,26294,calcitonin antagonist,MoA,Phase 2,Gene,Chemical_Compound
15360,26294,calcitonin antagonist,MoA,Phase 2,Gene,Chemical_Compound
26295,26296,telomerase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12820,26297,EGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12820,26298,EGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
13503,26298,EGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25482,26300,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25524,26300,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25525,26300,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25484,26300,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25526,26300,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25527,26300,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26301,26300,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
4142,26304,HSP inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6267,26306,GABA receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
2983,26306,GABA receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
7644,26306,GABA receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
25480,26306,GABA receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
26076,26306,GABA receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
25739,26308,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26309,26310,glutamate receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
4179,26311,NFkB pathway inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26312,26311,NFkB pathway inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26313,26311,NFkB pathway inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12390,26315,integrin antagonist,MoA,Phase 2,Gene,Chemical_Compound
15018,26315,integrin antagonist,MoA,Phase 2,Gene,Chemical_Compound
12390,26316,integrin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15018,26316,integrin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12529,26317,vitamin B,MoA,Launched,Gene,Chemical_Compound
9676,26317,vitamin B,MoA,Launched,Gene,Chemical_Compound
11890,26317,vitamin B,MoA,Launched,Gene,Chemical_Compound
11124,26317,vitamin B,MoA,Launched,Gene,Chemical_Compound
11287,26317,vitamin B,MoA,Launched,Gene,Chemical_Compound
3758,26317,vitamin B,MoA,Launched,Gene,Chemical_Compound
12876,26317,vitamin B,MoA,Launched,Gene,Chemical_Compound
12960,26317,vitamin B,MoA,Launched,Gene,Chemical_Compound
5326,26317,vitamin B,MoA,Launched,Gene,Chemical_Compound
7776,26318,dipeptidyl peptidase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4111,26320,XIAP inhibitor,MoA,Phase 2,Gene,Chemical_Compound
8257,26320,XIAP inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26156,26321,lymphocyte function-associated antigen negative modulator,MoA,Preclinical,Gene,Chemical_Compound
4822,26322,tyrosine phosphatase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11394,26323,PKC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7999,26323,PKC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26324,26323,PKC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15278,26323,PKC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25792,26323,PKC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15860,26323,PKC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4362,26323,PKC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9010,26323,PKC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7160,26323,PKC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13539,26323,PKC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8467,26323,PKC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10228,26323,PKC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7205,26328,synthetic estrogen,MoA,Phase 1,Gene,Chemical_Compound
11306,26328,synthetic estrogen,MoA,Phase 1,Gene,Chemical_Compound
25509,26328,synthetic estrogen,MoA,Phase 1,Gene,Chemical_Compound
25648,26328,synthetic estrogen,MoA,Phase 1,Gene,Chemical_Compound
10054,26328,synthetic estrogen,MoA,Phase 1,Gene,Chemical_Compound
11306,26329,autotaxin inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25509,26329,autotaxin inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
13177,26329,autotaxin inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
26110,26330,glycine transporter inhibitor,MoA,Phase 3,Gene,Chemical_Compound
10974,26330,glycine transporter inhibitor,MoA,Phase 3,Gene,Chemical_Compound
2701,26332,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5102,26332,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12661,26333,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12661,26334,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15404,26334,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6916,26335,ATPase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26336,26335,ATPase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26112,26338,FGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25762,26339,cannabinoid receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
26340,26341,CC chemokine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
5086,26342,endothelin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
14620,26343,potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
15211,26344,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8140,26344,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4068,26345,fatty acid binding protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4939,26346,IKK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8369,26346,IKK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8140,26347,CDK inhibitor|cell cycle inhibitor|MCL1 inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5091,26347,CDK inhibitor|cell cycle inhibitor|MCL1 inhibitor,MoA,Phase 1,Gene,Chemical_Compound
11612,26347,CDK inhibitor|cell cycle inhibitor|MCL1 inhibitor,MoA,Phase 1,Gene,Chemical_Compound
10564,26348,melanocortin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
11394,26349,IGF-1 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26350,26349,IGF-1 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8140,26349,IGF-1 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25692,26349,IGF-1 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13503,26349,IGF-1 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11540,26349,IGF-1 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25596,26349,IGF-1 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26324,26349,IGF-1 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15278,26349,IGF-1 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10658,26349,IGF-1 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7305,26349,IGF-1 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12215,26349,IGF-1 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13065,26351,inosine monophosphate dehydrogenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11579,26351,inosine monophosphate dehydrogenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26352,26353,integrin antagonist,MoA,Phase 2,Gene,Chemical_Compound
26354,26353,integrin antagonist,MoA,Phase 2,Gene,Chemical_Compound
12820,26355,EGFR inhibitor|protein tyrosine kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
13503,26355,EGFR inhibitor|protein tyrosine kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
11113,26355,EGFR inhibitor|protein tyrosine kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9880,26356,retinoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26156,26357,ICAM1 antagonist|leukocyte function-associated antigen receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
12820,26358,EGFR inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
13503,26358,EGFR inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25516,26358,EGFR inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25596,26358,EGFR inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11394,26359,IGF-1 inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11540,26359,IGF-1 inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4206,26360,AXL kinase inhibitor|c-Met inhibitor|FLT3 inhibitor|hepatocyte growth factor receptor inhibitor|macrophage migration inhibiting factor inhibitor|tyrosine kinase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
26361,26360,AXL kinase inhibitor|c-Met inhibitor|FLT3 inhibitor|hepatocyte growth factor receptor inhibitor|macrophage migration inhibiting factor inhibitor|tyrosine kinase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
10658,26360,AXL kinase inhibitor|c-Met inhibitor|FLT3 inhibitor|hepatocyte growth factor receptor inhibitor|macrophage migration inhibiting factor inhibitor|tyrosine kinase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
26362,26360,AXL kinase inhibitor|c-Met inhibitor|FLT3 inhibitor|hepatocyte growth factor receptor inhibitor|macrophage migration inhibiting factor inhibitor|tyrosine kinase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
9698,26360,AXL kinase inhibitor|c-Met inhibitor|FLT3 inhibitor|hepatocyte growth factor receptor inhibitor|macrophage migration inhibiting factor inhibitor|tyrosine kinase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25596,26363,c-Met inhibitor|VEGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
10658,26363,c-Met inhibitor|VEGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
10835,26364,smoothened receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
6951,26365,CDC inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
2589,26365,CDC inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
5991,26366,lysophosphatidic acid receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25435,26367,sigma receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
9765,26368,IP1 prostacyclin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25457,26369,adrenergic receptor antagonist|serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
13904,26369,adrenergic receptor antagonist|serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25459,26369,adrenergic receptor antagonist|serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25435,26369,adrenergic receptor antagonist|serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25635,26370,opioid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25756,26370,opioid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25757,26370,opioid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25435,26380,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25457,26381,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25459,26381,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25425,26381,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25430,26381,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25431,26381,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25432,26381,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25433,26381,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25435,26381,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
6992,26381,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
5086,26382,endothelin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
6063,26383,endothelin receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
12074,26384,Ras GTPase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12208,26384,Ras GTPase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5102,26385,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26287,26386,ribosomal protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8352,26386,ribosomal protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15242,26386,ribosomal protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15101,26387,kinesin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8601,26388,protein synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14783,26388,protein synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2855,26394,dihydroorotate dehydrogenase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25482,26395,GABA benzodiazepine site receptor partial agonist,MoA,Phase 2,Gene,Chemical_Compound
25524,26395,GABA benzodiazepine site receptor partial agonist,MoA,Phase 2,Gene,Chemical_Compound
25525,26395,GABA benzodiazepine site receptor partial agonist,MoA,Phase 2,Gene,Chemical_Compound
25484,26395,GABA benzodiazepine site receptor partial agonist,MoA,Phase 2,Gene,Chemical_Compound
25526,26395,GABA benzodiazepine site receptor partial agonist,MoA,Phase 2,Gene,Chemical_Compound
25527,26395,GABA benzodiazepine site receptor partial agonist,MoA,Phase 2,Gene,Chemical_Compound
14717,26398,cyclin D inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25692,26403,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
5125,26403,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26062,26403,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25839,26403,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25596,26403,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25644,26404,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25435,26405,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25436,26405,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25437,26405,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25737,26405,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25738,26405,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25438,26405,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
6992,26405,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25439,26405,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25846,26405,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7362,26406,cholesterol inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25544,26407,adrenergic receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25688,26407,adrenergic receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25802,26407,adrenergic receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25425,26408,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25427,26408,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25428,26408,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
4066,26409,phosphodiesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8060,26409,phosphodiesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25756,26410,opioid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25737,26411,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25738,26411,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
7742,26413,cyclooxygenase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25549,26413,cyclooxygenase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25688,26418,adrenergic receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25476,26419,glycine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25477,26419,glycine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25478,26419,glycine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25479,26419,glycine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
9193,26419,glycine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
5091,26420,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26421,26422,ATPase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13604,26423,mitotic kinesin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25805,26424,dopamine reuptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25842,26424,dopamine reuptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25684,26424,dopamine reuptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
13052,26425,GABA receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
15607,26426,integrin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15018,26426,integrin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6933,26427,imidazoline receptor ligand,MoA,Preclinical,Gene,Chemical_Compound
7546,26427,imidazoline receptor ligand,MoA,Preclinical,Gene,Chemical_Compound
26217,26432,cyclooxygenase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
15412,26432,cyclooxygenase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
9550,26438,PI3K inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25730,26438,PI3K inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25544,26440,adrenergic receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
13866,26445,tripeptidyl peptidase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25430,26446,dopamine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25431,26446,dopamine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25432,26446,dopamine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25433,26446,dopamine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25434,26446,dopamine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25435,26446,dopamine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25438,26446,dopamine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
7504,26448,EGFR inhibitor|SRC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7571,26450,glutathione transferase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25560,26451,carbonic anhydrase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
3470,26453,11-beta hydroxysteroid dehydrogenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4822,26454,tyrosine phosphatase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6834,26454,tyrosine phosphatase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5664,26454,tyrosine phosphatase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25679,26455,lipoxygenase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25679,26456,lipoxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25635,26457,opioid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25757,26457,opioid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25635,26458,opioid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
6933,26459,monoamine oxidase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25438,26460,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
6992,26460,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25439,26460,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
8140,26461,IKK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7430,26461,IKK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7999,26461,IKK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25596,26461,IKK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3637,26461,IKK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5210,26461,IKK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8140,26462,pyruvate dehydrogenase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7430,26462,pyruvate dehydrogenase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7999,26462,pyruvate dehydrogenase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25596,26462,pyruvate dehydrogenase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3637,26462,pyruvate dehydrogenase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5210,26462,pyruvate dehydrogenase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13667,26463,PARP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26464,26465,CC chemokine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7160,26466,protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26478,26479,calcium-activated chloride channel inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25679,26480,HIV integrase inhibitor|lipoxygenase inhibitor|nitric oxide production inhibitor|tumor necrosis factor production inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9956,26480,HIV integrase inhibitor|lipoxygenase inhibitor|nitric oxide production inhibitor|tumor necrosis factor production inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3757,26481,HIV integrase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26495,26496,calcium sensing receptor negative allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
26146,26497,motilin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
11394,26498,calcium/calmodulin dependent protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14689,26498,calcium/calmodulin dependent protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12808,26498,calcium/calmodulin dependent protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6235,26498,calcium/calmodulin dependent protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6103,26501,TRPV activator,MoA,Phase 1,Gene,Chemical_Compound
15859,26502,topoisomerase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
11394,26506,EGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
12820,26506,EGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
13503,26506,EGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
11113,26506,EGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
11929,26507,mineralocorticoid receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
7954,26508,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
6103,26511,TRPV agonist,MoA,Preclinical,Gene,Chemical_Compound
6052,26511,TRPV agonist,MoA,Preclinical,Gene,Chemical_Compound
7763,26513,ribonucleotide reductase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26546,26547,calcium channel blocker,MoA,Phase 3,Gene,Chemical_Compound
5861,26548,angiotensin antagonist,MoA,Phase 1,Gene,Chemical_Compound
3101,26549,WNT signaling inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12953,26550,histamine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
15081,26553,NADPH quinone oxidoreductase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11901,26554,sodium/hydrogen exchanger inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25688,26557,adrenergic receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25431,26558,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
6933,26560,monoamine oxidase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
7546,26560,monoamine oxidase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
2425,26567,GTPase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3841,26568,glucosidase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4602,26568,glucosidase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
2657,26569,cathepsin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4410,26569,cathepsin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26570,26569,cathepsin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25730,26571,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7205,26572,androgen receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
11017,26573,valosin-containing protein inhibitor,MoA,Phase 1,Gene,Chemical_Compound
10038,26574,glutaminase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26309,26575,glutamate receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
25679,26576,lipoxygenase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7553,26577,DNA protein kinase inhibitor|mTOR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7553,26578,mTOR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9010,26579,JNK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7574,26580,apoptosis stimulant,MoA,Preclinical,Gene,Chemical_Compound
12400,26580,apoptosis stimulant,MoA,Preclinical,Gene,Chemical_Compound
12376,26581,G protein signaling inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26582,26581,G protein signaling inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12376,26583,G protein signaling inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12376,26584,G protein signaling inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25455,26585,acetylcholine receptor allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
3101,26586,WNT signaling inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4142,26587,HSP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4024,26587,HSP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13256,26588,Aurora kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8198,26588,Aurora kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25800,26588,Aurora kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13256,26589,Aurora kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8198,26589,Aurora kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25800,26589,Aurora kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25750,26590,nicotinic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
6578,26591,retinoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
6578,26592,retinoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
15211,26593,CDK inhibitor|glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5957,26593,CDK inhibitor|glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7999,26593,CDK inhibitor|glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11612,26594,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25539,26595,glutamate receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
26178,26596,opioid receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25757,26596,opioid receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
5098,26597,KIT inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26062,26597,KIT inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25516,26597,KIT inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26063,26597,KIT inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25596,26597,KIT inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25517,26597,KIT inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7305,26597,KIT inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
12215,26597,KIT inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
8931,26607,RAF inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
5363,26607,RAF inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
11513,26608,JAK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11243,26609,ALK tyrosine kinase receptor inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26251,26613,CCK receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
8250,26614,ACAT inhibitor|cholesterol inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26615,26616,triacylglycerol lipase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7675,26621,microtubule stimulant|tubulin polymerization inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26622,26623,rap guanine nucleotide exchange factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25935,26624,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
7954,26625,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25610,26625,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
9723,26625,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25611,26625,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
7954,26626,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
9723,26626,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25611,26626,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
12859,26627,ATM kinase inhibitor|ATR kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15729,26627,ATM kinase inhibitor|ATR kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9899,26628,MDM inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25544,26629,adrenergic receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25688,26629,adrenergic receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25802,26629,adrenergic receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
13052,26630,GABA receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
25544,26631,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25802,26631,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
12709,26632,mitochondrial Na+/Ca2+ exchanger antagonist|sodium/calcium exchange inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11055,26633,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
4116,26633,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
14073,26633,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
14881,26633,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
12820,26634,EGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12820,26635,EGFR inhibitor|PKC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26636,26635,EGFR inhibitor|PKC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13052,26637,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25444,26637,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
10301,26637,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
2570,26637,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26165,26637,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
13052,26638,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25444,26638,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
10301,26638,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
2570,26638,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26165,26638,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
8198,26639,MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26324,26639,MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3016,26639,MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4794,26639,MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4670,26639,MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15211,26640,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8140,26640,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26641,26642,neuropeptide receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
15211,26643,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13052,26644,GABA receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
7954,26645,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25610,26645,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
9723,26645,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25611,26645,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25482,26646,benzodiazepine receptor agonist|GABA benzodiazepine site receptor partial agonist,MoA,Phase 1,Gene,Chemical_Compound
25524,26646,benzodiazepine receptor agonist|GABA benzodiazepine site receptor partial agonist,MoA,Phase 1,Gene,Chemical_Compound
25525,26646,benzodiazepine receptor agonist|GABA benzodiazepine site receptor partial agonist,MoA,Phase 1,Gene,Chemical_Compound
25484,26646,benzodiazepine receptor agonist|GABA benzodiazepine site receptor partial agonist,MoA,Phase 1,Gene,Chemical_Compound
25526,26646,benzodiazepine receptor agonist|GABA benzodiazepine site receptor partial agonist,MoA,Phase 1,Gene,Chemical_Compound
25527,26646,benzodiazepine receptor agonist|GABA benzodiazepine site receptor partial agonist,MoA,Phase 1,Gene,Chemical_Compound
7954,26647,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25610,26647,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
9723,26647,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25611,26647,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25482,26648,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25529,26648,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25532,26648,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
5125,26649,fibroblast growth factor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25643,26649,fibroblast growth factor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25644,26649,fibroblast growth factor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7236,26650,monocarboxylate transporter inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8427,26653,gamma secretase modulator,MoA,Phase 2,Gene,Chemical_Compound
9956,26654,glutamate inhibitor|macrophage migration inhibiting factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7430,26656,CHK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6912,26657,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7999,26657,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15211,26658,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6912,26658,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7999,26658,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15278,26658,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25630,26660,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25482,26662,GABA receptor modulator,MoA,Withdrawn,Gene,Chemical_Compound
6772,26679,acetylcholinesterase inhibitor,MoA,Launched,Gene,Chemical_Compound
6772,26689,acetylcholine precursor,MoA,Phase 3,Gene,Chemical_Compound
7295,26689,acetylcholine precursor,MoA,Phase 3,Gene,Chemical_Compound
25575,26689,acetylcholine precursor,MoA,Phase 3,Gene,Chemical_Compound
2541,26689,acetylcholine precursor,MoA,Phase 3,Gene,Chemical_Compound
26690,26689,acetylcholine precursor,MoA,Phase 3,Gene,Chemical_Compound
26691,26689,acetylcholine precursor,MoA,Phase 3,Gene,Chemical_Compound
8006,26689,acetylcholine precursor,MoA,Phase 3,Gene,Chemical_Compound
3453,26689,acetylcholine precursor,MoA,Phase 3,Gene,Chemical_Compound
25539,26692,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26693,26694,serine/threonine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2655,26695,breast cancer resistance protein inhibitor,MoA,Phase 1,Gene,Chemical_Compound
3218,26695,breast cancer resistance protein inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25824,26695,breast cancer resistance protein inhibitor,MoA,Phase 1,Gene,Chemical_Compound
3061,26695,breast cancer resistance protein inhibitor,MoA,Phase 1,Gene,Chemical_Compound
12820,26696,EGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7553,26696,EGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5937,26697,aryl hydrocarbon receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7553,26698,PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9550,26698,PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
6722,26698,PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
12010,26698,PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25730,26698,PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
6394,26699,retinoid receptor binder,MoA,Preclinical,Gene,Chemical_Compound
14114,26699,retinoid receptor binder,MoA,Preclinical,Gene,Chemical_Compound
26700,26701,GAT inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7425,26702,ACAT inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7143,26702,ACAT inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7742,26703,fatty acid synthase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
7742,26706,cyclooxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25549,26706,cyclooxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25766,26707,G protein-coupled receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
6871,26708,protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26435,26709,G protein-coupled receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
5632,26710,MAP kinase phosphatase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10054,26711,PPAR receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
26712,26713,dehydropeptidase inhibitor,MoA,Launched,Gene,Chemical_Compound
6480,26715,integrin antagonist,MoA,Phase 3,Gene,Chemical_Compound
13803,26715,integrin antagonist,MoA,Phase 3,Gene,Chemical_Compound
2917,26717,phosphodiesterase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
11220,26717,phosphodiesterase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7016,26717,phosphodiesterase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
12331,26718,phosphodiesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12852,26718,phosphodiesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8982,26720,transient receptor potential channel agonist,MoA,Preclinical,Gene,Chemical_Compound
25544,26721,adrenergic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25688,26721,adrenergic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25802,26721,adrenergic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26195,26727,guanylate cyclase activator,MoA,Phase 2,Gene,Chemical_Compound
26197,26727,guanylate cyclase activator,MoA,Phase 2,Gene,Chemical_Compound
26728,26729,leukotriene receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25438,26730,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26732,26733,P glycoprotein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10521,26734,aldose reductase inhibitor|TRPV agonist,MoA,Preclinical,Gene,Chemical_Compound
26652,26735,CAR antagonist,MoA,Preclinical,Gene,Chemical_Compound
26736,26735,CAR antagonist,MoA,Preclinical,Gene,Chemical_Compound
10054,26735,CAR antagonist,MoA,Preclinical,Gene,Chemical_Compound
5811,26737,metalloproteinase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25942,26737,metalloproteinase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25943,26737,metalloproteinase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
3434,26737,metalloproteinase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
11359,26737,metalloproteinase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26189,26737,metalloproteinase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25486,26737,metalloproteinase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25425,26740,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25428,26740,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25498,26740,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25845,26740,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25480,26740,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
14073,26741,glutamate receptor potentiator,MoA,Preclinical,Gene,Chemical_Compound
14881,26741,glutamate receptor potentiator,MoA,Preclinical,Gene,Chemical_Compound
25457,26742,adrenergic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26309,26744,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26745,26744,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26746,26744,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25864,26744,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26747,26744,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26022,26748,nitric oxide stimulant,MoA,Phase 1,Gene,Chemical_Compound
25438,26749,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25438,26750,serotonin receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25480,26750,serotonin receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25739,26750,serotonin receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25839,26750,serotonin receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
26736,26754,constitutive androstane receptor (CAR) agonist,MoA,Preclinical,Gene,Chemical_Compound
2655,26757,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14584,26757,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4516,26757,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26758,26757,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26759,26757,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25561,26757,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26760,26757,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4459,26757,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13136,26757,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26106,26757,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10925,26757,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12672,26757,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26761,26757,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2945,26757,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14810,26757,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8907,26757,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9956,26757,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11127,26757,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25812,26757,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6012,26757,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26762,26757,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26763,26757,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15699,26757,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11535,26757,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5305,26757,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25739,26764,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
13671,26765,actin related protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10028,26765,actin related protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8913,26765,actin related protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8665,26765,actin related protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14930,26765,actin related protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8672,26765,actin related protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5309,26765,actin related protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11513,26766,NFkB pathway inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7268,26766,NFkB pathway inhibitor,MoA,Phase 1,Gene,Chemical_Compound
14238,26767,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25482,26768,benzodiazepine receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25524,26768,benzodiazepine receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25525,26768,benzodiazepine receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25526,26768,benzodiazepine receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25529,26768,benzodiazepine receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25532,26768,benzodiazepine receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25756,26778,chelating agent,MoA,Withdrawn,Gene,Chemical_Compound
12953,26779,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25497,26779,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25498,26779,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25845,26779,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26004,26789,potassium channel blocker,MoA,Phase 2,Gene,Chemical_Compound
5315,26789,potassium channel blocker,MoA,Phase 2,Gene,Chemical_Compound
6933,26799,monoamine oxidase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25963,26804,potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
25802,26806,adrenergic receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
26807,26806,adrenergic receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
14270,26806,adrenergic receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
26808,26806,adrenergic receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25488,26809,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4362,26809,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25876,26810,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25874,26810,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
15461,26810,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25878,26810,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
12820,26811,EGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25520,26812,Bruton's tyrosine kinase (BTK) inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4116,26813,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25708,26814,sodium channel blocker,MoA,Phase 1,Gene,Chemical_Compound
25710,26814,sodium channel blocker,MoA,Phase 1,Gene,Chemical_Compound
15834,26847,adenylyl cyclase activator,MoA,Phase 2,Gene,Chemical_Compound
11922,26847,adenylyl cyclase activator,MoA,Phase 2,Gene,Chemical_Compound
6821,26848,beta-secretase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7553,26849,DNA dependent protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7366,26849,DNA dependent protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25762,26853,cannabinoid receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
7246,26854,PKC inhibitor|protein tyrosine kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4822,26854,PKC inhibitor|protein tyrosine kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7246,26855,mineralocorticoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
14989,26855,mineralocorticoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
11929,26855,mineralocorticoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
7205,26858,androgen receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
13147,26859,MAPK-interacting kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13147,26860,MAPK-interacting kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12125,26863,glycogen phosphorylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26002,26864,potassium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
25918,26865,corticotropin releasing factor receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25942,26866,matrix metalloprotease inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25943,26866,matrix metalloprotease inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3434,26866,matrix metalloprotease inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11359,26866,matrix metalloprotease inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25486,26866,matrix metalloprotease inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25892,26867,cholesteryl ester transfer protein inhibitor,MoA,Phase 1,Gene,Chemical_Compound
12529,26868,acetyl-CoA carboxylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9676,26868,acetyl-CoA carboxylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25517,26869,PDGFR tyrosine kinase receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7305,26869,PDGFR tyrosine kinase receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12215,26869,PDGFR tyrosine kinase receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13503,26870,EGFR inhibitor|protein tyrosine kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
8250,26871,PPAR receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
12125,26872,glycogen phosphorylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25435,26873,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25436,26874,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25760,26875,cannabinoid receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
12386,26876,tachykinin antagonist,MoA,Phase 2,Gene,Chemical_Compound
26877,26878,carboxypeptidase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26879,26878,carboxypeptidase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26880,26881,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
15441,26882,bromodomain inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25882,26883,tumor necrosis factor release inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11013,26884,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15441,26885,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11013,26886,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13737,26887,pyruvate dehydrogenase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25536,26888,glutamate receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
11055,26888,glutamate receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
4116,26888,glutamate receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
14073,26888,glutamate receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
14881,26888,glutamate receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
9956,26889,macrophage migration inhibiting factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5098,26894,PDGFR tyrosine kinase receptor inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25516,26894,PDGFR tyrosine kinase receptor inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25517,26894,PDGFR tyrosine kinase receptor inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7305,26894,PDGFR tyrosine kinase receptor inhibitor,MoA,Phase 3,Gene,Chemical_Compound
12215,26894,PDGFR tyrosine kinase receptor inhibitor,MoA,Phase 3,Gene,Chemical_Compound
12596,26898,MTH1 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8464,26902,acetylcholinesterase inhibitor|STAT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9558,26903,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25842,26904,dopamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25613,26905,fructose biphosphate inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12390,26906,integrin antagonist,MoA,Phase 2,Gene,Chemical_Compound
25539,26907,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25942,26908,metalloproteinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25943,26908,metalloproteinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
3434,26908,metalloproteinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11359,26908,metalloproteinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25486,26908,metalloproteinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6821,26909,beta-secretase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8772,26910,toll-like receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26911,26912,toll-like receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26913,26912,toll-like receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
12820,26914,EGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
13503,26914,EGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8257,26915,apoptosis inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9854,26916,PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5090,26916,PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26067,26917,smoothened receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
26918,26917,smoothened receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
10835,26917,smoothened receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
7538,26919,cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor|NFkB pathway inhibitor,MoA,Launched,Gene,Chemical_Compound
10661,26919,cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor|NFkB pathway inhibitor,MoA,Launched,Gene,Chemical_Compound
7468,26919,cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor|NFkB pathway inhibitor,MoA,Launched,Gene,Chemical_Compound
25559,26919,cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor|NFkB pathway inhibitor,MoA,Launched,Gene,Chemical_Compound
25560,26919,cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor|NFkB pathway inhibitor,MoA,Launched,Gene,Chemical_Compound
25561,26919,cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor|NFkB pathway inhibitor,MoA,Launched,Gene,Chemical_Compound
26565,26919,cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor|NFkB pathway inhibitor,MoA,Launched,Gene,Chemical_Compound
26566,26919,cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor|NFkB pathway inhibitor,MoA,Launched,Gene,Chemical_Compound
25478,26919,cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor|NFkB pathway inhibitor,MoA,Launched,Gene,Chemical_Compound
25692,26919,cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor|NFkB pathway inhibitor,MoA,Launched,Gene,Chemical_Compound
10953,26919,cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor|NFkB pathway inhibitor,MoA,Launched,Gene,Chemical_Compound
9444,26919,cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor|NFkB pathway inhibitor,MoA,Launched,Gene,Chemical_Compound
25943,26919,cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor|NFkB pathway inhibitor,MoA,Launched,Gene,Chemical_Compound
25486,26919,cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor|NFkB pathway inhibitor,MoA,Launched,Gene,Chemical_Compound
25826,26919,cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor|NFkB pathway inhibitor,MoA,Launched,Gene,Chemical_Compound
7742,26919,cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor|NFkB pathway inhibitor,MoA,Launched,Gene,Chemical_Compound
25549,26919,cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor|NFkB pathway inhibitor,MoA,Launched,Gene,Chemical_Compound
25716,26919,cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor|NFkB pathway inhibitor,MoA,Launched,Gene,Chemical_Compound
3018,26920,JAK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
11513,26920,JAK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5688,26920,JAK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
14146,26921,sigma receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25610,26922,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
4128,26923,aldehyde dehydrogenase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5683,26924,PKA activator,MoA,Preclinical,Gene,Chemical_Compound
11449,26925,casein kinase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
6613,26925,casein kinase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
3507,26925,casein kinase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
2739,26925,casein kinase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25544,26929,adrenergic receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25435,26929,adrenergic receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25437,26929,adrenergic receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
9441,26935,protein synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26285,26940,ATPase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13256,26949,Aurora kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8198,26949,Aurora kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25596,26949,Aurora kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26950,26951,sphingosine 1-phosphate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26950,26952,sphingosine 1-phosphate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26953,26954,neuropeptide receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26955,26956,sphingosine 1-phosphate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
6636,26957,sphingosine 1-phosphate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
12229,26958,sphingosine 1-phosphate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
7675,26964,tubulin polymerization inhibitor,MoA,Phase 2,Gene,Chemical_Compound
8887,26969,microtubule inhibitor,MoA,Phase 2,Gene,Chemical_Compound
3018,26970,JAK inhibitor,MoA,Phase 3,Gene,Chemical_Compound
11513,26970,JAK inhibitor,MoA,Phase 3,Gene,Chemical_Compound
5688,26970,JAK inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25429,26971,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
4117,26972,leucine rich repeat kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25730,26973,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14361,26978,toll-like receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9444,26979,histone acetyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26981,26982,enkephalinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26983,26982,enkephalinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25581,26982,enkephalinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6267,26984,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
25536,26984,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
11055,26984,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
4116,26984,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
14073,26984,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
14881,26984,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
26985,26984,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
8814,26986,TGF beta receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10571,26986,TGF beta receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7177,26986,TGF beta receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7675,26987,microtubule inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9448,26988,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
9483,26994,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9854,26994,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5097,26994,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
11261,26994,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
10915,26994,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
15412,26994,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26219,26994,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
11559,26994,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
3712,26994,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
12820,26995,EGFR inhibitor,MoA,Launched,Gene,Chemical_Compound
13503,26995,EGFR inhibitor,MoA,Launched,Gene,Chemical_Compound
11113,26995,EGFR inhibitor,MoA,Launched,Gene,Chemical_Compound
2746,26997,estrogen receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
26998,26997,estrogen receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25648,26997,estrogen receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
26676,26997,estrogen receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
4128,26999,antioxidant,MoA,Phase 1,Gene,Chemical_Compound
25757,27000,opioid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25892,27002,cholesteryl ester transfer protein inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26797,27026,thromboxane receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
12329,27027,KDM2A inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15154,27027,KDM2A inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11097,27027,KDM2A inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26113,27030,CC chemokine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
13256,27032,Aurora kinase inhibitor|growth factor receptor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
8198,27032,Aurora kinase inhibitor|growth factor receptor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25800,27032,Aurora kinase inhibitor|growth factor receptor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5125,27032,Aurora kinase inhibitor|growth factor receptor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25850,27032,Aurora kinase inhibitor|growth factor receptor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4084,27032,Aurora kinase inhibitor|growth factor receptor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7754,27032,Aurora kinase inhibitor|growth factor receptor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25692,27035,non-nucleoside reverse transcriptase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
3221,27035,non-nucleoside reverse transcriptase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
15193,27037,hypoxia inducible factor inhibitor,MoA,Phase 3,Gene,Chemical_Compound
27039,27040,phospholipase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
10054,27041,PPAR receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
5086,27045,endothelin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25478,27051,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
15803,27053,thromboxane synthase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15803,27054,thromboxane synthase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11931,27055,ATPase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7264,27056,dipeptidyl peptidase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25733,27057,free fatty acid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25517,27058,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7305,27058,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor,MoA,Phase 1,Gene,Chemical_Compound
27059,27060,potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
27061,27060,potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
12919,27060,potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
26756,27062,chloride channel blocker|gap junction modulator|glutamate inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5911,27063,discoidin domain receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12706,27063,discoidin domain receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5688,27066,JAK inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
8965,27068,focal adhesion kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7553,27073,mTOR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
6772,27075,acetylcholinesterase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26371,27079,proteasome inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25727,27079,proteasome inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25692,27079,proteasome inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
26133,27079,proteasome inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
6756,27083,membrane permeability inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6512,27084,HMGCR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5174,27085,phosphodiesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11929,27088,progestogen hormone,MoA,Preclinical,Gene,Chemical_Compound
25457,27089,adrenergic receptor agonist|dopamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25430,27089,adrenergic receptor agonist|dopamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25431,27089,adrenergic receptor agonist|dopamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
12953,27090,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25439,27101,acetylcholine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
14022,27107,mineralocorticoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
11929,27107,mineralocorticoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
6772,27108,acetylcholinesterase inhibitor|monoamine oxidase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25935,27113,membrane integrity inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27114,27113,membrane integrity inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26746,27113,membrane integrity inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25864,27113,membrane integrity inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26747,27113,membrane integrity inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10762,27113,membrane integrity inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5210,27113,membrane integrity inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2589,27113,membrane integrity inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5683,27113,membrane integrity inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25650,27113,membrane integrity inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12125,27113,membrane integrity inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25603,27113,membrane integrity inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27115,27113,membrane integrity inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27116,27113,membrane integrity inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26985,27113,membrane integrity inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13804,27113,membrane integrity inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14233,27113,membrane integrity inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26251,27119,CCK receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25611,27121,calmodulin antagonist,MoA,Phase 2,Gene,Chemical_Compound
25539,27127,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
12298,27128,PPAR receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
25668,27129,melatonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25625,27131,adenosine kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25626,27131,adenosine kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25509,27132,estrogen receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25430,27138,dopamine reuptake inhibitor,MoA,Phase 3,Gene,Chemical_Compound
6933,27138,dopamine reuptake inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7546,27138,dopamine reuptake inhibitor,MoA,Phase 3,Gene,Chemical_Compound
11306,27146,estrogen receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25509,27146,estrogen receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
26998,27146,estrogen receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25648,27146,estrogen receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
10606,27150,ATPase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7742,27153,prostanoid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25549,27153,prostanoid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25430,27154,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25431,27154,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25432,27154,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25433,27154,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25434,27154,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
26880,27158,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25539,27158,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25497,27162,histamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25498,27162,histamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25845,27162,histamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
12953,27166,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25808,27169,angiotensin converting enzyme activator,MoA,Phase 3,Gene,Chemical_Compound
9070,27169,angiotensin converting enzyme activator,MoA,Phase 3,Gene,Chemical_Compound
26499,27169,angiotensin converting enzyme activator,MoA,Phase 3,Gene,Chemical_Compound
15211,27171,CDK inhibitor,MoA,Phase 3,Gene,Chemical_Compound
8140,27171,CDK inhibitor,MoA,Phase 3,Gene,Chemical_Compound
5957,27171,CDK inhibitor,MoA,Phase 3,Gene,Chemical_Compound
11612,27171,CDK inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25742,27173,prostanoid receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
3402,27173,prostanoid receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25744,27173,prostanoid receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25745,27173,prostanoid receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25672,27173,prostanoid receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
26085,27173,prostanoid receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25674,27173,prostanoid receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
9689,27173,prostanoid receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
7233,27173,prostanoid receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25746,27173,prostanoid receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
6210,27173,prostanoid receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
26797,27173,prostanoid receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25789,27174,apoptosis stimulant,MoA,Preclinical,Gene,Chemical_Compound
25826,27180,nitric oxide synthase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26022,27180,nitric oxide synthase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25539,27182,glutamate receptor negative allosteric modulator,MoA,Phase 2,Gene,Chemical_Compound
25435,27183,dopamine reuptake inhibitor|serotonin reuptake inhibitor,MoA,Launched,Gene,Chemical_Compound
25438,27183,dopamine reuptake inhibitor|serotonin reuptake inhibitor,MoA,Launched,Gene,Chemical_Compound
25439,27183,dopamine reuptake inhibitor|serotonin reuptake inhibitor,MoA,Launched,Gene,Chemical_Compound
10661,27192,immunostimulant,MoA,Phase 3,Gene,Chemical_Compound
25560,27192,immunostimulant,MoA,Phase 3,Gene,Chemical_Compound
25561,27192,immunostimulant,MoA,Phase 3,Gene,Chemical_Compound
25536,27193,sigma receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
11055,27193,sigma receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
4116,27193,sigma receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
14146,27193,sigma receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25536,27194,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
11055,27194,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
4116,27194,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
14073,27194,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
14881,27194,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25455,27195,adrenergic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25539,27196,glutamate receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
12032,27197,ALK tyrosine kinase receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25596,27198,VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26602,27199,elastase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25876,27200,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25874,27200,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
8240,27200,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25536,27200,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
11055,27200,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
4116,27200,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25679,27202,lipoxygenase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25733,27204,PPAR receptor agonist,MoA,Launched,Gene,Chemical_Compound
7742,27204,PPAR receptor agonist,MoA,Launched,Gene,Chemical_Compound
25549,27204,PPAR receptor agonist,MoA,Launched,Gene,Chemical_Compound
25615,27208,MRP inhibitor|P glycoprotein inhibitor,MoA,Phase 3,Gene,Chemical_Compound
5315,27209,potassium channel blocker,MoA,Withdrawn,Gene,Chemical_Compound
25839,27209,potassium channel blocker,MoA,Withdrawn,Gene,Chemical_Compound
9725,27209,potassium channel blocker,MoA,Withdrawn,Gene,Chemical_Compound
8281,27209,potassium channel blocker,MoA,Withdrawn,Gene,Chemical_Compound
7675,27211,tubulin polymerization inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25435,27215,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25436,27215,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25437,27215,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25737,27215,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25738,27215,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25438,27215,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25440,27215,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25846,27215,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25792,27217,p38 MAPK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15860,27217,p38 MAPK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6521,27217,p38 MAPK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4362,27217,p38 MAPK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12032,27219,AMPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2718,27219,AMPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7642,27219,AMPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27048,27219,AMPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14084,27219,AMPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26062,27219,AMPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25516,27219,AMPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25596,27219,AMPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26324,27219,AMPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3016,27219,AMPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13837,27219,AMPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26287,27219,AMPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15699,27219,AMPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5098,27222,EGFR inhibitor|FGFR inhibitor|FLT3 inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
12820,27222,EGFR inhibitor|FGFR inhibitor|FLT3 inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
5125,27222,EGFR inhibitor|FGFR inhibitor|FLT3 inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25643,27222,EGFR inhibitor|FGFR inhibitor|FLT3 inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25644,27222,EGFR inhibitor|FGFR inhibitor|FLT3 inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26062,27222,EGFR inhibitor|FGFR inhibitor|FLT3 inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25516,27222,EGFR inhibitor|FGFR inhibitor|FLT3 inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26063,27222,EGFR inhibitor|FGFR inhibitor|FLT3 inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
6131,27222,EGFR inhibitor|FGFR inhibitor|FLT3 inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25596,27222,EGFR inhibitor|FGFR inhibitor|FLT3 inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25517,27222,EGFR inhibitor|FGFR inhibitor|FLT3 inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7305,27222,EGFR inhibitor|FGFR inhibitor|FLT3 inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
12215,27222,EGFR inhibitor|FGFR inhibitor|FLT3 inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7954,27231,adenosine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25610,27231,adenosine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
9723,27231,adenosine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25611,27231,adenosine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25688,27232,sodium channel activator,MoA,Phase 2,Gene,Chemical_Compound
26004,27233,potassium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
25615,27234,histamine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
12953,27234,histamine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
14073,27235,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
14881,27235,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
13667,27236,PARP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5851,27236,PARP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25847,27237,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
8814,27238,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11306,27239,selective estrogen receptor modulator (SERM),MoA,Phase 3,Gene,Chemical_Compound
15412,27247,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11559,27247,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27205,27248,toll-like receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
27249,27250,structural glycoprotein antagonist,MoA,Phase 1,Gene,Chemical_Compound
13803,27250,structural glycoprotein antagonist,MoA,Phase 1,Gene,Chemical_Compound
25549,27252,cyclooxygenase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9550,27254,PI3K inhibitor,MoA,Launched,Gene,Chemical_Compound
6722,27254,PI3K inhibitor,MoA,Launched,Gene,Chemical_Compound
12010,27254,PI3K inhibitor,MoA,Launched,Gene,Chemical_Compound
25730,27254,PI3K inhibitor,MoA,Launched,Gene,Chemical_Compound
10846,27257,dynamin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9664,27257,dynamin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9354,27257,dynamin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10846,27258,dynamin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26998,27260,estrogen-related receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25648,27260,estrogen-related receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
4597,27261,gamma secretase modulator,MoA,Phase 1,Gene,Chemical_Compound
9210,27261,gamma secretase modulator,MoA,Phase 1,Gene,Chemical_Compound
11996,27261,gamma secretase modulator,MoA,Phase 1,Gene,Chemical_Compound
5315,27262,potassium channel blocker,MoA,Phase 1,Gene,Chemical_Compound
25839,27262,potassium channel blocker,MoA,Phase 1,Gene,Chemical_Compound
5789,27263,calpain inhibitor|cysteine protease inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27264,27265,calcium-activated chloride channel inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13667,27266,PARP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2655,27268,aldose reductase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25497,27269,histamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
27270,27271,cyclooxygenase inhibitor|glutathione peroxidase agonist|H+/K+-ATPase inhibitor|nitric oxide synthase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
4142,27272,HSP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4024,27272,HSP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6394,27273,retinoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
14114,27273,retinoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
6578,27273,retinoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
10054,27279,PPAR receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
6340,27283,polycomb protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27284,27285,hemoglobin oxygen release stimulant,MoA,Phase 3,Gene,Chemical_Compound
27187,27285,hemoglobin oxygen release stimulant,MoA,Phase 3,Gene,Chemical_Compound
25610,27286,adrenergic receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
10054,27287,PPAR receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
12820,27291,EGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26309,27292,glutamate receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
26745,27292,glutamate receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
26746,27292,glutamate receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
26747,27292,glutamate receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
12099,27293,neuropilin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
8888,27294,Ras GTPase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27295,27294,Ras GTPase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25425,27296,sodium/hydrogen exchanger inhibitor|transient receptor potential polycystic inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25810,27296,sodium/hydrogen exchanger inhibitor|transient receptor potential polycystic inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25812,27296,sodium/hydrogen exchanger inhibitor|transient receptor potential polycystic inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25826,27297,nitric oxide synthase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26022,27297,nitric oxide synthase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11013,27298,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25615,27299,P glycoprotein inhibitor,MoA,Phase 1,Gene,Chemical_Compound
6690,27300,exportin antagonist,MoA,Phase 1,Gene,Chemical_Compound
14682,27301,antineoplastic agent,MoA,Phase 3,Gene,Chemical_Compound
8250,27302,PPAR receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
12298,27302,PPAR receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
10054,27302,PPAR receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25488,27303,gonadotropin releasing factor hormone receptor antagonist,MoA,Launched,Gene,Chemical_Compound
6039,27304,bone formation stimulant,MoA,Phase 3,Gene,Chemical_Compound
13054,27305,oxidative stress inducer,MoA,Phase 3,Gene,Chemical_Compound
3984,27308,purinergic receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25536,27309,glutamate receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
4116,27309,glutamate receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
10661,27310,glutathione transferase inhibitor|non-nucleoside reverse transcriptase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7468,27310,glutathione transferase inhibitor|non-nucleoside reverse transcriptase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25559,27310,glutathione transferase inhibitor|non-nucleoside reverse transcriptase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25560,27310,glutathione transferase inhibitor|non-nucleoside reverse transcriptase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
10662,27310,glutathione transferase inhibitor|non-nucleoside reverse transcriptase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25561,27310,glutathione transferase inhibitor|non-nucleoside reverse transcriptase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26402,27310,glutathione transferase inhibitor|non-nucleoside reverse transcriptase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
13346,27310,glutathione transferase inhibitor|non-nucleoside reverse transcriptase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26565,27310,glutathione transferase inhibitor|non-nucleoside reverse transcriptase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25562,27310,glutathione transferase inhibitor|non-nucleoside reverse transcriptase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26566,27310,glutathione transferase inhibitor|non-nucleoside reverse transcriptase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11449,27310,glutathione transferase inhibitor|non-nucleoside reverse transcriptase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7999,27310,glutathione transferase inhibitor|non-nucleoside reverse transcriptase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5683,27310,glutathione transferase inhibitor|non-nucleoside reverse transcriptase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7160,27310,glutathione transferase inhibitor|non-nucleoside reverse transcriptase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26636,27310,glutathione transferase inhibitor|non-nucleoside reverse transcriptase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12086,27310,glutathione transferase inhibitor|non-nucleoside reverse transcriptase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26201,27310,glutathione transferase inhibitor|non-nucleoside reverse transcriptase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6368,27311,bradykinin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25482,27312,GABA receptor positive allosteric modulator,MoA,Phase 3,Gene,Chemical_Compound
25524,27312,GABA receptor positive allosteric modulator,MoA,Phase 3,Gene,Chemical_Compound
25525,27312,GABA receptor positive allosteric modulator,MoA,Phase 3,Gene,Chemical_Compound
25484,27312,GABA receptor positive allosteric modulator,MoA,Phase 3,Gene,Chemical_Compound
25526,27312,GABA receptor positive allosteric modulator,MoA,Phase 3,Gene,Chemical_Compound
25527,27312,GABA receptor positive allosteric modulator,MoA,Phase 3,Gene,Chemical_Compound
25529,27312,GABA receptor positive allosteric modulator,MoA,Phase 3,Gene,Chemical_Compound
25532,27312,GABA receptor positive allosteric modulator,MoA,Phase 3,Gene,Chemical_Compound
25435,27313,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25436,27313,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
8257,27316,HCV inhibitor|XIAP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10658,27317,hepatocyte growth factor receptor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25846,27318,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
27319,27320,phosphodiesterase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5861,27321,angiotensin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
9232,27323,protein synthesis inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11449,27324,11-beta hydroxysteroid dehydrogenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4728,27326,caspase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11931,27326,caspase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12849,27326,caspase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25482,27330,GABA receptor modulator,MoA,Phase 3,Gene,Chemical_Compound
7713,27332,PARP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11344,27332,PARP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11306,27333,estrogen receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
2496,27337,dihydropyrimidine dehydrogenase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
11770,27337,dihydropyrimidine dehydrogenase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25716,27337,dihydropyrimidine dehydrogenase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
13256,27338,Aurora kinase inhibitor|FLT3 inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25516,27338,Aurora kinase inhibitor|FLT3 inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25596,27338,Aurora kinase inhibitor|FLT3 inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7305,27338,Aurora kinase inhibitor|FLT3 inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
8965,27338,Aurora kinase inhibitor|FLT3 inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15699,27338,Aurora kinase inhibitor|FLT3 inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7954,27343,phosphodiesterase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25610,27343,phosphodiesterase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
9723,27343,phosphodiesterase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25611,27343,phosphodiesterase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
2917,27343,phosphodiesterase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
11220,27343,phosphodiesterase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
9483,27345,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
9854,27345,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
5097,27345,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
3712,27345,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
11394,27349,PKC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7999,27349,PKC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7160,27349,PKC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26636,27349,PKC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
15338,27349,PKC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
27350,27349,PKC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
15310,27351,endoplasmic reticulum oxidation inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25792,27352,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4362,27352,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27353,27354,"indoleamine 2,3-dioxygenase inhibitor",MoA,Phase 3,Gene,Chemical_Compound
13886,27360,steroid,MoA,Preclinical,Gene,Chemical_Compound
6821,27361,bacterial DNA gyrase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4190,27361,bacterial DNA gyrase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26133,27362,bacterial DNA gyrase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
9444,27362,bacterial DNA gyrase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
4190,27362,bacterial DNA gyrase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
4623,27362,bacterial DNA gyrase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
3377,27362,bacterial DNA gyrase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
3434,27362,bacterial DNA gyrase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
7675,27372,microtubule stabilizing agent|tubulin polymerization inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7675,27373,microtubule stabilizing agent|tubulin polymerization inhibitor,MoA,Phase 2,Gene,Chemical_Compound
27374,27375,trace amine associated receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
11618,27377,amyloid protein inhibitor|antiamyloidogenic agent,MoA,Phase 3,Gene,Chemical_Compound
4795,27380,histone lysine methyltransferase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
4795,27381,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11013,27382,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11013,27383,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6842,27384,protein arginine N-methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10465,27385,protein arginine N-methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3470,27386,estrogen receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
11306,27387,estrogen receptor agonist,MoA,Launched,Gene,Chemical_Compound
25509,27387,estrogen receptor agonist,MoA,Launched,Gene,Chemical_Compound
26201,27388,mediator release inhibitor|SYK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6394,27389,retinoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
5523,27390,ion channel antagonist,MoA,Preclinical,Gene,Chemical_Compound
12820,27391,EGFR inhibitor|tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6039,27392,vitamin D receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
5125,27393,FGFR inhibitor,MoA,Launched,Gene,Chemical_Compound
25643,27393,FGFR inhibitor,MoA,Launched,Gene,Chemical_Compound
25644,27393,FGFR inhibitor,MoA,Launched,Gene,Chemical_Compound
26112,27393,FGFR inhibitor,MoA,Launched,Gene,Chemical_Compound
15404,27397,MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11306,27399,estrogen receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25509,27399,estrogen receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25635,27405,acetylcholinesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25757,27405,acetylcholinesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26622,27406,EPAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14196,27406,EPAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11306,27410,selective estrogen receptor modulator (SERM),MoA,Phase 3,Gene,Chemical_Compound
11306,27413,contraceptive agent,MoA,Preclinical,Gene,Chemical_Compound
15687,27422,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
2917,27422,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4832,27423,beta catenin inhibitor|porcupine inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25431,27432,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25432,27432,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25433,27432,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25432,27436,dopamine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
8128,27444,carnitine palmitoyltransferase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9550,27449,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6722,27449,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12010,27449,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25730,27449,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6394,27451,protein synthesis inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25585,27451,protein synthesis inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
7538,27454,catalase stimulant,MoA,Preclinical,Gene,Chemical_Compound
15961,27454,catalase stimulant,MoA,Preclinical,Gene,Chemical_Compound
25892,27455,cholesteryl ester transfer protein inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25876,27456,glutamate receptor negative allosteric modulator,MoA,Launched,Gene,Chemical_Compound
4822,27456,glutamate receptor negative allosteric modulator,MoA,Launched,Gene,Chemical_Compound
9689,27457,prostaglandin inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25746,27457,prostaglandin inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6103,27459,ATPase inhibitor|TRPV agonist,MoA,Preclinical,Gene,Chemical_Compound
25455,27460,acetylcholine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
3775,27461,TGF beta receptor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
2687,27461,TGF beta receptor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
10228,27462,SIRT inhibitor,MoA,Phase 2,Gene,Chemical_Compound
27463,27464,growth hormone releasing factor agonist,MoA,Phase 2,Gene,Chemical_Compound
25896,27464,growth hormone releasing factor agonist,MoA,Phase 2,Gene,Chemical_Compound
15859,27465,topoisomerase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
4987,27468,cadherin antagonist,MoA,Phase 2,Gene,Chemical_Compound
25966,27469,nootropic agent,MoA,Withdrawn,Gene,Chemical_Compound
11127,27470,phosphodiesterase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7713,27471,WNT signaling inhibitor negative control,MoA,Preclinical,Gene,Chemical_Compound
14540,27472,glutathione transferase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
3200,27475,utrophin enhancer,MoA,Phase 2,Gene,Chemical_Compound
13667,27476,PARP inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9912,27476,PARP inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7713,27476,PARP inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11344,27476,PARP inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25435,27477,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
5845,27479,glucosidase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25438,27482,dopamine receptor antagonist|serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
7761,27483,Ras GTPase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7742,27489,cyclooxygenase inhibitor,MoA,Launched,Gene,Chemical_Compound
25549,27489,cyclooxygenase inhibitor,MoA,Launched,Gene,Chemical_Compound
27246,27493,tryptophan hydroxylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27494,27493,tryptophan hydroxylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27495,27493,tryptophan hydroxylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6992,27496,calcium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
25539,27498,glutamate receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25688,27506,adrenergic receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
6394,27508,apoptosis stimulant|retinoid receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
13503,27510,EGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10661,27511,antioxidant,MoA,Phase 2,Gene,Chemical_Compound
7468,27511,antioxidant,MoA,Phase 2,Gene,Chemical_Compound
25559,27511,antioxidant,MoA,Phase 2,Gene,Chemical_Compound
25560,27511,antioxidant,MoA,Phase 2,Gene,Chemical_Compound
25561,27511,antioxidant,MoA,Phase 2,Gene,Chemical_Compound
26565,27511,antioxidant,MoA,Phase 2,Gene,Chemical_Compound
26566,27511,antioxidant,MoA,Phase 2,Gene,Chemical_Compound
26652,27513,FXR agonist,MoA,Preclinical,Gene,Chemical_Compound
15193,27515,hypoxia inducible factor prolyl hydroxylase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
13877,27515,hypoxia inducible factor prolyl hydroxylase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7815,27515,hypoxia inducible factor prolyl hydroxylase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15193,27516,hypoxia inducible factor prolyl hydroxylase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
13877,27516,hypoxia inducible factor prolyl hydroxylase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7458,27516,hypoxia inducible factor prolyl hydroxylase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
9448,27517,inositol monophosphatase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9448,27518,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
12298,27519,PPAR receptor antagonist|WNT signaling inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10054,27519,PPAR receptor antagonist|WNT signaling inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2655,27520,aldose reductase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
15101,27521,kinesin inhibitor|kinesin-like spindle protein inhibitor,MoA,Phase 3,Gene,Chemical_Compound
3018,27522,JAK inhibitor,MoA,Phase 3,Gene,Chemical_Compound
11513,27522,JAK inhibitor,MoA,Phase 3,Gene,Chemical_Compound
5688,27522,JAK inhibitor,MoA,Phase 3,Gene,Chemical_Compound
10575,27522,JAK inhibitor,MoA,Phase 3,Gene,Chemical_Compound
8006,27527,phospholipase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3453,27527,phospholipase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12390,27528,integrin antagonist,MoA,Phase 2,Gene,Chemical_Compound
3218,27530,Aurora kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4190,27530,Aurora kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25635,27531,opioid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25757,27532,opioid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25549,27533,cyclooxygenase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12976,27534,niacinamide phosphoribosyltransferase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12386,27535,tachykinin antagonist,MoA,Phase 2,Gene,Chemical_Compound
25481,27535,tachykinin antagonist,MoA,Phase 2,Gene,Chemical_Compound
14620,27542,potassium channel agonist,MoA,Phase 3,Gene,Chemical_Compound
12919,27542,potassium channel agonist,MoA,Phase 3,Gene,Chemical_Compound
25849,27542,potassium channel agonist,MoA,Phase 3,Gene,Chemical_Compound
26258,27542,potassium channel agonist,MoA,Phase 3,Gene,Chemical_Compound
5437,27542,potassium channel agonist,MoA,Phase 3,Gene,Chemical_Compound
2702,27553,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
27264,27553,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
7205,27553,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
8056,27553,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26520,27553,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26521,27553,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26522,27553,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26523,27553,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26524,27553,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
9492,27553,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26525,27553,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26526,27553,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26527,27553,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26528,27553,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26529,27553,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26530,27553,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26531,27553,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
5653,27553,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26532,27553,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26533,27553,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26534,27553,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26535,27553,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26536,27553,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26537,27553,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
10537,27553,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26538,27553,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26539,27553,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
25812,27553,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
7742,27553,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
25549,27553,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26676,27553,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
25964,27553,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
27554,27553,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
10671,27555,Bcr-Abl kinase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
12215,27555,Bcr-Abl kinase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25435,27571,serotonin receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25436,27571,serotonin receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
9210,27573,gamma secretase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
6821,27573,gamma secretase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
6940,27573,gamma secretase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
8427,27573,gamma secretase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
15842,27573,gamma secretase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7742,27573,gamma secretase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25549,27573,gamma secretase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26062,27585,VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26063,27585,VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25596,27585,VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
10658,27585,VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26684,27587,alcohol dehydrogenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26504,27587,alcohol dehydrogenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25499,27590,platelet activating factor receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
15834,27591,adenylyl cyclase activator,MoA,Launched,Gene,Chemical_Compound
11922,27591,adenylyl cyclase activator,MoA,Launched,Gene,Chemical_Compound
4221,27591,adenylyl cyclase activator,MoA,Launched,Gene,Chemical_Compound
27593,27594,tubulin polymerization inhibitor|VE-cadherin antagonist,MoA,Phase 3,Gene,Chemical_Compound
5373,27601,WNT5a peptide mimetic,MoA,Phase 2,Gene,Chemical_Compound
15452,27602,calcium channel activator,MoA,Preclinical,Gene,Chemical_Compound
25857,27602,calcium channel activator,MoA,Preclinical,Gene,Chemical_Compound
26139,27603,RAGE receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
5086,27604,endothelin receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
15278,27605,MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5632,27605,MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7091,27606,serine/threonine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7299,27606,serine/threonine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8255,27606,serine/threonine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3857,27606,serine/threonine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26975,27607,elastase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26133,27607,elastase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9947,27615,protein arginine N-methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15803,27616,thromboxane synthase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7177,27618,TGF beta receptor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6772,27619,acetylcholinesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5106,27620,G protein-coupled receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
5106,27621,estrogen receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25482,27635,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25524,27635,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25525,27635,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25484,27635,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25526,27635,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25527,27635,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25532,27635,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25482,27638,benzodiazepine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25524,27638,benzodiazepine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25525,27638,benzodiazepine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25484,27638,benzodiazepine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25526,27638,benzodiazepine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25527,27638,benzodiazepine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25530,27638,benzodiazepine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
27639,27638,benzodiazepine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
27640,27638,benzodiazepine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
27641,27638,benzodiazepine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
7205,27650,androgen receptor modulator,MoA,Phase 3,Gene,Chemical_Compound
25494,27650,androgen receptor modulator,MoA,Phase 3,Gene,Chemical_Compound
10661,27652,beta amyloid protein neurotoxicity inhibitor|PPAR receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
7468,27652,beta amyloid protein neurotoxicity inhibitor|PPAR receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25559,27652,beta amyloid protein neurotoxicity inhibitor|PPAR receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25560,27652,beta amyloid protein neurotoxicity inhibitor|PPAR receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25561,27652,beta amyloid protein neurotoxicity inhibitor|PPAR receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26565,27652,beta amyloid protein neurotoxicity inhibitor|PPAR receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26566,27652,beta amyloid protein neurotoxicity inhibitor|PPAR receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25555,27652,beta amyloid protein neurotoxicity inhibitor|PPAR receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
4988,27654,caspase activator,MoA,Phase 2,Gene,Chemical_Compound
13052,27655,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25444,27655,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25482,27655,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25524,27655,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25525,27655,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25526,27655,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25529,27655,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25532,27655,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26101,27655,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
10301,27655,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
2570,27655,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26165,27655,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26700,27655,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
7742,27656,cyclooxygenase inhibitor|prostanoid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25549,27656,cyclooxygenase inhibitor|prostanoid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25482,27657,GABA receptor modulator,MoA,Phase 3,Gene,Chemical_Compound
25524,27657,GABA receptor modulator,MoA,Phase 3,Gene,Chemical_Compound
25525,27657,GABA receptor modulator,MoA,Phase 3,Gene,Chemical_Compound
25484,27657,GABA receptor modulator,MoA,Phase 3,Gene,Chemical_Compound
25526,27657,GABA receptor modulator,MoA,Phase 3,Gene,Chemical_Compound
25527,27657,GABA receptor modulator,MoA,Phase 3,Gene,Chemical_Compound
4142,27658,HSP inhibitor,MoA,Phase 3,Gene,Chemical_Compound
27659,27660,GLI antagonist,MoA,Preclinical,Gene,Chemical_Compound
27659,27661,GLI antagonist,MoA,Preclinical,Gene,Chemical_Compound
14108,27661,GLI antagonist,MoA,Preclinical,Gene,Chemical_Compound
7644,27663,glutamate receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25536,27663,glutamate receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
11055,27663,glutamate receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
4116,27663,glutamate receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
14073,27663,glutamate receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
14881,27663,glutamate receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25537,27663,glutamate receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25538,27663,glutamate receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
5861,27664,dopamine reuptake inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25842,27664,dopamine reuptake inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25842,27665,dopamine reuptake inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11394,27666,AKT inhibitor,MoA,Phase 3,Gene,Chemical_Compound
3526,27666,AKT inhibitor,MoA,Phase 3,Gene,Chemical_Compound
12280,27666,AKT inhibitor,MoA,Phase 3,Gene,Chemical_Compound
8109,27666,AKT inhibitor,MoA,Phase 3,Gene,Chemical_Compound
4111,27667,XIAP inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26118,27667,XIAP inhibitor,MoA,Phase 1,Gene,Chemical_Compound
27668,27667,XIAP inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8257,27667,XIAP inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9550,27669,Pim kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
11306,27670,selective estrogen receptor destabilizer,MoA,Phase 2,Gene,Chemical_Compound
25520,27671,Bruton's tyrosine kinase (BTK) inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8931,27672,RAF inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9550,27673,PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6722,27673,PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12010,27673,PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25730,27673,PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
27049,27674,mTOR inhibitor|PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
27675,27674,mTOR inhibitor|PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7553,27674,mTOR inhibitor|PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9550,27674,mTOR inhibitor|PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6722,27674,mTOR inhibitor|PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12010,27674,mTOR inhibitor|PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25730,27674,mTOR inhibitor|PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26201,27674,mTOR inhibitor|PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15278,27676,MAP kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5632,27676,MAP kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
4142,27677,HSP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4142,27679,HSP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13350,27681,apoptosis inhibitor|DNA synthesis inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7763,27681,apoptosis inhibitor|DNA synthesis inhibitor,MoA,Phase 1,Gene,Chemical_Compound
14565,27681,apoptosis inhibitor|DNA synthesis inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26277,27684,GLP receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25935,27685,tyrosine kinase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
11306,27685,tyrosine kinase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
25509,27685,tyrosine kinase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
2746,27685,tyrosine kinase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
26998,27685,tyrosine kinase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
25648,27685,tyrosine kinase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
14989,27685,tyrosine kinase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
13590,27685,tyrosine kinase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
10054,27685,tyrosine kinase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
14264,27685,tyrosine kinase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
12902,27685,tyrosine kinase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
26676,27685,tyrosine kinase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
4116,27687,glutamate receptor downregulator,MoA,Phase 3,Gene,Chemical_Compound
7384,27688,glucosylceramidase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15859,27689,topoisomerase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5210,27691,PKC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2589,27691,PKC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15287,27691,PKC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25651,27691,PKC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27692,27693,gamma glutamyltransferase Inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4905,27694,GGTase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25516,27695,FLT3 inhibitor,MoA,Launched,Gene,Chemical_Compound
6267,27697,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7644,27697,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
6267,27698,platelet activating factor receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
2983,27698,platelet activating factor receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
26103,27698,platelet activating factor receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
7644,27698,platelet activating factor receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25480,27698,platelet activating factor receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
26076,27698,platelet activating factor receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25549,27699,NFkB pathway inhibitor|nitric oxide synthase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25839,27700,angiogenesis inhibitor|apoptosis stimulant,MoA,Launched,Gene,Chemical_Compound
9483,27701,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
9854,27701,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
5097,27701,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
11261,27701,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
10915,27701,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
15412,27701,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26219,27701,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
11559,27701,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
3712,27701,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
27702,27703,glucokinase activator,MoA,Preclinical,Gene,Chemical_Compound
27704,27705,NADPH oxidase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5166,27705,NADPH oxidase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15826,27706,transglutaminase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25935,27707,DeltaF508-CFTR Correctors,MoA,Withdrawn,Gene,Chemical_Compound
7205,27712,androgen receptor modulator,MoA,Phase 1,Gene,Chemical_Compound
7205,27713,androgen receptor modulator,MoA,Phase 1,Gene,Chemical_Compound
9154,27717,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
27692,27717,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
6756,27717,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
12399,27717,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
14248,27717,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
27718,27717,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
27719,27717,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
14602,27717,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
4539,27717,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
27720,27717,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
27721,27717,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
3601,27717,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
3681,27717,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
5967,27717,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
4560,27717,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
27722,27717,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
27723,27717,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
27724,27717,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
5920,27717,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
27725,27717,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
11606,27717,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
27726,27717,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
9992,27717,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
6954,27717,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
27727,27717,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
27728,27717,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
4716,27717,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
9632,27717,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
14540,27717,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
27729,27717,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
13233,27717,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
7475,27717,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
27730,27717,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
27731,27717,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
15622,27717,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
8020,27717,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
9508,27717,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
6207,27717,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
25882,27733,tumor necrosis factor release inhibitor,MoA,Phase 3,Gene,Chemical_Compound
14084,27735,immunophilin ligand,MoA,Preclinical,Gene,Chemical_Compound
12976,27736,NAMPT inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
10671,27737,Bcr-Abl kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5733,27737,Bcr-Abl kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10671,27738,Bcr-Abl kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5733,27738,Bcr-Abl kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25850,27739,growth factor receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5987,27739,growth factor receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27347,27739,growth factor receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27702,27740,glucokinase inhibitor|protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3987,27740,glucokinase inhibitor|protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25756,27741,opioid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25757,27741,opioid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7160,27742,protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26636,27742,protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15338,27742,protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27350,27742,protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25651,27742,protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9030,27743,ARF inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25596,27744,VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
10658,27744,VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4988,27747,BCL inhibitor|MCL1 inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26280,27748,G protein-coupled receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
14084,27749,FKBP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12976,27750,NAMPT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25669,27751,G protein-coupled receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
25762,27752,cannabinoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25762,27753,cannabinoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25432,27754,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25739,27755,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25435,27756,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25436,27756,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25437,27756,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25737,27756,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25738,27756,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25438,27756,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
6992,27756,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25439,27756,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25846,27756,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
27249,27757,integrin antagonist,MoA,Preclinical,Gene,Chemical_Compound
13803,27757,integrin antagonist,MoA,Preclinical,Gene,Chemical_Compound
27758,27759,tachykinin antagonist,MoA,Preclinical,Gene,Chemical_Compound
25481,27759,tachykinin antagonist,MoA,Preclinical,Gene,Chemical_Compound
26652,27760,estrogen receptor agonist|FXR antagonist|progesterone receptor agonist,MoA,Launched,Gene,Chemical_Compound
7954,27761,adenosine receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25610,27761,adenosine receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25739,27766,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25437,27767,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
8116,27768,ubiquitin ligase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10881,27768,ubiquitin ligase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13052,27769,GABA receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
7954,27770,adenosine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25610,27770,adenosine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
9723,27770,adenosine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25611,27770,adenosine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
27205,27771,toll-like receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
26201,27772,SYK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6387,27773,histone demethylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27774,27775,histone lysine demethylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6387,27775,histone lysine demethylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9798,27776,histone lysine demethylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6912,27777,glycogen synthase kinase inhibitor|lipoxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7999,27777,glycogen synthase kinase inhibitor|lipoxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12298,27778,PPAR receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25730,27779,PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
13256,27780,Aurora kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8198,27780,Aurora kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25800,27780,Aurora kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26732,27780,Aurora kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25692,27780,Aurora kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
27781,27782,glucose dependent insulinotropic receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25518,27783,urotensin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25435,27784,serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25436,27784,serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25437,27784,serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
11243,27785,insulin growth factor receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11540,27785,insulin growth factor receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6131,27785,insulin growth factor receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26287,27785,insulin growth factor receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11540,27786,IGF-1 inhibitor|insulin growth factor receptor inhibitor|insulin receptor ligand,MoA,Preclinical,Gene,Chemical_Compound
6131,27786,IGF-1 inhibitor|insulin growth factor receptor inhibitor|insulin receptor ligand,MoA,Preclinical,Gene,Chemical_Compound
11394,27787,AKT inhibitor,MoA,Phase 2,Gene,Chemical_Compound
3526,27787,AKT inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12280,27787,AKT inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7553,27788,mTOR inhibitor|PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9550,27788,mTOR inhibitor|PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
6722,27788,mTOR inhibitor|PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
12010,27788,mTOR inhibitor|PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25730,27788,mTOR inhibitor|PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25889,27789,lipoxygenase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6052,27790,transient receptor potential channel antagonist,MoA,Preclinical,Gene,Chemical_Compound
4190,27791,fatty acid synthase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12081,27792,epoxide hydolase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
27793,27794,bile acid transporter inhibitor,MoA,Phase 2,Gene,Chemical_Compound
13256,27795,phosphoinositide dependent kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8198,27795,phosphoinositide dependent kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5210,27795,phosphoinositide dependent kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2917,27796,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4117,27797,leucine rich repeat kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8630,27798,protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27799,27798,protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6722,27800,PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
13539,27801,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9815,27801,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11372,27802,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7604,27802,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11013,27803,histone lysine methyltransferase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
10382,27804,protein phosphatase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9052,27805,lactate dehydrogenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9798,27806,histone lysine demethylase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25669,27807,free fatty acid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
12298,27808,PPAR receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
13539,27809,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14549,27810,PLK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
11013,27811,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4670,27812,serum/glucocorticoid regulated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14344,27812,serum/glucocorticoid regulated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11394,27813,AKT inhibitor,MoA,Phase 1,Gene,Chemical_Compound
3526,27813,AKT inhibitor,MoA,Phase 1,Gene,Chemical_Compound
12280,27813,AKT inhibitor,MoA,Phase 1,Gene,Chemical_Compound
3857,27813,AKT inhibitor,MoA,Phase 1,Gene,Chemical_Compound
2819,27813,AKT inhibitor,MoA,Phase 1,Gene,Chemical_Compound
27814,27813,AKT inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25650,27813,AKT inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8109,27813,AKT inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5745,27813,AKT inhibitor,MoA,Phase 1,Gene,Chemical_Compound
14022,27815,glucocorticoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
8751,27816,centromere associated protein inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5098,27817,FLT3 inhibitor|tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25516,27817,FLT3 inhibitor|tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25517,27817,FLT3 inhibitor|tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12215,27817,FLT3 inhibitor|tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25455,27818,cholinergic receptor agonist,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25826,27824,nitric oxide synthase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26891,27825,creatine kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
27827,27828,oxoeicosanoid receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
26700,27829,GABA uptake inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27830,27829,GABA uptake inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27831,27829,GABA uptake inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27832,27829,GABA uptake inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12298,27833,PPAR receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25733,27834,G protein-coupled receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
10054,27835,PPAR receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
5098,27836,cFMS kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26133,27837,elastase inhibitor|leukocyte elastase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9389,27838,LXR agonist,MoA,Preclinical,Gene,Chemical_Compound
11621,27838,LXR agonist,MoA,Preclinical,Gene,Chemical_Compound
25762,27839,cannabinoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26652,27840,FXR agonist,MoA,Preclinical,Gene,Chemical_Compound
26641,27841,neuropeptide receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25850,27842,growth factor receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8250,27843,PPAR receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
12298,27843,PPAR receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25850,27844,leucine rich repeat kinase inhibitor|RAF inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
5363,27844,leucine rich repeat kinase inhibitor|RAF inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
26301,27845,calcium channel activator,MoA,Preclinical,Gene,Chemical_Compound
12820,27846,EGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13503,27846,EGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25746,27847,prostanoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
8250,27848,PPAR receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
8250,27849,PPAR receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26324,27850,ALK tyrosine kinase receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4362,27850,ALK tyrosine kinase receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2687,27850,ALK tyrosine kinase receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25839,27851,melanin inhibitor,MoA,Phase 1,Gene,Chemical_Compound
27852,27851,melanin inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25762,27853,cannabinoid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
14549,27854,PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15249,27854,PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25733,27855,free fatty acid receptor agonist|G protein-coupled receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25669,27855,free fatty acid receptor agonist|G protein-coupled receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
13590,27856,PPAR receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
10054,27856,PPAR receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
9880,27856,PPAR receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25876,27857,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25874,27857,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
15461,27857,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25878,27857,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
10671,27858,Bcr-Abl kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5733,27858,Bcr-Abl kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7713,27859,tankyrase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11344,27859,tankyrase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26693,27860,PKA inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12829,27860,PKA inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5683,27860,PKA inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15091,27861,autotaxin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25876,27862,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25876,27863,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
8006,27868,phospholipase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
3453,27868,phospholipase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6933,27874,monoamine oxidase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7546,27874,monoamine oxidase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4988,27875,BCL inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10521,27876,TRPA1 channel blocker,MoA,Phase 1,Gene,Chemical_Compound
6052,27877,transient receptor potential channel antagonist,MoA,Preclinical,Gene,Chemical_Compound
4498,27878,ubiquitin ligase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7505,27878,ubiquitin ligase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5487,27878,ubiquitin ligase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7954,27879,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25610,27879,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
9723,27879,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25611,27879,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
8198,27881,Aurora kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6312,27882,ACAT inhibitor,MoA,Launched,Gene,Chemical_Compound
27883,27882,ACAT inhibitor,MoA,Launched,Gene,Chemical_Compound
8276,27882,ACAT inhibitor,MoA,Launched,Gene,Chemical_Compound
27884,27882,ACAT inhibitor,MoA,Launched,Gene,Chemical_Compound
8198,27885,flavanone glycoside,MoA,Launched,Gene,Chemical_Compound
25662,27885,flavanone glycoside,MoA,Launched,Gene,Chemical_Compound
25575,27887,cholinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25466,27887,cholinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25468,27887,cholinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26967,27887,cholinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
11394,27888,AKT inhibitor|differentiation inducer|NFKB pathway inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25688,27895,adrenergic receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
14196,27897,GTPase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12820,27898,EGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
6842,27899,protein arginine N-methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14549,27900,PLK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25536,27905,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
11055,27905,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
4116,27905,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
14073,27905,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
14881,27905,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25679,27906,AKT inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7742,27906,AKT inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25549,27906,AKT inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7446,27907,protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25845,27908,histamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
6772,27909,acetylcholinesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12829,27925,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5683,27925,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13539,27925,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25719,27927,progesterone receptor agonist,MoA,Launched,Gene,Chemical_Compound
6772,27928,cholinesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6933,27931,monoamine oxidase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7546,27931,monoamine oxidase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7504,27933,aldose reductase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2655,27933,aldose reductase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8369,27934,IKK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25904,27934,IKK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25882,27934,IKK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
10548,27935,PARP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5991,27936,lysophosphatidic acid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
27937,27936,lysophosphatidic acid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
5912,27938,bromodomain inhibitor,MoA,Phase 2,Gene,Chemical_Compound
13913,27938,bromodomain inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15441,27938,bromodomain inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5912,27939,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13913,27939,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15441,27939,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15549,27940,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12665,27941,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9444,27941,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7954,27942,adenosine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25610,27942,adenosine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
9723,27942,adenosine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25611,27942,adenosine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25581,27944,hydroxycarboxylic acid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
7954,27945,phosphodiesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26199,27945,phosphodiesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12852,27945,phosphodiesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7016,27945,phosphodiesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11127,27945,phosphodiesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27185,27945,phosphodiesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4066,27945,phosphodiesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26490,27945,phosphodiesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26491,27945,phosphodiesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25536,27946,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
7362,27947,lipoprotein lipase activator,MoA,Phase 2,Gene,Chemical_Compound
14892,27954,growth hormone secretagogue receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25896,27954,growth hormone secretagogue receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25849,27956,voltage-gated potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
2670,27956,voltage-gated potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
25849,27957,voltage-gated potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
25705,27958,sodium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
25707,27958,sodium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
11127,27959,phosphodiesterase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
11127,27960,PPAR receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
3101,27962,beta-catenin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25688,27963,adrenergic receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25802,27963,adrenergic receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25497,27964,histamine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
26797,27965,thromboxane receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
26732,27966,opioid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25635,27966,opioid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25756,27966,opioid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25757,27966,opioid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25518,27966,opioid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25802,27967,adrenergic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25544,27968,adrenergic receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25688,27968,adrenergic receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
10521,27969,TRPV agonist,MoA,Phase 1,Gene,Chemical_Compound
25901,27969,TRPV agonist,MoA,Phase 1,Gene,Chemical_Compound
27970,27971,mucin production enhancer,MoA,Phase 3,Gene,Chemical_Compound
3101,27975,beta catenin inhibitor|WNT signaling inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15592,27975,beta catenin inhibitor|WNT signaling inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8814,27976,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10571,27976,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9958,27976,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14238,27976,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27977,27978,insulin sensitizer,MoA,Phase 1,Gene,Chemical_Compound
25846,27979,serotonin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
9899,27981,MDM inhibitor,MoA,Phase 3,Gene,Chemical_Compound
8459,27981,MDM inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25425,27982,adrenergic receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25549,27982,adrenergic receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
27353,27984,"indoleamine 2,3-dioxygenase inhibitor",MoA,Preclinical,Gene,Chemical_Compound
25876,27985,glutamate receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
25874,27985,glutamate receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
15461,27985,glutamate receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
25878,27985,glutamate receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
7217,27986,XIAP inhibitor,MoA,Phase 3,Gene,Chemical_Compound
13933,27986,XIAP inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25874,27987,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25876,27988,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
4116,27989,adrenergic receptor antagonist|glutamate receptor antagonist,MoA,Launched,Gene,Chemical_Compound
14146,27991,sigma receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
8369,27993,IKK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8369,27994,IKK inhibitor|SYK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8369,27995,IKK inhibitor|NFkB pathway inhibitor,MoA,Phase 1,Gene,Chemical_Compound
27996,27997,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26187,27997,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25942,27997,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25568,27997,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25943,27997,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
3377,27997,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
3434,27997,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
11359,27997,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26189,27997,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25486,27997,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25498,28001,histamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25845,28001,histamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25425,28004,adrenergic receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25427,28004,adrenergic receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25498,28008,histamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25845,28008,histamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25498,28009,histamine receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25498,28010,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
10658,28011,c-Met inhibitor,MoA,Phase 3,Gene,Chemical_Compound
6408,28012,calcineurin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26340,28013,CC chemokine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25684,28015,selective serotonin reuptake inhibitor (SSRI),MoA,Withdrawn,Gene,Chemical_Compound
6933,28017,norepinephrine transporter inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7546,28017,norepinephrine transporter inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14989,28018,PPAR receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
8250,28018,PPAR receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
12298,28018,PPAR receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
10054,28018,PPAR receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25482,28020,benzodiazepine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
15211,28021,CDK inhibitor|glycogen synthase kinase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
5957,28021,CDK inhibitor|glycogen synthase kinase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
6912,28021,CDK inhibitor|glycogen synthase kinase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
15211,28022,CDK inhibitor|glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8140,28022,CDK inhibitor|glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5957,28022,CDK inhibitor|glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28023,28022,CDK inhibitor|glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7999,28022,CDK inhibitor|glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10661,28024,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7468,28024,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25559,28024,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25560,28024,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26565,28024,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25562,28024,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26566,28024,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5937,28027,"aryl hydrocarbon receptor agonist|indoleamine 2,3-dioxygenase inhibitor",MoA,Phase 2/Phase 3,Gene,Chemical_Compound
28029,28030,cyclooxygenase inhibitor|prostanoid receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
26113,28030,cyclooxygenase inhibitor|prostanoid receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
7742,28030,cyclooxygenase inhibitor|prostanoid receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25549,28030,cyclooxygenase inhibitor|prostanoid receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
27353,28032,"indoleamine 2,3-dioxygenase inhibitor",MoA,Phase 2,Gene,Chemical_Compound
9320,28035,Hec1 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13667,28036,PARP inhibitor,MoA,Phase 3,Gene,Chemical_Compound
13667,28037,neurotrophic agent,MoA,Launched,Gene,Chemical_Compound
10548,28037,neurotrophic agent,MoA,Launched,Gene,Chemical_Compound
26280,28039,FXR agonist,MoA,Phase 1,Gene,Chemical_Compound
6480,28040,integrin antagonist,MoA,Phase 1,Gene,Chemical_Compound
28041,28040,integrin antagonist,MoA,Phase 1,Gene,Chemical_Compound
25498,28043,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25845,28043,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25935,28044,CFTR channel antagonist,MoA,Phase 2,Gene,Chemical_Compound
15193,28045,histone demethylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3933,28045,histone demethylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7729,28045,histone demethylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6387,28045,histone demethylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15193,28046,hypoxia inducible factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12329,28046,hypoxia inducible factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7203,28046,hypoxia inducible factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7091,28047,p21 activated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6772,28048,acetylcholinesterase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
6933,28051,monoamine oxidase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
7546,28051,monoamine oxidase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25435,28052,serotonin receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
6063,28055,endothelin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25560,28056,steroid sulfatase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
8251,28056,steroid sulfatase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25435,28058,adrenergic receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25436,28058,adrenergic receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25692,28059,cytochrome P450 inhibitor,MoA,Phase 3,Gene,Chemical_Compound
9956,28060,macrophage migration inhibiting factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28061,28062,gene expression stimulant,MoA,Phase 2,Gene,Chemical_Compound
28063,28062,gene expression stimulant,MoA,Phase 2,Gene,Chemical_Compound
25482,28069,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25524,28069,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25525,28069,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25484,28069,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25526,28069,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25527,28069,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
27639,28069,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
27640,28069,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
27641,28069,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
13052,28070,guanylate cyclase activator,MoA,Preclinical,Gene,Chemical_Compound
7742,28078,cyclooxygenase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25549,28078,cyclooxygenase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
15101,28080,kinesin inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4881,28082,eukaryotic translation initiation factor inhibitor|PERK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8630,28082,eukaryotic translation initiation factor inhibitor|PERK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10606,28083,ATPase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
28085,28086,neural stem cell inducer,MoA,Preclinical,Gene,Chemical_Compound
3018,28087,JAK inhibitor,MoA,Phase 3,Gene,Chemical_Compound
28088,28089,TGF beta receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5937,28090,aryl hydrocarbon receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
12559,28091,phosphodiesterase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
8332,28093,GEF inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25778,28094,CC chemokine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
8214,28095,ubiquitin C-terminal hydrolase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4832,28103,porcupine inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5688,28105,JAK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25756,28106,opioid receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25842,28107,dopamine reuptake inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28108,28109,histone lysine demethylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8427,28110,gamma secretase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25845,28111,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25593,28112,orexin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25595,28112,orexin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26880,28113,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25769,28114,FAAH inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6103,28115,TRPV antagonist,MoA,Preclinical,Gene,Chemical_Compound
9483,28116,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26217,28116,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26218,28116,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9854,28116,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5097,28116,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11261,28116,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
10915,28116,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15412,28116,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26219,28116,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11559,28116,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
3712,28116,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9899,28116,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26340,28117,CC chemokine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25431,28118,dopamine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
10658,28119,tyrosine kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26309,28120,glutamate receptor positive allosteric modulator,MoA,Phase 2,Gene,Chemical_Compound
2882,28121,hypoxia inducible factor prolyl hydroxylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25769,28122,FAAH inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25453,28123,purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
28124,28125,G protein-coupled receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
13256,28126,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8198,28126,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15211,28126,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8140,28126,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25845,28127,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
15441,28128,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28129,28128,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26178,28130,opioid receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
28131,28132,lysophospholipid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
6636,28132,lysophospholipid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
28133,28134,cytokine production inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25904,28134,cytokine production inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5939,28134,cytokine production inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25882,28134,cytokine production inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25762,28135,cannabinoid receptor inverse agonist,MoA,Phase 1,Gene,Chemical_Compound
7713,28136,tankyrase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11344,28136,tankyrase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14594,28137,monoacylglycerol lipase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6263,28138,WNT pathway inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8180,28138,WNT pathway inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7999,28138,WNT pathway inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7713,28139,tankyrase inhibitor|WNT signaling inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11344,28139,tankyrase inhibitor|WNT signaling inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4362,28140,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14594,28141,monoacylglucerol lipase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25769,28142,FAAH inhibitor|monoacylglycerol lipase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14594,28142,FAAH inhibitor|monoacylglycerol lipase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5174,28143,K-Ras inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10606,28144,ATPase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15101,28145,kinesin-like spindle protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2655,28146,bone resorption inhibitor|estrogen-related receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
28147,28146,bone resorption inhibitor|estrogen-related receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
25679,28146,bone resorption inhibitor|estrogen-related receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
7205,28146,bone resorption inhibitor|estrogen-related receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
3061,28146,bone resorption inhibitor|estrogen-related receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
6756,28146,bone resorption inhibitor|estrogen-related receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
3470,28146,bone resorption inhibitor|estrogen-related receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
28148,28146,bone resorption inhibitor|estrogen-related receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
25876,28149,kainate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
8240,28149,kainate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
11697,28149,kainate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
28150,28149,kainate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
28151,28149,kainate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
28152,28149,kainate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
15859,28153,topoisomerase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
5762,28154,chondrocyte differentiation stimulator,MoA,Preclinical,Gene,Chemical_Compound
12709,28155,sodium/calcium exchange inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28156,28155,sodium/calcium exchange inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26676,28155,sodium/calcium exchange inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7423,28155,sodium/calcium exchange inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15699,28157,SRC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15796,28158,neprilysin inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12529,28159,ACAT inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9676,28159,ACAT inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9815,28160,rho associated kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
8783,28161,CDK inhibitor|glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15211,28161,CDK inhibitor|glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5957,28161,CDK inhibitor|glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7999,28161,CDK inhibitor|glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25555,28168,P selectin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8931,28169,RAF inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25516,28169,RAF inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25517,28169,RAF inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12215,28169,RAF inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3094,28170,CDC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8442,28170,CDC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8241,28170,CDC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28171,28172,hexokinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3126,28173,neural stem cell inducer,MoA,Preclinical,Gene,Chemical_Compound
5991,28174,lysophosphatidic acid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
27937,28174,lysophosphatidic acid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
5098,28175,c-Fms inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25596,28175,c-Fms inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25517,28175,c-Fms inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12215,28175,c-Fms inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25596,28176,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3736,28177,mannosidase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9845,28177,mannosidase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25819,28178,lipoprotein antagonist,MoA,Preclinical,Gene,Chemical_Compound
6051,28179,proteasome inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10858,28179,proteasome inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14594,28180,monoacylglucerol lipase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11394,28181,calcium/calmodulin dependent protein kinase inhibitor|purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
14689,28181,calcium/calmodulin dependent protein kinase inhibitor|purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7430,28181,calcium/calmodulin dependent protein kinase inhibitor|purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26324,28181,calcium/calmodulin dependent protein kinase inhibitor|purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
15278,28181,calcium/calmodulin dependent protein kinase inhibitor|purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25792,28181,calcium/calmodulin dependent protein kinase inhibitor|purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
15860,28181,calcium/calmodulin dependent protein kinase inhibitor|purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
4362,28181,calcium/calmodulin dependent protein kinase inhibitor|purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
9010,28181,calcium/calmodulin dependent protein kinase inhibitor|purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25453,28181,calcium/calmodulin dependent protein kinase inhibitor|purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7160,28181,calcium/calmodulin dependent protein kinase inhibitor|purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
13539,28181,calcium/calmodulin dependent protein kinase inhibitor|purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
8467,28181,calcium/calmodulin dependent protein kinase inhibitor|purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
4670,28181,calcium/calmodulin dependent protein kinase inhibitor|purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
14689,28182,calcium/calmodulin dependent protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25615,28183,BCRP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9925,28183,BCRP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6690,28184,exportin antagonist,MoA,Preclinical,Gene,Chemical_Compound
6690,28185,exportin antagonist,MoA,Preclinical,Gene,Chemical_Compound
11243,28186,ALK inihibitor,MoA,Preclinical,Gene,Chemical_Compound
26062,28187,VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26063,28187,VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25596,28187,VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26947,28188,BCRP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7553,28189,mTOR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12859,28190,ATM kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7366,28190,ATM kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12859,28191,ATM kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28192,28193,ribosyl cyclase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10671,28194,Abl kinase inhibitor|Aurora kinase inhibitor|FLT3 inhibitor,MoA,Phase 1,Gene,Chemical_Compound
13256,28194,Abl kinase inhibitor|Aurora kinase inhibitor|FLT3 inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8198,28194,Abl kinase inhibitor|Aurora kinase inhibitor|FLT3 inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25516,28194,Abl kinase inhibitor|Aurora kinase inhibitor|FLT3 inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7954,28195,adenosine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25610,28195,adenosine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
9723,28195,adenosine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25611,28195,adenosine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
15699,28196,SRC inhibitor|tubulin polymerization inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26435,28197,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25536,28197,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
11055,28197,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
4116,28197,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
8381,28198,WNT pathway inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11705,28199,bone morphogenic protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6423,28200,sphingosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10793,28211,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
28212,28211,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
13038,28211,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
28213,28211,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
11314,28211,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
28214,28211,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
4921,28211,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
28209,28211,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
5996,28211,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
12204,28211,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
12388,28211,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
5307,28211,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
12988,28211,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
13929,28211,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
25536,28211,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
11055,28211,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
4116,28211,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
14073,28211,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
14881,28211,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
25984,28211,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
9837,28211,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
26762,28211,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
3728,28211,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
10033,28211,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
7703,28211,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
26880,28225,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25539,28225,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
5967,28225,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
28226,28225,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
13927,28225,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
14287,28225,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
28229,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
6774,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
2838,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
10239,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
11314,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
7434,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
4811,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28231,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
2502,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
8449,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28232,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
8597,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28233,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
2695,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28234,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28235,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28236,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
9559,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
13524,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
7571,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
15068,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
10038,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28237,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
11343,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
26834,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
13666,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
12483,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
12988,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
13929,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28203,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
4976,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
25876,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
25874,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
15461,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
25878,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
15100,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28238,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
8240,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
11697,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28150,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28151,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28152,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
25536,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
11055,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
4116,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
14073,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
14881,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
25537,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
25538,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
26880,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
26309,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
26745,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
27114,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
26746,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
25864,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
26747,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28239,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
14445,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28240,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28241,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
2867,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28242,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
8985,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
3728,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
26756,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
6507,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28243,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28244,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
15832,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28245,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
25577,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28246,28230,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
26107,28250,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
3441,28250,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
8418,28250,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
28251,28250,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
28206,28250,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
28207,28250,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
27191,28253,dopamine beta hydroxylase inhibitor|eukaryotic translation initiation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9274,28253,dopamine beta hydroxylase inhibitor|eukaryotic translation initiation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26325,28254,nitric oxide synthase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25826,28254,nitric oxide synthase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26022,28255,nitric oxide synthase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
26325,28256,nitric oxide synthase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25826,28256,nitric oxide synthase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26022,28256,nitric oxide synthase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8597,28257,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
10552,28257,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
14888,28257,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
8007,28257,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
7098,28257,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
6564,28257,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
7328,28257,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28258,28257,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
14818,28257,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
7829,28257,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
2562,28257,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
5524,28257,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
3949,28257,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
15545,28257,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28259,28257,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28260,28257,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
26845,28257,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
8600,28257,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28261,28257,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28262,28257,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28263,28257,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28233,28264,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25874,28264,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
8240,28264,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
11697,28264,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26880,28264,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26309,28264,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26745,28264,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25539,28264,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25864,28264,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26747,28264,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26641,28266,neuropeptide receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25746,28267,prostanoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
12298,28268,PPAR receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
28269,28270,glucagon receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26251,28271,CCK receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
26253,28271,CCK receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
27022,28271,CCK receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25474,28272,oxytocin receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
26037,28272,oxytocin receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
26038,28272,oxytocin receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25482,28273,GABA receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
25524,28273,GABA receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
25525,28273,GABA receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
25526,28273,GABA receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
25532,28273,GABA receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
7066,28274,thromboxane receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25536,28275,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
11055,28275,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
4116,28275,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
14073,28275,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
14881,28275,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7370,28276,inositol monophosphatase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25431,28277,sigma receptor agonist|sigma receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
14146,28277,sigma receptor agonist|sigma receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25435,28278,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25436,28278,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25437,28278,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25536,28279,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25536,28280,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
11055,28280,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
4116,28280,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
14073,28280,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
14881,28280,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
12386,28281,tachykinin antagonist,MoA,Preclinical,Gene,Chemical_Compound
25481,28281,tachykinin antagonist,MoA,Preclinical,Gene,Chemical_Compound
12386,28282,tachykinin antagonist,MoA,Preclinical,Gene,Chemical_Compound
25432,28283,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25433,28283,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25705,28283,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25707,28283,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25430,28284,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25431,28284,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25432,28284,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25433,28284,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25435,28284,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25438,28284,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25846,28284,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25847,28284,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25544,28285,adrenergic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25688,28285,adrenergic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25802,28285,adrenergic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
12386,28286,tachykinin antagonist,MoA,Preclinical,Gene,Chemical_Compound
3238,28287,farnesyltransferase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9178,28287,farnesyltransferase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
10119,28287,farnesyltransferase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7233,28288,prostanoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25482,28289,GABA receptor partial agonist,MoA,Preclinical,Gene,Chemical_Compound
25524,28289,GABA receptor partial agonist,MoA,Preclinical,Gene,Chemical_Compound
25525,28289,GABA receptor partial agonist,MoA,Preclinical,Gene,Chemical_Compound
25526,28289,GABA receptor partial agonist,MoA,Preclinical,Gene,Chemical_Compound
28298,28299,immunosuppressant,MoA,Phase 3,Gene,Chemical_Compound
25850,28301,tropomyosin receptor kinase inhibitor,MoA,Launched,Gene,Chemical_Compound
5987,28301,tropomyosin receptor kinase inhibitor,MoA,Launched,Gene,Chemical_Compound
27347,28301,tropomyosin receptor kinase inhibitor,MoA,Launched,Gene,Chemical_Compound
12953,28304,glutamate receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25846,28304,glutamate receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
28305,28306,actin polymerization inhibitor,MoA,Phase 1,Gene,Chemical_Compound
28307,28306,actin polymerization inhibitor,MoA,Phase 1,Gene,Chemical_Compound
3448,28306,actin polymerization inhibitor,MoA,Phase 1,Gene,Chemical_Compound
28308,28309,bacterial permeability inducer,MoA,Phase 3,Gene,Chemical_Compound
28310,28309,bacterial permeability inducer,MoA,Phase 3,Gene,Chemical_Compound
26029,28309,bacterial permeability inducer,MoA,Phase 3,Gene,Chemical_Compound
11320,28309,bacterial permeability inducer,MoA,Phase 3,Gene,Chemical_Compound
27136,28309,bacterial permeability inducer,MoA,Phase 3,Gene,Chemical_Compound
14361,28309,bacterial permeability inducer,MoA,Phase 3,Gene,Chemical_Compound
7546,28311,monoamine oxidase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
4111,28312,XIAP inhibitor,MoA,Phase 2,Gene,Chemical_Compound
8257,28312,XIAP inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6312,28313,diacylglycerol O acyltransferase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
4206,28314,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26361,28314,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9698,28314,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26693,28315,haspin kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10671,28316,bone morphogenic protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12032,28316,bone morphogenic protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4687,28316,bone morphogenic protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15826,28317,tissue transglutaminase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12032,28318,bone morphogenic protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2718,28318,bone morphogenic protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14114,28319,retinoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25593,28321,orexin receptor antagonist,MoA,Launched,Gene,Chemical_Compound
25595,28321,orexin receptor antagonist,MoA,Launched,Gene,Chemical_Compound
25480,28325,serotonin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25516,28328,FLT3 inhibitor|growth factor receptor inhibitor|JAK inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25850,28328,FLT3 inhibitor|growth factor receptor inhibitor|JAK inhibitor,MoA,Phase 3,Gene,Chemical_Compound
14561,28330,nitric oxide production inhibitor|tau aggregation inhibitor,MoA,Phase 3,Gene,Chemical_Compound
12369,28334,acetylcholine receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
27021,28335,potassium channel activator,MoA,Phase 3,Gene,Chemical_Compound
25476,28338,acetylcholine receptor antagonist,MoA,Launched,Gene,Chemical_Compound
12953,28352,histamine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25520,28358,Bruton's tyrosine kinase (BTK) inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4832,28359,porcupine inhibitor,MoA,Phase 2,Gene,Chemical_Compound
10571,28360,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25824,28361,cytochrome P450 inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
28362,28361,cytochrome P450 inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
25546,28363,voltage-gated sodium channel blocker,MoA,Phase 3,Gene,Chemical_Compound
4822,28364,topoisomerase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25679,28365,cyclooxygenase inhibitor|lipoxygenase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25833,28365,cyclooxygenase inhibitor|lipoxygenase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25549,28365,cyclooxygenase inhibitor|lipoxygenase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25882,28368,tumor necrosis factor production inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2635,28370,LIM kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12757,28376,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
5098,28376,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26062,28376,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25516,28376,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26063,28376,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25596,28376,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25517,28376,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
12215,28376,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
4084,28376,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
15208,28376,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
4068,28377,oxidative stress inducer,MoA,Phase 3,Gene,Chemical_Compound
25733,28377,oxidative stress inducer,MoA,Phase 3,Gene,Chemical_Compound
25669,28377,oxidative stress inducer,MoA,Phase 3,Gene,Chemical_Compound
28310,28377,oxidative stress inducer,MoA,Phase 3,Gene,Chemical_Compound
12000,28377,oxidative stress inducer,MoA,Phase 3,Gene,Chemical_Compound
10054,28377,oxidative stress inducer,MoA,Phase 3,Gene,Chemical_Compound
25901,28377,oxidative stress inducer,MoA,Phase 3,Gene,Chemical_Compound
25849,28378,potassium channel blocker,MoA,Phase 3,Gene,Chemical_Compound
2670,28378,potassium channel blocker,MoA,Phase 3,Gene,Chemical_Compound
26258,28378,potassium channel blocker,MoA,Phase 3,Gene,Chemical_Compound
5437,28378,potassium channel blocker,MoA,Phase 3,Gene,Chemical_Compound
11540,28379,IGF-1 inhibitor,MoA,Phase 3,Gene,Chemical_Compound
6131,28379,IGF-1 inhibitor,MoA,Phase 3,Gene,Chemical_Compound
28380,28379,IGF-1 inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26280,28387,FXR antagonist|vitamin D receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26652,28387,FXR antagonist|vitamin D receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26803,28387,FXR antagonist|vitamin D receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
6039,28387,FXR antagonist|vitamin D receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
15101,28388,kinesin-like spindle protein inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26037,28389,vasopressin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
5987,28390,tropomyosin receptor kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15666,28391,survival motor neuron protein modulator,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
11261,28392,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10915,28392,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28393,28394,neurotrophic agent,MoA,Phase 1,Gene,Chemical_Compound
4435,28397,O6-alkylguanine-DNA alkyltransferase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11455,28399,glycinamide ribonucleotide formyltransferase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
3238,28401,farnesyltransferase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7761,28401,farnesyltransferase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
5174,28401,farnesyltransferase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
14659,28401,farnesyltransferase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
27702,28402,glucokinase inhibitor,MoA,Launched,Gene,Chemical_Compound
25529,28406,benzodiazepine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
15687,28406,benzodiazepine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25482,28407,GABA receptor modulator,MoA,Phase 2,Gene,Chemical_Compound
26251,28408,CCK receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
26253,28408,CCK receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
4362,28412,p38 MAPK inhibitor,MoA,Phase 3,Gene,Chemical_Compound
2657,28416,cysteine peptidase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28418,28419,lysophosphatidic acid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
4117,28420,leucine rich repeat kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25539,28421,glutamate receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
28422,28423,leukocyte activator,MoA,Phase 2,Gene,Chemical_Compound
27970,28423,leukocyte activator,MoA,Phase 2,Gene,Chemical_Compound
25610,28424,adenosine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
7809,28426,endonuclease inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15859,28426,endonuclease inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12902,28426,endonuclease inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5125,28427,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26062,28427,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25596,28427,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25517,28427,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7305,28427,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12215,28427,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4084,28427,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25610,28428,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
9723,28428,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25431,28430,dopamine receptor modulator|serotonin receptor antagonist,MoA,Launched,Gene,Chemical_Compound
25438,28430,dopamine receptor modulator|serotonin receptor antagonist,MoA,Launched,Gene,Chemical_Compound
7742,28432,cyclooxygenase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25549,28432,cyclooxygenase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
27977,28433,sodium channel blocker,MoA,Phase 1,Gene,Chemical_Compound
15859,28435,glucosidase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25667,28436,melatonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25668,28436,melatonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7205,28437,LXR agonist,MoA,Phase 1,Gene,Chemical_Compound
9389,28437,LXR agonist,MoA,Phase 1,Gene,Chemical_Compound
11621,28437,LXR agonist,MoA,Phase 1,Gene,Chemical_Compound
26803,28437,LXR agonist,MoA,Phase 1,Gene,Chemical_Compound
14022,28437,LXR agonist,MoA,Phase 1,Gene,Chemical_Compound
27494,28438,tryptophan hydroxylase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7197,28439,LIM kinase inhibitor|rho associated kinase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
13539,28439,LIM kinase inhibitor|rho associated kinase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
9815,28439,LIM kinase inhibitor|rho associated kinase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25760,28440,cannabinoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
7999,28442,glycogen synthase kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
2687,28443,TGF beta receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28088,28443,TGF beta receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26745,28444,glutamate receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25876,28445,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25874,28445,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
15461,28445,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25878,28445,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
8240,28445,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
2687,28446,TGF beta receptor inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
25769,28447,FAAH inhibitor|FAAH reuptake inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4362,28448,p38 MAPK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
28422,28449,leukotriene receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
26253,28450,CCK receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
10974,28451,glycine transporter inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7205,28452,androgen receptor modulator,MoA,Phase 2,Gene,Chemical_Compound
28422,28453,leukotriene receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
27970,28453,leukotriene receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
8467,28454,ribosomal protein inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7430,28455,CHK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7430,28456,CHK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
27702,28457,glucokinase activator,MoA,Phase 2,Gene,Chemical_Compound
6992,28458,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
11513,28459,JAK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5688,28459,JAK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
10658,28460,MET inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6821,28461,beta-secretase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
11612,28462,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5125,28463,FGFR antagonist,MoA,Phase 1,Gene,Chemical_Compound
25643,28463,FGFR antagonist,MoA,Phase 1,Gene,Chemical_Compound
25644,28463,FGFR antagonist,MoA,Phase 1,Gene,Chemical_Compound
26112,28463,FGFR antagonist,MoA,Phase 1,Gene,Chemical_Compound
25596,28463,FGFR antagonist,MoA,Phase 1,Gene,Chemical_Compound
26253,28464,CCK receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
6821,28465,beta-secretase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
11394,28466,DNA dependent protein kinase inhibitor|mTOR inhibitor|phosphodiesterase inhibitor|PI3K inhibitor|PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7430,28466,DNA dependent protein kinase inhibitor|mTOR inhibitor|phosphodiesterase inhibitor|PI3K inhibitor|PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7999,28466,DNA dependent protein kinase inhibitor|mTOR inhibitor|phosphodiesterase inhibitor|PI3K inhibitor|PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26324,28466,DNA dependent protein kinase inhibitor|mTOR inhibitor|phosphodiesterase inhibitor|PI3K inhibitor|PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15278,28466,DNA dependent protein kinase inhibitor|mTOR inhibitor|phosphodiesterase inhibitor|PI3K inhibitor|PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25792,28466,DNA dependent protein kinase inhibitor|mTOR inhibitor|phosphodiesterase inhibitor|PI3K inhibitor|PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15860,28466,DNA dependent protein kinase inhibitor|mTOR inhibitor|phosphodiesterase inhibitor|PI3K inhibitor|PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4362,28466,DNA dependent protein kinase inhibitor|mTOR inhibitor|phosphodiesterase inhibitor|PI3K inhibitor|PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9010,28466,DNA dependent protein kinase inhibitor|mTOR inhibitor|phosphodiesterase inhibitor|PI3K inhibitor|PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7553,28466,DNA dependent protein kinase inhibitor|mTOR inhibitor|phosphodiesterase inhibitor|PI3K inhibitor|PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9550,28466,DNA dependent protein kinase inhibitor|mTOR inhibitor|phosphodiesterase inhibitor|PI3K inhibitor|PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6722,28466,DNA dependent protein kinase inhibitor|mTOR inhibitor|phosphodiesterase inhibitor|PI3K inhibitor|PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12010,28466,DNA dependent protein kinase inhibitor|mTOR inhibitor|phosphodiesterase inhibitor|PI3K inhibitor|PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25730,28466,DNA dependent protein kinase inhibitor|mTOR inhibitor|phosphodiesterase inhibitor|PI3K inhibitor|PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2589,28466,DNA dependent protein kinase inhibitor|mTOR inhibitor|phosphodiesterase inhibitor|PI3K inhibitor|PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14549,28466,DNA dependent protein kinase inhibitor|mTOR inhibitor|phosphodiesterase inhibitor|PI3K inhibitor|PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7160,28466,DNA dependent protein kinase inhibitor|mTOR inhibitor|phosphodiesterase inhibitor|PI3K inhibitor|PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7366,28466,DNA dependent protein kinase inhibitor|mTOR inhibitor|phosphodiesterase inhibitor|PI3K inhibitor|PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13539,28466,DNA dependent protein kinase inhibitor|mTOR inhibitor|phosphodiesterase inhibitor|PI3K inhibitor|PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8467,28466,DNA dependent protein kinase inhibitor|mTOR inhibitor|phosphodiesterase inhibitor|PI3K inhibitor|PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4670,28466,DNA dependent protein kinase inhibitor|mTOR inhibitor|phosphodiesterase inhibitor|PI3K inhibitor|PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26309,28467,glutamate receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
5789,28468,cathepsin inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8931,28469,RAF inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5363,28469,RAF inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7553,28470,mTOR inhibitor|PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5912,28471,casein kinase inhibitor|mTOR inhibitor|PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13913,28471,casein kinase inhibitor|mTOR inhibitor|PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15441,28471,casein kinase inhibitor|mTOR inhibitor|PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25437,28472,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25760,28473,cannabinoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25435,28474,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25436,28474,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25437,28474,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25737,28474,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25738,28474,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25438,28474,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
6992,28474,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25439,28474,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25847,28474,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
2687,28475,p38 MAPK inhibitor|TGF beta receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25436,28476,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25437,28476,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25438,28476,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
6992,28476,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25876,28477,glutamate receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
25874,28477,glutamate receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
15461,28477,glutamate receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
25878,28477,glutamate receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
26880,28478,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25480,28479,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26076,28479,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
27022,28480,ATP-sensitive potassium channel antagonist,MoA,Phase 2,Gene,Chemical_Compound
26067,28481,smoothened receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26918,28481,smoothened receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
10835,28481,smoothened receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
28482,28483,phospholipase activator,MoA,Preclinical,Gene,Chemical_Compound
14152,28483,phospholipase activator,MoA,Preclinical,Gene,Chemical_Compound
11488,28483,phospholipase activator,MoA,Preclinical,Gene,Chemical_Compound
6437,28483,phospholipase activator,MoA,Preclinical,Gene,Chemical_Compound
4515,28483,phospholipase activator,MoA,Preclinical,Gene,Chemical_Compound
11559,28484,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25482,28488,PPAR receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
10054,28488,PPAR receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25603,28494,cytomegalovirus inhibitor|protein kinase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25942,28495,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
28496,28495,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
28497,28495,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25568,28495,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25943,28495,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
3377,28495,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
28498,28495,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
5977,28495,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
15309,28495,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
3352,28495,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
3434,28495,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
28499,28495,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
13421,28495,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
28500,28495,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
6157,28495,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
27499,28495,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
28501,28495,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
28502,28495,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
13383,28495,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
11359,28495,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
28503,28495,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26189,28495,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25486,28495,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25756,28507,opioid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25539,28508,glutamate receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25929,28510,glucose dependent insulinotropic receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
28515,28516,NOD like receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26178,28517,nociceptin/orphanin FQ receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25435,28518,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25437,28518,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25737,28518,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25438,28518,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
6992,28518,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25439,28518,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25846,28518,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
9854,28519,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28520,28521,NFkB pathway inhibitor,MoA,Phase 1,Gene,Chemical_Compound
10846,28522,dynamin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25438,28523,serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
6992,28523,serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25439,28523,serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25613,28524,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25435,28525,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25435,28526,serotonin receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
5851,28527,PPAR receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
28531,28532,neurotensin receptor antagonist,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
28342,28532,neurotensin receptor antagonist,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
25733,28536,ATP citrase lyase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26340,28542,potassium channel blocker,MoA,Phase 2,Gene,Chemical_Compound
6512,28543,HMGCR inhibitor,MoA,Launched,Gene,Chemical_Compound
8464,28544,STAT inhibitor,MoA,Phase 3,Gene,Chemical_Compound
15556,28545,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7815,28554,hypoxia inducible factor inhibitor,MoA,Phase 1,Gene,Chemical_Compound
15068,28561,vitamin K,MoA,Phase 2,Gene,Chemical_Compound
3433,28561,vitamin K,MoA,Phase 2,Gene,Chemical_Compound
2633,28561,vitamin K,MoA,Phase 2,Gene,Chemical_Compound
10398,28563,MALT1 inhibitor (JH),MoA,Phase 2,Gene,Chemical_Compound
12902,28570,topoisomerase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9483,28572,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9854,28572,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13065,28573,inosine monophosphate dehydrogenase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25438,28578,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
6992,28578,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25439,28578,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25480,28578,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
26076,28578,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25846,28578,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25847,28578,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
7742,28580,cyclooxygenase inhibitor|opioid receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
10671,28583,Bcr-Abl kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5733,28583,Bcr-Abl kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25457,28584,adrenergic receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25635,28585,immunostimulant,MoA,Phase 2,Gene,Chemical_Compound
6772,28589,acetylcholinesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12953,28591,histamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
7504,28596,angiotensin converting enzyme inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7809,28602,DNA repair enzyme inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25476,28610,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25455,28614,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25435,28621,anti-HCVE2,MoA,Preclinical,Gene,Chemical_Compound
25436,28621,anti-HCVE2,MoA,Preclinical,Gene,Chemical_Compound
25437,28621,anti-HCVE2,MoA,Preclinical,Gene,Chemical_Compound
25737,28621,anti-HCVE2,MoA,Preclinical,Gene,Chemical_Compound
25738,28621,anti-HCVE2,MoA,Preclinical,Gene,Chemical_Compound
25438,28621,anti-HCVE2,MoA,Preclinical,Gene,Chemical_Compound
6992,28621,anti-HCVE2,MoA,Preclinical,Gene,Chemical_Compound
25439,28621,anti-HCVE2,MoA,Preclinical,Gene,Chemical_Compound
25440,28621,anti-HCVE2,MoA,Preclinical,Gene,Chemical_Compound
25846,28621,anti-HCVE2,MoA,Preclinical,Gene,Chemical_Compound
25847,28621,anti-HCVE2,MoA,Preclinical,Gene,Chemical_Compound
7742,28627,cyclooxygenase inhibitor,MoA,Launched,Gene,Chemical_Compound
25549,28627,cyclooxygenase inhibitor,MoA,Launched,Gene,Chemical_Compound
6772,28628,acetylcholinesterase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
6512,28631,HMGCR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5851,28633,PARP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25824,28634,estrogen receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25716,28634,estrogen receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
8883,28635,proteasome inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25455,28636,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
4206,28637,VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10658,28637,VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12373,28638,PI4K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25876,28640,glutamate receptor modulator,MoA,Phase 2,Gene,Chemical_Compound
27264,28641,T-type calcium channel blocker,MoA,Withdrawn,Gene,Chemical_Compound
15452,28641,T-type calcium channel blocker,MoA,Withdrawn,Gene,Chemical_Compound
25855,28641,T-type calcium channel blocker,MoA,Withdrawn,Gene,Chemical_Compound
25856,28641,T-type calcium channel blocker,MoA,Withdrawn,Gene,Chemical_Compound
25501,28641,T-type calcium channel blocker,MoA,Withdrawn,Gene,Chemical_Compound
25503,28641,T-type calcium channel blocker,MoA,Withdrawn,Gene,Chemical_Compound
25504,28641,T-type calcium channel blocker,MoA,Withdrawn,Gene,Chemical_Compound
25857,28641,T-type calcium channel blocker,MoA,Withdrawn,Gene,Chemical_Compound
12253,28641,T-type calcium channel blocker,MoA,Withdrawn,Gene,Chemical_Compound
12231,28641,T-type calcium channel blocker,MoA,Withdrawn,Gene,Chemical_Compound
15940,28641,T-type calcium channel blocker,MoA,Withdrawn,Gene,Chemical_Compound
8646,28641,T-type calcium channel blocker,MoA,Withdrawn,Gene,Chemical_Compound
25742,28641,T-type calcium channel blocker,MoA,Withdrawn,Gene,Chemical_Compound
3402,28641,T-type calcium channel blocker,MoA,Withdrawn,Gene,Chemical_Compound
25744,28641,T-type calcium channel blocker,MoA,Withdrawn,Gene,Chemical_Compound
25745,28641,T-type calcium channel blocker,MoA,Withdrawn,Gene,Chemical_Compound
11055,28643,glutamate receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
4116,28643,glutamate receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
14073,28643,glutamate receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
14881,28643,glutamate receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
10054,28646,PPAR receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
7546,28649,monoamine oxidase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
4179,28653,DNA replication inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6621,28653,DNA replication inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26108,28653,DNA replication inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25966,28653,DNA replication inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6772,28654,serotonin reuptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25476,28654,serotonin reuptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25430,28654,serotonin reuptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25431,28654,serotonin reuptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25438,28654,serotonin reuptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
6992,28654,serotonin reuptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25439,28654,serotonin reuptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
6933,28654,serotonin reuptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25684,28654,serotonin reuptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
28658,28659,MRE11A exonuclease inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28664,28665,antitumor agent,MoA,Phase 2,Gene,Chemical_Compound
25760,28671,cannabinoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
15788,28672,niacin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25581,28672,niacin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
7205,28673,androgen receptor modulator,MoA,Phase 2,Gene,Chemical_Compound
26340,28674,CC chemokine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
28269,28675,glucagon receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
4943,28676,WEE1 kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11394,28677,AKT inhibitor,MoA,Phase 2,Gene,Chemical_Compound
3526,28677,AKT inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12280,28677,AKT inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6103,28678,TRPV antagonist,MoA,Phase 2,Gene,Chemical_Compound
5125,28679,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25643,28679,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25644,28679,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
26062,28679,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25516,28679,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
26063,28679,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25596,28679,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
26361,28679,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
10658,28679,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
26362,28679,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25850,28679,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
5987,28679,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
12215,28679,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25746,28680,prostaglandin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26293,28681,calcitonin antagonist,MoA,Phase 2,Gene,Chemical_Compound
25595,28682,orexin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
28683,28684,bombesin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
27781,28684,bombesin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
28685,28684,bombesin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
13256,28686,Aurora kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8198,28686,Aurora kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25800,28686,Aurora kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
14267,28687,leukotriene receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
26728,28687,leukotriene receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25593,28688,orexin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25595,28688,orexin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
10658,28689,c-Met inhibitor,MoA,Phase 1,Gene,Chemical_Compound
4093,28690,stearoyl-CoA desaturase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
13256,28691,Aurora kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6467,28692,MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7553,28693,mTOR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9550,28693,mTOR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12010,28693,mTOR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25730,28693,mTOR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9550,28694,PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
13256,28695,Aurora kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25480,28696,serotonin receptor partial agonist,MoA,Preclinical,Gene,Chemical_Compound
26076,28696,serotonin receptor partial agonist,MoA,Preclinical,Gene,Chemical_Compound
25739,28696,serotonin receptor partial agonist,MoA,Preclinical,Gene,Chemical_Compound
2425,28697,GTPase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4358,28698,CLK inhibitor|DYRK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12918,28698,CLK inhibitor|DYRK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28699,28700,liver receptor homolog inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
25766,28701,G protein-coupled receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
9683,28702,transient receptor potential channel antagonist,MoA,Preclinical,Gene,Chemical_Compound
26676,28702,transient receptor potential channel antagonist,MoA,Preclinical,Gene,Chemical_Compound
26258,28703,potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
25501,28704,T-type calcium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
25503,28704,T-type calcium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
25504,28704,T-type calcium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
7815,28705,hypoxia inducible factor activator,MoA,Preclinical,Gene,Chemical_Compound
27022,28706,potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
3297,28707,serine/threonine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28708,28709,inward rectifier potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
3453,28710,phospholipase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28531,28711,neurotensin agonist,MoA,Preclinical,Gene,Chemical_Compound
13743,28712,ubiquitin specific protease inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8534,28713,histone lysine demethylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25692,28714,MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25792,28714,MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15860,28714,MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4362,28714,MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12032,28715,ALK tyrosine kinase receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25617,28715,ALK tyrosine kinase receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2718,28715,ALK tyrosine kinase receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14701,28716,lysophospholipase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8285,28717,potassium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
25900,28717,potassium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
8931,28718,RAF inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5363,28718,RAF inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7423,28719,myosin light chain kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6578,28720,retinoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25435,28721,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7713,28722,tankyrase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9483,28723,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26218,28723,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9854,28723,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5097,28723,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6933,28726,monoamine oxidase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7546,28726,monoamine oxidase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
13877,28728,hypoxia inducible factor inhibitor,MoA,Phase 3,Gene,Chemical_Compound
15101,28733,kinesin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25610,28737,cytochrome P450 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25509,28737,cytochrome P450 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4190,28737,cytochrome P450 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13177,28737,cytochrome P450 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28326,28737,cytochrome P450 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5947,28738,other antibiotic,MoA,Launched,Gene,Chemical_Compound
26062,28740,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26063,28740,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25596,28740,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25517,28740,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
28007,28741,toll-like receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
26880,28745,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
27114,28745,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25539,28745,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
28746,28747,mitotic kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28746,28748,monopolar spindle 1 kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28746,28749,monopolar spindle 1 kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15803,28750,thromboxane synthase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25482,28751,GABA receptor inverse agonist,MoA,Phase 1,Gene,Chemical_Compound
25524,28751,GABA receptor inverse agonist,MoA,Phase 1,Gene,Chemical_Compound
25525,28751,GABA receptor inverse agonist,MoA,Phase 1,Gene,Chemical_Compound
25526,28751,GABA receptor inverse agonist,MoA,Phase 1,Gene,Chemical_Compound
7538,28752,gamma secretase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9723,28753,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25611,28753,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25611,28754,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
28755,28756,purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7954,28757,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25610,28757,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
9723,28757,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25611,28757,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25778,28758,CC chemokine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
26309,28759,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26745,28759,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
12820,28760,protein tyrosine kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
13503,28760,protein tyrosine kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25482,28761,benzodiazepine receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25524,28761,benzodiazepine receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25525,28761,benzodiazepine receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25484,28761,benzodiazepine receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25526,28761,benzodiazepine receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25527,28761,benzodiazepine receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
27639,28761,benzodiazepine receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
27640,28761,benzodiazepine receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
27641,28761,benzodiazepine receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
11127,28762,phosphodiesterase inhibitor|platelet aggregation inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25730,28765,androgen receptor agonist|cytochrome P450 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26325,28766,PKC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7160,28766,PKC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25901,28767,transient receptor potential channel antagonist,MoA,Preclinical,Gene,Chemical_Compound
25845,28770,histamine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
4498,28771,ubiquitin ligase transport promoter,MoA,Preclinical,Gene,Chemical_Compound
15165,28773,free radical scavenger,MoA,Launched,Gene,Chemical_Compound
3897,28773,free radical scavenger,MoA,Launched,Gene,Chemical_Compound
4128,28773,free radical scavenger,MoA,Launched,Gene,Chemical_Compound
8067,28773,free radical scavenger,MoA,Launched,Gene,Chemical_Compound
3849,28773,free radical scavenger,MoA,Launched,Gene,Chemical_Compound
3224,28773,free radical scavenger,MoA,Launched,Gene,Chemical_Compound
15060,28773,free radical scavenger,MoA,Launched,Gene,Chemical_Compound
6512,28773,free radical scavenger,MoA,Launched,Gene,Chemical_Compound
3470,28773,free radical scavenger,MoA,Launched,Gene,Chemical_Compound
5416,28773,free radical scavenger,MoA,Launched,Gene,Chemical_Compound
11579,28773,free radical scavenger,MoA,Launched,Gene,Chemical_Compound
25542,28773,free radical scavenger,MoA,Launched,Gene,Chemical_Compound
25624,28773,free radical scavenger,MoA,Launched,Gene,Chemical_Compound
6856,28773,free radical scavenger,MoA,Launched,Gene,Chemical_Compound
25964,28773,free radical scavenger,MoA,Launched,Gene,Chemical_Compound
25431,28776,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25432,28776,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25435,28776,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25756,28785,opioid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25757,28785,opioid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25635,28787,opioid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25756,28787,opioid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25757,28787,opioid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25635,28788,opioid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25756,28788,opioid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25757,28788,opioid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25457,28789,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
13904,28789,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25459,28789,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25435,28789,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25738,28789,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
8464,28790,STAT inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25824,28794,aromatase inhibitor|TRPV antagonist,MoA,Phase 1,Gene,Chemical_Compound
3061,28794,aromatase inhibitor|TRPV antagonist,MoA,Phase 1,Gene,Chemical_Compound
25509,28794,aromatase inhibitor|TRPV antagonist,MoA,Phase 1,Gene,Chemical_Compound
6756,28794,aromatase inhibitor|TRPV antagonist,MoA,Phase 1,Gene,Chemical_Compound
3470,28794,aromatase inhibitor|TRPV antagonist,MoA,Phase 1,Gene,Chemical_Compound
28796,28797,cytochrome P450 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25436,28798,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26253,28799,CCK receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25710,28801,voltage-gated sodium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
28029,28802,CC chemokine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
26113,28802,CC chemokine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
4988,28803,BCL inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15946,28803,BCL inhibitor,MoA,Phase 2,Gene,Chemical_Compound
13433,28803,BCL inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25918,28804,corticotropin releasing factor receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25789,28805,CC chemokine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25876,28806,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25874,28806,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
15461,28806,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25878,28806,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
8240,28806,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25536,28806,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
11055,28806,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
4116,28806,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
13052,28807,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25444,28807,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
13697,28807,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7525,28808,complement antagonist,MoA,Preclinical,Gene,Chemical_Compound
14146,28809,sigma receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25476,28811,acetylcholine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
7954,28812,adenosine receptor agonist,MoA,Launched,Gene,Chemical_Compound
25610,28812,adenosine receptor agonist,MoA,Launched,Gene,Chemical_Compound
9723,28812,adenosine receptor agonist,MoA,Launched,Gene,Chemical_Compound
25611,28812,adenosine receptor agonist,MoA,Launched,Gene,Chemical_Compound
5426,28813,RIPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4687,28814,necroptosis inhibitor|RIPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25457,28817,adrenergic inhibitor|norepinephrine reuptake inhibitor|serotonin receptor antagonist|serotonin reuptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
13904,28817,adrenergic inhibitor|norepinephrine reuptake inhibitor|serotonin receptor antagonist|serotonin reuptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25425,28817,adrenergic inhibitor|norepinephrine reuptake inhibitor|serotonin receptor antagonist|serotonin reuptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25692,28817,adrenergic inhibitor|norepinephrine reuptake inhibitor|serotonin receptor antagonist|serotonin reuptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25435,28817,adrenergic inhibitor|norepinephrine reuptake inhibitor|serotonin receptor antagonist|serotonin reuptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25438,28817,adrenergic inhibitor|norepinephrine reuptake inhibitor|serotonin receptor antagonist|serotonin reuptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25439,28817,adrenergic inhibitor|norepinephrine reuptake inhibitor|serotonin receptor antagonist|serotonin reuptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25805,28817,adrenergic inhibitor|norepinephrine reuptake inhibitor|serotonin receptor antagonist|serotonin reuptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25842,28817,adrenergic inhibitor|norepinephrine reuptake inhibitor|serotonin receptor antagonist|serotonin reuptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25684,28817,adrenergic inhibitor|norepinephrine reuptake inhibitor|serotonin receptor antagonist|serotonin reuptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25476,28818,acetylcholine receptor agonist|benzodiazepine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
15859,28822,topoisomerase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12902,28822,topoisomerase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
27191,28826,dopamine beta hydroxylase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
28830,28831,neural stem cell inducer,MoA,Preclinical,Gene,Chemical_Compound
9786,28831,neural stem cell inducer,MoA,Preclinical,Gene,Chemical_Compound
9483,28833,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15412,28833,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3757,28834,NFkB pathway inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26325,28835,nitric oxide synthase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25826,28835,nitric oxide synthase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26022,28835,nitric oxide synthase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25432,28836,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25433,28837,dopamine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25918,28838,corticotropin releasing factor receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
9052,28839,lactate dehydrogenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14383,28840,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12567,28840,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11138,28840,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7541,28842,monoamine oxidase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
6933,28842,monoamine oxidase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
7546,28842,monoamine oxidase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25760,28850,cannabinoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25544,28852,adrenergic receptor antagonist,MoA,Launched,Gene,Chemical_Compound
25688,28852,adrenergic receptor antagonist,MoA,Launched,Gene,Chemical_Compound
25457,28857,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25805,28866,norepinephrine reuptake inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25842,28866,norepinephrine reuptake inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25684,28866,norepinephrine reuptake inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7541,28867,catechol O methyltransferase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25476,28869,cholinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
11784,28872,nuclear factor erythroid derived|like (NRF2) activator,MoA,Preclinical,Gene,Chemical_Compound
11922,28873,adenylyl cyclase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27353,28874,"indoleamine 2,3-dioxygenase inhibitor",MoA,Phase 1,Gene,Chemical_Compound
25536,28875,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
11055,28875,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
4116,28875,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
14073,28875,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
14881,28875,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25516,28876,PLK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
14549,28876,PLK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26290,28876,PLK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15249,28876,PLK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11017,28877,ATPase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4602,28878,glucosidase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27831,28879,GABA uptake inhibitor|GAT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25742,28880,T-type calcium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
3402,28880,T-type calcium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
25744,28880,T-type calcium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
25745,28880,T-type calcium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26178,28881,opioid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
14146,28882,GABA uptake inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26700,28882,GABA uptake inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25549,28883,cyclooxygenase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
14630,28884,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27730,28885,tubulin polymerization inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14565,28886,thymidylate synthase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25431,28888,dopamine reuptake inhibitor|noradrenaline uptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25805,28888,dopamine reuptake inhibitor|noradrenaline uptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25842,28888,dopamine reuptake inhibitor|noradrenaline uptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25635,28890,opioid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25756,28890,opioid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25757,28890,opioid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
6992,28897,selective serotonin reuptake inhibitor (SSRI),MoA,Phase 1,Gene,Chemical_Compound
10054,28903,ICAM1 antagonist,MoA,Phase 2,Gene,Chemical_Compound
27264,28904,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
10798,28904,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
12348,28904,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
10521,28904,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26495,28905,calcium receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26641,28906,neuropeptide receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
11931,28907,caspase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3018,28908,JAK inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
11513,28908,JAK inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
5688,28908,JAK inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
10575,28908,JAK inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
14620,28909,calcium-activated potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
25839,28910,voltage-gated potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
27018,28910,voltage-gated potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
14620,28910,voltage-gated potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
14620,28911,calcium-activated potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
26301,28912,calcium-activated potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
27059,28912,calcium-activated potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
27061,28912,calcium-activated potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
12919,28912,calcium-activated potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
25839,28913,voltage-gated potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
25466,28914,acetylcholine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26968,28914,acetylcholine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
9995,28915,voltage-gated potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
14620,28916,potassium channel agonist,MoA,Phase 2,Gene,Chemical_Compound
26301,28917,calcium-activated potassium channel modulator,MoA,Preclinical,Gene,Chemical_Compound
27059,28917,calcium-activated potassium channel modulator,MoA,Preclinical,Gene,Chemical_Compound
27061,28917,calcium-activated potassium channel modulator,MoA,Preclinical,Gene,Chemical_Compound
25468,28918,acetylcholine receptor allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
9483,28919,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25942,28920,matrix metalloprotease inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25603,28921,ACAT inhibitor|sterol regulatory element binding protein (SREBP) inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25475,28922,CC chemokine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
8140,28923,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5572,28923,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8725,28924,ubiquitin specific protease inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13743,28924,ubiquitin specific protease inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28925,28924,ubiquitin specific protease inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15555,28924,ubiquitin specific protease inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8534,28926,histone demethylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4541,28926,histone demethylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28927,28928,CDC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2946,28928,CDC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28929,28928,CDC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15323,28930,ubiquitin-conjugating enzyme inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28927,28931,CDC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2946,28931,CDC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25468,28932,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25750,28932,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26641,28933,neuropeptide receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
28342,28934,neurotensin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
10054,28935,PPAR receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
11540,28936,IGF-1 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13667,28937,PARP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9558,28938,cyclin D inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8140,28938,cyclin D inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9558,28939,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8140,28939,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7366,28940,DNA dependent protein kinase inhibitor|mTOR inhibitor|PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7366,28941,DNA dependent protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9899,28942,MDM inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8459,28942,MDM inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11540,28943,insulin growth factor receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11540,28944,IGF-1 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6131,28944,IGF-1 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4142,28945,HSP inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4024,28945,HSP inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15729,28946,mTOR inhibitor|PI3K inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7553,28946,mTOR inhibitor|PI3K inhibitor,MoA,Phase 3,Gene,Chemical_Compound
9550,28946,mTOR inhibitor|PI3K inhibitor,MoA,Phase 3,Gene,Chemical_Compound
12010,28946,mTOR inhibitor|PI3K inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25730,28946,mTOR inhibitor|PI3K inhibitor,MoA,Phase 3,Gene,Chemical_Compound
5125,28947,FGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25643,28947,FGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25644,28947,FGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26112,28947,FGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25596,28947,FGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
6296,28948,ephrin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11513,28949,JAK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10658,28950,MET inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7264,28951,dipeptidyl peptidase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4142,28952,HSP inhibitor,MoA,Phase 1,Gene,Chemical_Compound
4024,28952,HSP inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8965,28953,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11243,28954,ALK tyrosine kinase receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6131,28954,ALK tyrosine kinase receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11344,28955,tankyrase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3877,28956,ceramidase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7091,28957,p21 activated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7954,28958,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25610,28958,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
9723,28958,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25611,28958,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
12067,28958,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
8748,28959,alcohol dehydrogenase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
28961,28962,Oct activator,MoA,Preclinical,Gene,Chemical_Compound
4988,28963,BCL inhibitor,MoA,Phase 3,Gene,Chemical_Compound
8464,28966,STAT inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25482,28967,GABA receptor modulator,MoA,Phase 3,Gene,Chemical_Compound
25524,28967,GABA receptor modulator,MoA,Phase 3,Gene,Chemical_Compound
25525,28967,GABA receptor modulator,MoA,Phase 3,Gene,Chemical_Compound
25526,28967,GABA receptor modulator,MoA,Phase 3,Gene,Chemical_Compound
13924,28968,trace amine associated receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
27374,28968,trace amine associated receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26085,28973,CRTH receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
5790,28974,cathepsin inhibitor,MoA,Phase 3,Gene,Chemical_Compound
14623,28975,guanylyl cyclase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26195,28975,guanylyl cyclase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26197,28975,guanylyl cyclase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14383,28976,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9798,28977,histone lysine demethylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12507,28978,WDR5/MLL interaction inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25929,28981,TRPV agonist,MoA,Preclinical,Gene,Chemical_Compound
25847,28982,cannabinoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
27136,28982,cannabinoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26280,28983,G protein-coupled receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25760,28984,cannabinoid receptor agonist|glucose dependent insulinotropic receptor agonist|potassium channel blocker|PPAR receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25929,28984,cannabinoid receptor agonist|glucose dependent insulinotropic receptor agonist|potassium channel blocker|PPAR receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25766,28984,cannabinoid receptor agonist|glucose dependent insulinotropic receptor agonist|potassium channel blocker|PPAR receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
8250,28984,cannabinoid receptor agonist|glucose dependent insulinotropic receptor agonist|potassium channel blocker|PPAR receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
5106,28985,estrogen receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
28986,28987,ATP synthase inhibitor|ATPase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15211,28991,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8140,28991,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5957,28991,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15278,28991,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14584,28998,nuclear factor erythroid derived|like (NRF2) activator,MoA,Phase 3,Gene,Chemical_Compound
25760,28999,TRPV agonist,MoA,Preclinical,Gene,Chemical_Compound
25929,28999,TRPV agonist,MoA,Preclinical,Gene,Chemical_Compound
6103,28999,TRPV agonist,MoA,Preclinical,Gene,Chemical_Compound
7504,29000,metalloproteinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15796,29000,metalloproteinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25929,29002,FAAH inhibitor,MoA,Preclinical,Gene,Chemical_Compound
29003,29004,cardiac myosin activator,MoA,Phase 3,Gene,Chemical_Compound
7000,29007,AKT inhibitor|MAP kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25746,29009,prostanoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25520,29010,Bruton's tyrosine kinase (BTK) inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26189,29011,matrix metalloprotease inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25674,29012,prostanoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
5572,29013,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7446,29013,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12215,29013,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25474,29014,vasopressin receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
26037,29014,vasopressin receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
26038,29014,vasopressin receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
7541,29015,catechol O methyltransferase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7541,29016,catechol O methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13256,29017,FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
8198,29017,FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
12820,29017,FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
5125,29017,FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25643,29017,FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25596,29017,FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7305,29017,FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
12215,29017,FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
28384,29018,angiotensin converting enzyme inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25438,29019,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
6992,29019,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25439,29019,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
7644,29020,glycine transporter inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26110,29020,glycine transporter inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25760,29021,cannabinoid receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
25425,29022,adrenergic receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
4988,29023,BCL inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26107,29026,NFkB pathway modulator,MoA,Launched,Gene,Chemical_Compound
26178,29028,opioid receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25757,29028,opioid receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25494,29029,androgen biosynthesis inhibitor|androgen receptor antagonist|cytochrome P450 inhibitor,MoA,Phase 3,Gene,Chemical_Compound
9798,29030,histone lysine demethylase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25435,29033,serotonin receptor agonist,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
7553,29034,mTOR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
12820,29035,EGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26062,29036,KIT inhibitor|VEGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25596,29036,KIT inhibitor|VEGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25517,29036,KIT inhibitor|VEGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7205,29039,androgen receptor modulator,MoA,Phase 3,Gene,Chemical_Compound
25474,29040,oxytocin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26038,29040,oxytocin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
13924,29041,coagulation factor inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25476,29042,acetylcholine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25477,29042,acetylcholine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25478,29042,acetylcholine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25479,29042,acetylcholine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
9193,29042,acetylcholine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
12413,29044,maternal embryonic leucine zipper kinase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
5912,29045,bromodomain inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
13913,29045,bromodomain inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
15441,29045,bromodomain inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
13539,29047,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9815,29047,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15441,29051,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8128,29052,carnitine palmitoyltransferase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
29053,29052,carnitine palmitoyltransferase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25476,29055,acetylcholine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25477,29055,acetylcholine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25478,29055,acetylcholine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25479,29055,acetylcholine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25476,29056,cholinergic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25477,29056,cholinergic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25478,29056,cholinergic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25479,29056,cholinergic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25716,29063,xanthine oxidase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
26955,29067,sphingosine 1-phosphate receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
28961,29068,Oct inducer,MoA,Preclinical,Gene,Chemical_Compound
4435,29069,O6-alkylguanine-DNA alkyltransferase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
9880,29070,retinoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
11931,29071,caspase activator,MoA,Phase 1,Gene,Chemical_Compound
8278,29073,phospholipase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25516,29074,FLT3 inhibitor|JAK inhibitor,MoA,Phase 3,Gene,Chemical_Compound
3018,29074,FLT3 inhibitor|JAK inhibitor,MoA,Phase 3,Gene,Chemical_Compound
11513,29074,FLT3 inhibitor|JAK inhibitor,MoA,Phase 3,Gene,Chemical_Compound
5688,29074,FLT3 inhibitor|JAK inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25692,29077,dopamine synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25762,29078,cannabinoid receptor agonist,MoA,Launched,Gene,Chemical_Compound
25929,29078,cannabinoid receptor agonist,MoA,Launched,Gene,Chemical_Compound
25766,29078,cannabinoid receptor agonist,MoA,Launched,Gene,Chemical_Compound
7553,29079,AKT inhibitor|mTOR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25518,29081,urotensin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
6578,29082,retinoid receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25431,29087,dopamine receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
7675,29092,tubulin polymerization inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25431,29093,dopamine receptor agonist|serotonin receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25432,29093,dopamine receptor agonist|serotonin receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25433,29093,dopamine receptor agonist|serotonin receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25435,29093,dopamine receptor agonist|serotonin receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25847,29093,dopamine receptor agonist|serotonin receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
9483,29098,NFkB pathway inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8369,29099,NFkB pathway inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3757,29099,NFkB pathway inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25499,29104,platelet activating factor receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
9483,29105,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
9854,29105,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
5097,29105,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
15412,29105,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25520,29106,Bruton's tyrosine kinase (BTK) inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9483,29107,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26217,29107,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15412,29107,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11559,29107,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11368,29108,potassium channel activator,MoA,Phase 1,Gene,Chemical_Compound
14630,29109,MEK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25479,29110,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25839,29111,potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
26143,29112,angiotensin antagonist,MoA,Phase 1,Gene,Chemical_Compound
25431,29113,dopamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25432,29113,dopamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
12820,29114,EGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25596,29114,EGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5086,29115,endothelin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
6063,29115,endothelin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
12820,29116,EGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27276,29117,neuropeptide receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
5125,29118,FGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12820,29119,SRC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5125,29119,SRC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12215,29119,SRC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14732,29119,SRC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15699,29119,SRC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4943,29119,SRC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25943,29120,collagenase inhibitor|metalloproteinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3434,29120,collagenase inhibitor|metalloproteinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11359,29120,collagenase inhibitor|metalloproteinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25431,29121,dopamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
12820,29122,EGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13503,29122,EGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15699,29122,EGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25431,29123,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25433,29123,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
5125,29124,FGFR inhibitor|VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25643,29124,FGFR inhibitor|VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25644,29124,FGFR inhibitor|VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26112,29124,FGFR inhibitor|VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26062,29124,FGFR inhibitor|VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26063,29124,FGFR inhibitor|VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25596,29124,FGFR inhibitor|VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7305,29124,FGFR inhibitor|VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12215,29124,FGFR inhibitor|VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25662,29125,calcium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
14630,29126,MEK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
13138,29126,MEK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
3942,29126,MEK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
14630,29127,MAP kinase inhibitor|MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15556,29127,MAP kinase inhibitor|MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4943,29128,PKC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7954,29129,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
11394,29130,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7430,29130,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7999,29130,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26324,29130,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14630,29130,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15278,29130,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25792,29130,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15860,29130,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4362,29130,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9010,29130,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7160,29130,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5363,29130,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13539,29130,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8467,29130,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4670,29130,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26484,29131,phosphodiesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25769,29132,FAAH activator,MoA,Preclinical,Gene,Chemical_Compound
29133,29134,programmed death ligand inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25438,29137,serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
12820,29138,EGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
2657,29148,aspartic protease inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6814,29148,aspartic protease inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4410,29148,aspartic protease inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25713,29148,aspartic protease inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9880,29149,retinoid receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25457,29150,dopamine receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
13904,29150,dopamine receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25459,29150,dopamine receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25425,29150,dopamine receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25427,29150,dopamine receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25428,29150,dopamine receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25430,29150,dopamine receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25431,29150,dopamine receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25432,29150,dopamine receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25433,29150,dopamine receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25434,29150,dopamine receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25435,29150,dopamine receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25436,29150,dopamine receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25437,29150,dopamine receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25438,29150,dopamine receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
6992,29150,dopamine receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25439,29150,dopamine receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
11394,29152,AKT inhibitor,MoA,Phase 3,Gene,Chemical_Compound
3238,29153,apoptosis stimulant|farnesyltransferase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7504,29155,angiotensin converting enzyme inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25536,29158,glutamate receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
11055,29158,glutamate receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
4116,29158,glutamate receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
11931,29159,caspase activator,MoA,Preclinical,Gene,Chemical_Compound
6876,29160,nedd activating enzyme inhibitor,MoA,Phase 3,Gene,Chemical_Compound
10062,29160,nedd activating enzyme inhibitor,MoA,Phase 3,Gene,Chemical_Compound
5098,29161,tyrosine kinase inhibitor,MoA,Launched,Gene,Chemical_Compound
25516,29161,tyrosine kinase inhibitor,MoA,Launched,Gene,Chemical_Compound
25517,29161,tyrosine kinase inhibitor,MoA,Launched,Gene,Chemical_Compound
4362,29162,MAP kinase inhibitor|TIE tyrosine kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
15208,29162,MAP kinase inhibitor|TIE tyrosine kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26484,29163,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11127,29164,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
3857,29165,p21 activated kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
13256,29166,Aurora kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8198,29166,Aurora kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
10658,29167,c-Met inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9689,29168,prostaglandin inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26491,29169,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25769,29170,FAAH inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6312,29171,diacylglycerol O acyltransferase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7553,29172,mTOR inhibitor|PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9550,29172,mTOR inhibitor|PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25462,29173,voltage-gated sodium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
27702,29174,glucokinase activator,MoA,Phase 2,Gene,Chemical_Compound
25896,29175,growth hormone secretagogue receptor inverse agonist,MoA,Phase 2,Gene,Chemical_Compound
7553,29176,mTOR inhibitor|PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9550,29176,mTOR inhibitor|PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4117,29177,serine/threonine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25474,29179,oxytocin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
26038,29179,oxytocin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25769,29180,FAAH inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10359,29181,SREBP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8965,29182,focal adhesion kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14264,29182,focal adhesion kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8467,29183,ribosomal protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7430,29184,CHK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8245,29184,CHK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
10571,29185,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9958,29185,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25692,29186,cytochrome P450 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10835,29187,smoothened receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
8965,29188,focal adhesion kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
14264,29188,focal adhesion kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
15211,29189,focal adhesion kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8140,29189,focal adhesion kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5091,29189,focal adhesion kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7999,29189,focal adhesion kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8369,29189,focal adhesion kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10571,29190,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9958,29190,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25769,29191,FAAH inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15091,29192,autotaxin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7246,29193,11-beta hydroxysteroid dehydrogenase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
15441,29194,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2525,29195,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5238,29195,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12567,29196,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4704,29197,phosphofructokinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
4704,29198,phosphofructokinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
13406,29199,JNK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9010,29199,JNK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
3688,29199,JNK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25792,29200,p38 MAPK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4362,29200,p38 MAPK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25455,29201,nicotinic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
10658,29202,c-Met inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13256,29203,Aurora kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8198,29203,Aurora kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25800,29203,Aurora kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15211,29204,CDC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8467,29204,CDC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15211,29205,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8140,29205,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5572,29205,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5957,29205,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5091,29205,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
11612,29205,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8140,29206,CDK inhibitor|growth factor receptor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5572,29206,CDK inhibitor|growth factor receptor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5091,29206,CDK inhibitor|growth factor receptor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25850,29206,CDK inhibitor|growth factor receptor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26880,29207,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
27114,29207,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
7742,29209,cyclooxygenase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
14533,29213,anticancer agent,MoA,Phase 2,Gene,Chemical_Compound
11368,29214,AMPK activator,MoA,Withdrawn,Gene,Chemical_Compound
13837,29214,AMPK activator,MoA,Withdrawn,Gene,Chemical_Compound
28856,29219,indicator dye,MoA,Withdrawn,Gene,Chemical_Compound
6772,29222,acetylcholinesterase inhibitor|beta amyloid synthesis inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7295,29222,acetylcholinesterase inhibitor|beta amyloid synthesis inhibitor,MoA,Phase 3,Gene,Chemical_Compound
6651,29224,cyclooxygenase inhibitor|prostanoid receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
7742,29224,cyclooxygenase inhibitor|prostanoid receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25549,29224,cyclooxygenase inhibitor|prostanoid receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
8459,29228,p53 stabilizing agent,MoA,Preclinical,Gene,Chemical_Compound
29229,29230,sodium/glucose cotransporter inhibitor,MoA,Launched,Gene,Chemical_Compound
7647,29230,sodium/glucose cotransporter inhibitor,MoA,Launched,Gene,Chemical_Compound
26008,29230,sodium/glucose cotransporter inhibitor,MoA,Launched,Gene,Chemical_Compound
25906,29231,sodium/glucose cotransporter inhibitor,MoA,Preclinical,Gene,Chemical_Compound
29232,29231,sodium/glucose cotransporter inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26504,29231,sodium/glucose cotransporter inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7907,29231,sodium/glucose cotransporter inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5937,29233,aryl hydrocarbon receptor ligand,MoA,Phase 1,Gene,Chemical_Compound
25482,29234,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25529,29234,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25532,29234,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
3526,29235,AKT inhibitor|pyruvate dehydrogenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5210,29235,AKT inhibitor|pyruvate dehydrogenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25509,29236,estrogen receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7553,29239,mTOR inhibitor|PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9550,29239,mTOR inhibitor|PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6722,29239,mTOR inhibitor|PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12010,29239,mTOR inhibitor|PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25730,29239,mTOR inhibitor|PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7366,29239,mTOR inhibitor|PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6992,29240,serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25739,29240,serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
27117,29241,H+/K+-ATPase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
28986,29242,SYK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
29243,29242,SYK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
29244,29242,SYK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3860,29242,SYK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2917,29245,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11220,29245,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25442,29245,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7016,29245,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6267,29247,GABA receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
2983,29247,GABA receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
26103,29247,GABA receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
7644,29247,GABA receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
6267,29248,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
2983,29248,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26103,29248,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7644,29248,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25480,29248,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26076,29248,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
8459,29256,TP53 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8459,29257,TP53 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13054,29258,HSP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8459,29258,HSP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9550,29259,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6722,29259,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12010,29259,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25730,29259,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6722,29260,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12010,29260,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25730,29260,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9550,29261,DNA protein kinase inhibitor|PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6722,29261,DNA protein kinase inhibitor|PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12010,29261,DNA protein kinase inhibitor|PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25730,29261,DNA protein kinase inhibitor|PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7366,29261,DNA protein kinase inhibitor|PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12373,29262,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14285,29262,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25730,29262,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2589,29265,Pim kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25435,29272,adrenergic receptor antagonist|serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
3061,29273,cytochrome P450 inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6933,29280,monoamine oxidase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7546,29280,monoamine oxidase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
6103,29280,monoamine oxidase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25438,29285,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25847,29285,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25438,29290,dopamine receptor antagonist|serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
8250,29291,PPAR receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
12331,29294,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25623,29295,purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25498,29297,histamine receptor antagonist,MoA,Launched,Gene,Chemical_Compound
9483,29300,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9854,29300,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5097,29300,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11559,29300,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
10086,29303,PI4K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3508,29304,PARP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13667,29304,PARP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7628,29304,PARP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5851,29304,PARP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25900,29305,potassium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
9448,29306,benzodiazepine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
7264,29307,dipeptidyl peptidase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12820,29308,EGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7553,29309,mTOR inhibitor|PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
4093,29312,stearoyl-CoA desaturase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8931,29313,RAF inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25596,29313,RAF inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5098,29314,receptor tyrosine protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25517,29314,receptor tyrosine protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8931,29315,serine/threonine kinase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
28233,29316,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25455,29317,acetylcholine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25437,29318,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25432,29319,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25438,29320,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
6992,29320,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25439,29320,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
6933,29320,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
7546,29320,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25455,29321,cholinergic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
3101,29322,beta-catenin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15592,29322,beta-catenin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13052,29323,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26156,29325,ICAM1 expression inhibitor,MoA,Phase 2,Gene,Chemical_Compound
8259,29326,immunostimulant,MoA,Preclinical,Gene,Chemical_Compound
11579,29326,immunostimulant,MoA,Preclinical,Gene,Chemical_Compound
25603,29326,immunostimulant,MoA,Preclinical,Gene,Chemical_Compound
26955,29329,sphingosine 1-phosphate receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25468,29332,acetylcholine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25750,29332,acetylcholine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
12820,29333,EGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
13503,29333,EGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11113,29333,EGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26378,29334,SRC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4084,29334,SRC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10671,29335,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12820,29335,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26378,29335,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25596,29335,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7553,29335,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7305,29335,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9550,29335,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6722,29335,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12010,29335,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25730,29335,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7366,29335,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15699,29335,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10671,29336,SRC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26324,29336,SRC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4687,29336,SRC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15699,29336,SRC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11306,29337,estrogen receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
10671,29338,Abl kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5733,29338,Abl kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7553,29339,mTOR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15197,29339,mTOR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11540,29340,IGF-1 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25544,29341,adrenergic receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
15452,29346,calcium channel blocker,MoA,Phase 2,Gene,Chemical_Compound
25760,29351,cyclooxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25762,29351,cyclooxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14146,29354,sigma receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25431,29355,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
14022,29359,glucocorticoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25494,29363,GABA receptor negative allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
7954,29364,adenosine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25610,29364,adenosine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
9723,29364,adenosine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25611,29364,adenosine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
4190,29365,nitric oxide donor,MoA,Launched,Gene,Chemical_Compound
6772,29367,TP53 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25509,29369,estrogen receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
14989,29369,estrogen receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25662,29370,sodium channel blocker,MoA,Phase 3,Gene,Chemical_Compound
26325,29371,nitric oxide synthase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25975,29382,topical anesthetic,MoA,Phase 2,Gene,Chemical_Compound
26251,29385,CCK receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
26253,29385,CCK receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25688,29399,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25802,29399,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25544,29400,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25435,29400,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25440,29400,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26945,29400,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
8497,29405,heme oxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25498,29407,histamine receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
26201,29409,JAK inhibitor|SYK inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
27049,29410,SYK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
27675,29410,SYK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26201,29410,SYK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
29411,29412,polycomb repressive complex inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25438,29414,serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25439,29414,serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
6992,29415,serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
29416,29417,NTPDase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7954,29418,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25610,29418,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25611,29418,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7954,29419,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
9723,29419,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25611,29419,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7954,29420,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25610,29420,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
9723,29420,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25611,29420,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7954,29421,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25610,29421,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
9723,29421,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25611,29421,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25929,29422,glucose dependent insulinotropic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25760,29423,cannabinoid receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
7205,29425,androgen receptor modulator,MoA,Phase 1,Gene,Chemical_Compound
5043,29426,hypoxia inducible factor inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25549,29427,cyclooxygenase inhibitor|PPAR receptor agonist,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
4142,29428,HSP inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25480,29429,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25739,29429,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
10835,29430,smoothened receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25911,29431,protein synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25913,29431,protein synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8519,29431,protein synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3534,29431,protein synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8676,29431,protein synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3469,29431,protein synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14831,29431,protein synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9285,29431,protein synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4016,29431,protein synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9441,29431,protein synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3152,29431,protein synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8971,29431,protein synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9205,29431,protein synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15211,29432,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8140,29432,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5572,29432,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5957,29432,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14020,29432,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26287,29432,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15699,29432,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8140,29433,tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5572,29433,tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5957,29433,tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15278,29433,tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5632,29433,tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10173,29433,tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8868,29434,tissue transglutaminase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25961,29434,tissue transglutaminase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15658,29434,tissue transglutaminase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25760,29435,thioredoxin inhibitor,MoA,Phase 2,Gene,Chemical_Compound
8988,29435,thioredoxin inhibitor,MoA,Phase 2,Gene,Chemical_Compound
13406,29437,JNK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9010,29437,JNK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
29438,29437,JNK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3688,29437,JNK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28746,29437,JNK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15859,29439,topoisomerase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12902,29439,topoisomerase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9483,29444,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7246,29445,NFkB pathway inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3757,29445,NFkB pathway inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15555,29447,ubiquitin specific protease inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15211,29448,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5572,29448,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11612,29448,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15555,29449,ubiquitin specific protease inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12976,29450,NAMPT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12331,29451,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12852,29451,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25679,29454,leukotriene synthesis inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25889,29454,leukotriene synthesis inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25431,29458,dopamine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25432,29458,dopamine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25430,29463,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25431,29463,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25432,29463,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25433,29463,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25435,29463,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25438,29463,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
6992,29463,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25439,29463,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25435,29464,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25437,29464,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25438,29464,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
6992,29464,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25439,29464,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25480,29464,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26076,29464,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25846,29464,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25684,29464,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
5098,29465,FLT3 inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25516,29465,FLT3 inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25517,29465,FLT3 inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7305,29465,FLT3 inhibitor,MoA,Phase 3,Gene,Chemical_Compound
12215,29465,FLT3 inhibitor,MoA,Phase 3,Gene,Chemical_Compound
4084,29465,FLT3 inhibitor,MoA,Phase 3,Gene,Chemical_Compound
4362,29466,sodium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
2687,29466,sodium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
25846,29467,serotonin receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
2687,29468,serine/threonine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4206,29469,AXL kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12115,29470,diacylglycerol kinase inhibitor|protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25438,29471,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
13052,29473,GABA receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
25431,29475,dopamine receptor antagonist,MoA,Launched,Gene,Chemical_Compound
25432,29475,dopamine receptor antagonist,MoA,Launched,Gene,Chemical_Compound
25435,29475,dopamine receptor antagonist,MoA,Launched,Gene,Chemical_Compound
25842,29476,dopamine-norepinephrine reuptake inhibitor,MoA,Phase 2,Gene,Chemical_Compound
8931,29477,RAF inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
2655,29484,aldose reductase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25425,29488,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25427,29488,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25428,29488,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25436,29488,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25437,29488,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25737,29488,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
6992,29488,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
15278,29489,ERK1 and ERK2 phosphorylation inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5632,29489,ERK1 and ERK2 phosphorylation inhibitor,MoA,Phase 1,Gene,Chemical_Compound
12074,29490,Ral GTPase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12208,29490,Ral GTPase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10671,29492,Bcr-Abl kinase inhibitor|TIE tyrosine kinase inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
5733,29492,Bcr-Abl kinase inhibitor|TIE tyrosine kinase inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
27049,29492,Bcr-Abl kinase inhibitor|TIE tyrosine kinase inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25516,29492,Bcr-Abl kinase inhibitor|TIE tyrosine kinase inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
26378,29492,Bcr-Abl kinase inhibitor|TIE tyrosine kinase inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
13693,29492,Bcr-Abl kinase inhibitor|TIE tyrosine kinase inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
15699,29492,Bcr-Abl kinase inhibitor|TIE tyrosine kinase inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25457,29494,adrenergic receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
14630,29495,MEK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15556,29495,MEK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25474,29498,vasopressin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
26036,29498,vasopressin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
26037,29498,vasopressin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
26038,29498,vasopressin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25536,29499,glutamate receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
13052,29500,benzodiazepine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
10252,29501,transferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25431,29502,dopamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25432,29502,dopamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25433,29502,dopamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25438,29502,dopamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
14146,29502,dopamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
28029,29504,CC chemokine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
26113,29504,CC chemokine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
2687,29505,TGF beta receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14361,29506,toll-like receptor inhibitor,MoA,Phase 3,Gene,Chemical_Compound
27205,29508,toll-like receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
28007,29508,toll-like receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
9483,29509,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5097,29509,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15412,29509,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11559,29509,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11449,29511,cytochrome P450 inhibitor|SIRT activator,MoA,Launched,Gene,Chemical_Compound
15081,29511,cytochrome P450 inhibitor|SIRT activator,MoA,Launched,Gene,Chemical_Compound
7742,29511,cytochrome P450 inhibitor|SIRT activator,MoA,Launched,Gene,Chemical_Compound
25549,29511,cytochrome P450 inhibitor|SIRT activator,MoA,Launched,Gene,Chemical_Compound
4142,29512,HSP inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25679,29519,leukotriene receptor antagonist|lipoxygenase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9925,29521,MRP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8198,29522,Aurora kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
29523,29522,Aurora kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14630,29522,Aurora kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15211,29524,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8140,29524,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
14176,29524,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5572,29524,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5957,29524,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
3218,29524,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5091,29524,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
11612,29524,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25516,29524,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7999,29524,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
11513,29524,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8862,29524,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
3688,29524,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5097,29525,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14744,29526,DNA methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10953,29526,DNA methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5125,29527,FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25643,29527,FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9483,29528,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5097,29528,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8427,29529,gamma secretase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9899,29530,MDM inhibitor,MoA,Phase 1,Gene,Chemical_Compound
12989,29531,triacylglycerol lipase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5452,29531,triacylglycerol lipase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4822,29533,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7233,29542,prostanoid receptor agonist,MoA,Launched,Gene,Chemical_Compound
14549,29546,cell cycle inhibitor|PLK inhibitor,MoA,Phase 3,Gene,Chemical_Compound
14146,29551,sigma receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
26293,29552,calcitonin antagonist,MoA,Launched,Gene,Chemical_Compound
25760,29554,cannabinoid receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25766,29554,cannabinoid receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25482,29557,benzodiazepine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
9899,29560,MDM inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25457,29561,serotonin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
13904,29561,serotonin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25459,29561,serotonin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25435,29561,serotonin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25436,29561,serotonin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25437,29561,serotonin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25438,29561,serotonin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
6992,29561,serotonin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25439,29561,serotonin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25440,29561,serotonin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25846,29561,serotonin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25847,29561,serotonin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25468,29563,acetylcholine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25750,29563,acetylcholine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
26546,29563,acetylcholine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
12555,29567,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10419,29567,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2635,29567,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6235,29567,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7091,29567,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9359,29567,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13539,29567,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9815,29567,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9798,29568,histone demethylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6052,29569,TRPV antagonist,MoA,Preclinical,Gene,Chemical_Compound
6052,29570,TRPV agonist,MoA,Preclinical,Gene,Chemical_Compound
4116,29571,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7237,29572,NGF binding inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28393,29572,NGF binding inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25433,29573,dopamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
9765,29574,prostanoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25482,29575,GABA benzodiazepine site receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
25524,29575,GABA benzodiazepine site receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
25525,29575,GABA benzodiazepine site receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
25484,29575,GABA benzodiazepine site receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
25526,29575,GABA benzodiazepine site receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
25527,29575,GABA benzodiazepine site receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
25529,29575,GABA benzodiazepine site receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
25532,29575,GABA benzodiazepine site receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
25482,29576,GABA benzodiazepine site receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
25524,29576,GABA benzodiazepine site receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
25525,29576,GABA benzodiazepine site receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
25526,29576,GABA benzodiazepine site receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
12331,29577,phosphodiesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2917,29577,phosphodiesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11220,29577,phosphodiesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25442,29577,phosphodiesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7016,29577,phosphodiesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4116,29578,glutamate receptor antagonist|monamine transporter modulator,MoA,Preclinical,Gene,Chemical_Compound
27702,29579,glucokinase activator,MoA,Preclinical,Gene,Chemical_Compound
25449,29580,purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
15211,29581,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9782,29582,oxidosqualene cyclase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14630,29583,MEK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8931,29584,MEK inhibitor|RAF inhibitor,MoA,Phase 1,Gene,Chemical_Compound
14630,29584,MEK inhibitor|RAF inhibitor,MoA,Phase 1,Gene,Chemical_Compound
15556,29584,MEK inhibitor|RAF inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5363,29584,MEK inhibitor|RAF inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25438,29585,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
6992,29585,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25439,29585,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
29586,29587,kynurenine 3-monooxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26880,29588,glutamate receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
7538,29589,beta amyloid protein neurotoxicity inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25435,29590,serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
12820,29591,EGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
6539,29593,cyclooxygenase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25549,29593,cyclooxygenase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
8140,29598,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11612,29598,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25733,29599,insulin sensitizer|PPAR receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
10054,29599,insulin sensitizer|PPAR receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
26676,29599,insulin sensitizer|PPAR receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
8982,29599,insulin sensitizer|PPAR receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
13177,29600,GABA transaminase inhibitor,MoA,Launched,Gene,Chemical_Compound
25966,29600,GABA transaminase inhibitor,MoA,Launched,Gene,Chemical_Compound
10606,29601,ATPase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26955,29607,sphingosine 1-phosphate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25901,29608,transient receptor potential channel antagonist,MoA,Preclinical,Gene,Chemical_Compound
13886,29609,glucose 6-phosphate dehydrogenase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25457,29610,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25459,29610,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25438,29611,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
6992,29611,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25439,29611,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26340,29612,CCR antagonist,MoA,Preclinical,Gene,Chemical_Compound
25438,29613,serotonin receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
6992,29613,serotonin receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25439,29613,serotonin receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25457,29614,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25459,29614,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25739,29615,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25739,29616,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
4179,29617,CC chemokine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26340,29617,CC chemokine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25480,29618,serotonin receptor partial agonist,MoA,Preclinical,Gene,Chemical_Compound
25739,29619,serotonin receptor partial agonist,MoA,Preclinical,Gene,Chemical_Compound
25739,29620,serotonin receptor partial agonist,MoA,Preclinical,Gene,Chemical_Compound
25425,29621,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
11784,29622,nitric oxide production inhibitor,MoA,Phase 2,Gene,Chemical_Compound
8593,29623,hedgehog pathway inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25435,29624,serotonin receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25436,29624,serotonin receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25437,29624,serotonin receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25438,29624,serotonin receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
6992,29624,serotonin receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25439,29624,serotonin receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25440,29624,serotonin receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25846,29624,serotonin receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
11929,29625,cytochrome P450 inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25688,29626,adrenergic receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
7205,29627,androgen receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
15859,29628,topoisomerase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
13667,29629,PARP inhibitor,MoA,Phase 3,Gene,Chemical_Compound
9912,29629,PARP inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25966,29630,tyrosinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25549,29633,cyclooxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3018,29636,JAK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11513,29636,JAK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27205,29637,toll-like receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
26156,29638,integrin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4362,29639,MAP kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25549,29639,MAP kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8140,29640,CDK inhibitor|DNA synthesis inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
14744,29640,CDK inhibitor|DNA synthesis inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25457,29641,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
13904,29641,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25459,29641,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25425,29641,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25427,29641,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25428,29641,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
8140,29642,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5572,29642,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26201,29643,SYK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
4084,29644,SYK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26201,29644,SYK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
15211,29645,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8140,29645,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5572,29645,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5091,29645,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26022,29646,nitric oxide synthase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4822,29648,nitric oxide stimulant,MoA,Phase 1,Gene,Chemical_Compound
26736,29649,CAR antagonist,MoA,Preclinical,Gene,Chemical_Compound
13667,29650,PARP inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25435,29651,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25769,29652,FAAH inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10661,29653,DNA polymerase inhibitor,MoA,Launched,Gene,Chemical_Compound
7468,29653,DNA polymerase inhibitor,MoA,Launched,Gene,Chemical_Compound
25560,29653,DNA polymerase inhibitor,MoA,Launched,Gene,Chemical_Compound
26566,29653,DNA polymerase inhibitor,MoA,Launched,Gene,Chemical_Compound
13052,29654,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25444,29654,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
10301,29654,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
2570,29654,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26165,29654,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
8982,29657,PKC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
13052,29658,benzodiazepine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
10835,29659,smoothened receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
7423,29659,smoothened receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
7538,29661,beta amyloid protein neurotoxicity inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10521,29662,mTOR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9180,29664,eukaryotic translation initiation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25486,29665,EGFR inhibitor|metalloproteinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25635,29666,opioid receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25756,29666,opioid receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25757,29666,opioid receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
4881,29667,eukaryotic translation initiation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11931,29668,apoptosis stimulant,MoA,Phase 1,Gene,Chemical_Compound
29669,29670,smoothened receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
10835,29670,smoothened receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
29669,29671,smoothened receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
10835,29671,smoothened receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7553,29674,PI3K inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25730,29674,PI3K inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
10671,29675,SRC inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
26324,29675,SRC inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
15699,29675,SRC inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
6404,29675,SRC inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
10974,29676,glycine transporter inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26063,29679,VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14285,29680,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9899,29681,MDM inhibitor,MoA,Phase 1,Gene,Chemical_Compound
13539,29682,rho associated kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
10658,29684,c-Met inhibitor,MoA,Phase 3,Gene,Chemical_Compound
6992,29686,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25439,29686,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
11394,29687,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25679,29687,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7430,29687,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7999,29687,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26324,29687,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15278,29687,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25792,29687,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15860,29687,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4362,29687,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9010,29687,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7160,29687,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13539,29687,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8467,29687,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4670,29687,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25739,29688,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
11394,29689,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25679,29689,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7430,29689,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26732,29689,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25692,29689,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8730,29689,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7999,29689,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26324,29689,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15278,29689,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13406,29689,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25792,29689,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15860,29689,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4362,29689,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9010,29689,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3688,29689,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7160,29689,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5363,29689,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4687,29689,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13539,29689,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8467,29689,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4670,29689,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15699,29689,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25882,29689,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25525,29690,GABA receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
25526,29690,GABA receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
25527,29690,GABA receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
25438,29691,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
6992,29691,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25439,29691,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25435,29692,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25436,29692,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25437,29692,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25438,29692,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
6992,29692,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25439,29692,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
9558,29693,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8140,29693,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6912,29693,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7999,29693,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7430,29694,CHK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
29695,29696,tachykinin antagonist,MoA,Preclinical,Gene,Chemical_Compound
25438,29697,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
6992,29697,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25439,29697,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
29695,29698,tachykinin antagonist,MoA,Preclinical,Gene,Chemical_Compound
26113,29699,CC chemokine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25438,29700,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
6992,29700,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25439,29700,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7553,29701,mTOR inhibitor|PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9550,29701,mTOR inhibitor|PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
6722,29701,mTOR inhibitor|PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
12010,29701,mTOR inhibitor|PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25730,29701,mTOR inhibitor|PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25792,29702,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4362,29702,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25549,29702,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13366,29703,p38 MAPK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
4362,29703,p38 MAPK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25438,29704,serotonin receptor inverse agonist,MoA,Phase 1,Gene,Chemical_Compound
6992,29704,serotonin receptor inverse agonist,MoA,Phase 1,Gene,Chemical_Compound
25439,29704,serotonin receptor inverse agonist,MoA,Phase 1,Gene,Chemical_Compound
25846,29704,serotonin receptor inverse agonist,MoA,Phase 1,Gene,Chemical_Compound
25846,29705,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26293,29706,calcitonin antagonist,MoA,Preclinical,Gene,Chemical_Compound
25847,29707,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25846,29708,serotonin receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
29709,29710,CC chemokine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25593,29711,orexin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25595,29711,orexin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
6103,29712,TRPV antagonist,MoA,Preclinical,Gene,Chemical_Compound
25846,29713,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25593,29714,orexin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25595,29714,orexin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
6912,29715,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7999,29715,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8467,29715,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15466,29716,TGF beta receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2687,29716,TGF beta receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6103,29717,TRPV antagonist,MoA,Preclinical,Gene,Chemical_Compound
2687,29718,ALK tyrosine kinase receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2687,29719,TGF beta receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8931,29720,RAF inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26178,29721,nociceptin/orphanin FQ receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25518,29722,urotensin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
12390,29723,integrin antagonist,MoA,Phase 1,Gene,Chemical_Compound
6480,29723,integrin antagonist,MoA,Phase 1,Gene,Chemical_Compound
15018,29723,integrin antagonist,MoA,Phase 1,Gene,Chemical_Compound
29724,29723,integrin antagonist,MoA,Phase 1,Gene,Chemical_Compound
6103,29725,TRPV antagonist,MoA,Phase 2,Gene,Chemical_Compound
25518,29726,urotensin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25846,29727,serotonin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
15101,29728,kinesin-like spindle protein inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
11394,29729,kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12280,29729,kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13539,29729,kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10555,29729,kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8467,29729,kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26280,29730,G protein-coupled receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
13539,29731,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9815,29731,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9483,29732,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26217,29732,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
9854,29732,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
5097,29732,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
11261,29732,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
10915,29732,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
15412,29732,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
3712,29732,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
14549,29733,PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9483,29734,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5097,29734,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7160,29735,protein kinase activator,MoA,Preclinical,Gene,Chemical_Compound
29736,29737,dihydroorotate dehydrogenase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25674,29738,prostanoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25549,29739,cyclooxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25674,29740,prostanoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7742,29741,cyclooxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7160,29742,protein tyrosine kinase activator,MoA,Preclinical,Gene,Chemical_Compound
25476,29743,G protein-coupled receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
25477,29743,G protein-coupled receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
25430,29743,G protein-coupled receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
25431,29743,G protein-coupled receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
26178,29744,nociceptin/orphanin FQ receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25430,29745,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25434,29745,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25439,29745,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25961,29745,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
29746,29745,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
27117,29747,ATPase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
12596,29748,MTH1 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7954,29749,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25610,29749,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
9723,29749,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25611,29749,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
8140,29750,CHK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7430,29750,CHK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15729,29751,antioxidant,MoA,Preclinical,Gene,Chemical_Compound
25476,29755,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25477,29755,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25478,29755,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25479,29755,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
9483,29756,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9854,29756,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5097,29756,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11261,29756,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10915,29756,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15412,29756,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26219,29756,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11559,29756,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3712,29756,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4362,29757,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2687,29758,TGF beta receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25942,29759,matrix metalloprotease inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25943,29759,matrix metalloprotease inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3434,29759,matrix metalloprotease inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25635,29760,opioid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
12386,29761,tachykinin antagonist,MoA,Phase 1,Gene,Chemical_Compound
25438,29762,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
6992,29762,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25439,29762,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7954,29763,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25480,29764,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26076,29764,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25435,29765,adrenergic receptor antagonist|serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25436,29765,adrenergic receptor antagonist|serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25536,29766,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25536,29767,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25482,29769,GABA receptor antagonist|TP53 activator,MoA,Preclinical,Gene,Chemical_Compound
25719,29770,progesterone receptor agonist,MoA,Launched,Gene,Chemical_Compound
11055,29773,glutamate receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
4116,29773,glutamate receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
14073,29773,glutamate receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
14881,29773,glutamate receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
14630,29775,MEK inhibitor,MoA,Phase 3,Gene,Chemical_Compound
8427,29776,gamma secretase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
4362,29777,cytokine production inhibitor|p38 MAPK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5125,29778,VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26062,29778,VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25596,29778,VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25517,29778,VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7305,29778,VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
12215,29778,VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
4084,29778,VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7538,29779,beta amyloid inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12919,29780,intermediate conductance potassium channel blocker,MoA,Phase 3,Gene,Chemical_Compound
6039,29781,vitamin D receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
26245,29782,D-amino acid oxidase Inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9899,29784,MDM inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25457,29786,dopamine receptor antagonist|serotonin receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
13904,29786,dopamine receptor antagonist|serotonin receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25459,29786,dopamine receptor antagonist|serotonin receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25431,29786,dopamine receptor antagonist|serotonin receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25432,29786,dopamine receptor antagonist|serotonin receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25433,29786,dopamine receptor antagonist|serotonin receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
12953,29786,dopamine receptor antagonist|serotonin receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25435,29786,dopamine receptor antagonist|serotonin receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25436,29786,dopamine receptor antagonist|serotonin receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25437,29786,dopamine receptor antagonist|serotonin receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25737,29786,dopamine receptor antagonist|serotonin receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25738,29786,dopamine receptor antagonist|serotonin receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25438,29786,dopamine receptor antagonist|serotonin receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25439,29786,dopamine receptor antagonist|serotonin receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25846,29786,dopamine receptor antagonist|serotonin receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25839,29786,dopamine receptor antagonist|serotonin receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
26085,29788,prostaglandin inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26955,29791,lysophospholipid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
29792,29793,neuropeptide receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26961,29793,neuropeptide receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
12665,29794,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9444,29794,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5154,29795,protein arginine N-methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14744,29796,DNA methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7960,29796,DNA methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10953,29796,DNA methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25516,29797,Pim kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
2589,29797,Pim kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26081,29797,Pim kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
2981,29797,Pim kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
13052,29798,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25444,29798,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
10658,29799,hepatocyte growth factor receptor inhibitor,MoA,Phase 1,Gene,Chemical_Compound
29800,29801,neuropeptide receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
6834,29802,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26968,29803,acetylcholine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25539,29804,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
27114,29805,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25539,29805,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
29806,29807,steroidogenic factor antagonist,MoA,Preclinical,Gene,Chemical_Compound
12331,29808,phosphodiesterase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
11877,29814,DNA methyltransferase inhibitor|RNA synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25855,29815,voltage-gated sodium channel blocker,MoA,Phase 2,Gene,Chemical_Compound
25462,29815,voltage-gated sodium channel blocker,MoA,Phase 2,Gene,Chemical_Compound
25705,29815,voltage-gated sodium channel blocker,MoA,Phase 2,Gene,Chemical_Compound
25707,29815,voltage-gated sodium channel blocker,MoA,Phase 2,Gene,Chemical_Compound
25708,29815,voltage-gated sodium channel blocker,MoA,Phase 2,Gene,Chemical_Compound
25546,29815,voltage-gated sodium channel blocker,MoA,Phase 2,Gene,Chemical_Compound
25710,29815,voltage-gated sodium channel blocker,MoA,Phase 2,Gene,Chemical_Compound
25457,29817,sigma receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
13904,29817,sigma receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25459,29817,sigma receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
14836,29819,SIRT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10228,29820,SIRT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14836,29820,SIRT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7472,29821,serine/threonine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2687,29821,serine/threonine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5086,29823,endothelin receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
6063,29823,endothelin receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
13268,29825,MDM inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14146,29826,sigma receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
12919,29827,potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
4362,29828,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25429,29829,dopamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25430,29829,dopamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25434,29829,dopamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25430,29830,dopamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25430,29831,dopamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25434,29831,dopamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25430,29832,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25434,29832,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25679,29833,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4362,29833,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26700,29834,GABA uptake inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7977,29835,histamine N-methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25692,29836,calcium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
8747,29836,calcium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
9830,29836,calcium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
28156,29836,calcium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
9683,29836,calcium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26676,29836,calcium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
6619,29836,calcium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
13933,29837,sphingosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25596,29838,VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25760,29839,cannabinoid receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25431,29839,cannabinoid receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25435,29839,cannabinoid receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
7954,29840,adenosine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25610,29840,adenosine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
9723,29840,adenosine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25611,29840,adenosine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
4111,29841,XIAP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26118,29841,XIAP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8257,29841,XIAP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13121,29842,sigma receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
29843,29844,autophagy inducer,MoA,Preclinical,Gene,Chemical_Compound
2589,29845,Pim kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
29792,29846,transient receptor potential channel agonist,MoA,Preclinical,Gene,Chemical_Compound
4822,29848,nitric oxide donor,MoA,Phase 2,Gene,Chemical_Compound
25457,29849,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
13904,29849,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25459,29849,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25425,29849,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25427,29849,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25428,29849,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
15452,29849,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25855,29849,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
11306,29852,selective estrogen receptor modulator (SERM),MoA,Preclinical,Gene,Chemical_Compound
13256,29853,Aurora kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8198,29853,Aurora kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25800,29853,Aurora kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
4142,29854,HSP inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
4024,29854,HSP inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
7497,29855,thyroid hormone receptor agonist,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
9538,29855,thyroid hormone receptor agonist,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
7295,29856,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26976,29856,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26977,29856,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9483,29856,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9854,29856,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5097,29856,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11559,29856,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
3018,29863,JAK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
2655,29869,aldose reductase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25906,29870,sodium/glucose cotransporter inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26504,29870,sodium/glucose cotransporter inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7160,29872,PKC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26636,29872,PKC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15338,29872,PKC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25649,29872,PKC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12426,29872,PKC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25650,29872,PKC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9986,29873,NFkB pathway inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13835,29873,NFkB pathway inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9899,29874,ubiquitin ligase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12902,29876,bacterial DNA gyrase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25560,29877,aspartate carbamoyltransferase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25561,29877,aspartate carbamoyltransferase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
2857,29878,deubiquitinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6726,29878,deubiquitinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25961,29879,glutamate receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
8148,29879,glutamate receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
29881,29882,gene expression stimulant,MoA,Preclinical,Gene,Chemical_Compound
25756,29884,opioid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25457,29887,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
13904,29887,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25459,29887,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25425,29887,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25427,29887,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25428,29887,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25435,29887,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
6992,29887,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
10228,29888,SIRT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5086,29889,endothelin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
4084,29890,receptor tyrosine protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11152,29891,bacterial cell wall synthesis inhibitor,MoA,Phase 3,Gene,Chemical_Compound
4380,29892,adenylyl cyclase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15325,29893,retinoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
29894,29893,retinoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
12386,29895,neurokinin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
10054,29896,PPAR receptor ligand,MoA,Preclinical,Gene,Chemical_Compound
29894,29897,retinoid receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
26728,29898,leukotriene receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
26251,29899,CCK receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
13406,29900,JNK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9010,29900,JNK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3688,29900,JNK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13406,29901,JNK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9815,29902,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25480,29903,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25544,29904,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25688,29904,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25802,29904,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25476,29905,acetylcholine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
4501,29906,SRC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26324,29906,SRC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4687,29906,SRC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3185,29907,serine arginine protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10173,29907,serine arginine protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10228,29908,SIRT activator,MoA,Preclinical,Gene,Chemical_Compound
10228,29909,SIRT activator,MoA,Phase 2,Gene,Chemical_Compound
25455,29910,acetylcholine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
12038,29911,myeloid differentiation primary response inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25950,29912,interleukin synthesis inhibitor,MoA,Phase 2,Gene,Chemical_Compound
8464,29913,STAT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5937,29914,aryl hydrocarbon receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
6115,29915,serine/threonine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12976,29916,NAMPT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12976,29917,NAMPT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14589,29917,NAMPT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25457,29919,adrenergic receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25476,29921,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25477,29921,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25478,29921,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25479,29921,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
9193,29921,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26666,29921,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
27645,29921,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
6267,29921,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
2983,29921,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26103,29921,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7644,29921,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
12386,29922,neurokinin receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25481,29922,neurokinin receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
29695,29922,neurokinin receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
29929,29930,antioxidant,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
10808,29933,dihydrofolate reductase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11784,29941,anticancer agent|aryl hydrocarbon receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25560,29944,carbonic anhydrase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25431,29945,dopamine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
29947,29948,calcitonin agonist,MoA,Preclinical,Gene,Chemical_Compound
5125,29949,fibroblast growth factor mimetic,MoA,Preclinical,Gene,Chemical_Compound
7742,29951,cyclooxygenase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25549,29951,cyclooxygenase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
13052,29954,GABA receptor inverse agonist,MoA,Phase 2,Gene,Chemical_Compound
25596,29955,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
10658,29956,hepatocyte growth factor receptor inhibitor|tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12215,29957,PDGFR tyrosine kinase receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9010,29958,JNK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25596,29959,PDGFR tyrosine kinase receptor inhibitor|tyrosine kinase inhibitor|VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12215,29959,PDGFR tyrosine kinase receptor inhibitor|tyrosine kinase inhibitor|VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15211,29960,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8140,29960,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5572,29960,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5957,29960,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9845,29961,alpha mannosidase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4362,29962,MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8240,29963,kainate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
11697,29963,kainate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
28150,29963,kainate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
28151,29963,kainate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
28152,29963,kainate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26756,29963,kainate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25876,29964,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25874,29964,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
15461,29964,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25878,29964,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26955,29966,sphingosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25876,29967,glutamate receptor modulator,MoA,Phase 2,Gene,Chemical_Compound
25874,29967,glutamate receptor modulator,MoA,Phase 2,Gene,Chemical_Compound
15461,29967,glutamate receptor modulator,MoA,Phase 2,Gene,Chemical_Compound
25878,29967,glutamate receptor modulator,MoA,Phase 2,Gene,Chemical_Compound
10054,29968,PPAR receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
7468,29969,carbonic anhydrase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26566,29969,carbonic anhydrase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10054,29970,PPAR receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
11127,29971,phosphodiesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14989,29972,LXR agonist,MoA,Preclinical,Gene,Chemical_Compound
13590,29972,LXR agonist,MoA,Preclinical,Gene,Chemical_Compound
9389,29972,LXR agonist,MoA,Preclinical,Gene,Chemical_Compound
11621,29972,LXR agonist,MoA,Preclinical,Gene,Chemical_Compound
26803,29972,LXR agonist,MoA,Preclinical,Gene,Chemical_Compound
14770,29972,LXR agonist,MoA,Preclinical,Gene,Chemical_Compound
9986,29973,AP inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7197,29974,LIM kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25610,29975,adenosine receptor modulator,MoA,Phase 2,Gene,Chemical_Compound
10571,29976,casein kinase inhibitor|MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9958,29976,casein kinase inhibitor|MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4362,29976,casein kinase inhibitor|MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25896,29977,growth hormone secretagogue receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
9483,29979,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
12125,29986,phosphorylase inhibitor,MoA,Launched,Gene,Chemical_Compound
26484,29987,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25604,29988,CC chemokine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
13503,29989,EGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7305,29990,VEGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8931,29991,RAF inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4362,29992,p38 MAPK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
14630,29993,MEK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25733,29994,insulin secretagogue,MoA,Phase 3,Gene,Chemical_Compound
8198,29995,Aurora kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
14549,29996,PLK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7264,29997,dipeptidyl peptidase inhibitor|fibroblast activation protein inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26067,29998,smoothened receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
26918,29998,smoothened receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
10835,29998,smoothened receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25876,29999,glutamate receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25874,29999,glutamate receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
15461,29999,glutamate receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25878,29999,glutamate receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
28362,30000,cytochrome P450 inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25904,30004,p38 MAPK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25792,30004,p38 MAPK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4362,30004,p38 MAPK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
3593,30004,p38 MAPK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25882,30004,p38 MAPK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25481,30005,tachykinin antagonist,MoA,Phase 2,Gene,Chemical_Compound
29695,30005,tachykinin antagonist,MoA,Phase 2,Gene,Chemical_Compound
25805,30007,adrenergic inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25719,30012,progesterone receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
5098,30014,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25516,30014,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25517,30014,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
3761,30014,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12215,30014,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4142,30015,HSP inhibitor,MoA,Phase 3,Gene,Chemical_Compound
28996,30017,AP inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25904,30018,anti-inflammatory agent|interleukin inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
26803,30018,anti-inflammatory agent|interleukin inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
25882,30018,anti-inflammatory agent|interleukin inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
9689,30019,prostaglandin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25478,30020,acetylcholine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25760,30021,cannabinoid receptor inverse agonist,MoA,Phase 3,Gene,Chemical_Compound
26022,30022,nitric oxide synthase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25615,30023,P glycoprotein inhibitor,MoA,Phase 3,Gene,Chemical_Compound
15859,30024,topoisomerase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9550,30025,PI3K inhibitor,MoA,Phase 3,Gene,Chemical_Compound
11261,30027,angiogenesis inhibitor|S100A9 inhibitor,MoA,Phase 3,Gene,Chemical_Compound
30028,30029,G protein-coupled receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
26687,30029,G protein-coupled receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
29374,30029,G protein-coupled receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
13308,30030,opioid receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
11013,30032,histone lysine methyltransferase inhibitor,MoA,Launched,Gene,Chemical_Compound
3728,30033,excitatory amino acid transporter inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26756,30033,excitatory amino acid transporter inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6507,30033,excitatory amino acid transporter inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28243,30033,excitatory amino acid transporter inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28244,30033,excitatory amino acid transporter inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13256,30034,Aurora kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4910,30035,MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14385,30035,MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12329,30036,histone demethylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8534,30036,histone demethylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7729,30036,histone demethylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12635,30036,histone demethylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27774,30036,histone demethylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15154,30036,histone demethylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11097,30036,histone demethylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7538,30037,gamma secretase modulator,MoA,Preclinical,Gene,Chemical_Compound
25769,30038,FAAH inhibitor,MoA,Preclinical,Gene,Chemical_Compound
30039,30040,formyl peptide receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25425,30041,adrenergic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25427,30041,adrenergic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25428,30041,adrenergic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25610,30042,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26280,30043,G protein-coupled receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
5345,30044,G protein-coupled receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
9483,30045,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9854,30045,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5097,30045,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11559,30045,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15607,30046,integrin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15018,30046,integrin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25901,30047,transient receptor potential channel antagonist,MoA,Preclinical,Gene,Chemical_Compound
25901,30048,transient receptor potential channel antagonist,MoA,Preclinical,Gene,Chemical_Compound
30049,30050,lysophosphatidic acid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
28746,30051,monopolar spindle 1 kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25710,30052,sodium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
28531,30053,neurotensin agonist,MoA,Preclinical,Gene,Chemical_Compound
28124,30054,G protein-coupled receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25474,30055,oxytocin receptor agonist|vasopressin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
30056,30055,oxytocin receptor agonist|vasopressin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26324,30057,SRC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8241,30058,DYRK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12918,30058,DYRK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26290,30059,PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13147,30060,MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5043,30061,hypoxia inducible factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26955,30062,sphingosine 1-phosphate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
11055,30063,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
27114,30064,glutamate receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
15412,30065,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25595,30066,orexin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
2589,30067,Pim kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7999,30068,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5688,30069,JAK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12390,30070,integrin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15018,30070,integrin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26435,30071,G protein-coupled receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25516,30072,FLT3 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10521,30073,transient receptor potential channel antagonist,MoA,Preclinical,Gene,Chemical_Compound
6821,30074,beta-secretase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25468,30075,acetylcholine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
7954,30077,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
26495,30078,calcium-sensing receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25839,30079,histamine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25438,30080,serotonin receptor partial agonist,MoA,Withdrawn,Gene,Chemical_Compound
6992,30080,serotonin receptor partial agonist,MoA,Withdrawn,Gene,Chemical_Compound
25439,30080,serotonin receptor partial agonist,MoA,Withdrawn,Gene,Chemical_Compound
25739,30080,serotonin receptor partial agonist,MoA,Withdrawn,Gene,Chemical_Compound
26340,30081,CC chemokine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25596,30083,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
3638,30084,calcitonin antagonist,MoA,Phase 3,Gene,Chemical_Compound
15360,30084,calcitonin antagonist,MoA,Phase 3,Gene,Chemical_Compound
25476,30085,acetylcholine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
27353,30093,ATPase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25961,30095,cyclooxygenase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7742,30095,cyclooxygenase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
10228,30098,SIRT inhibitor|TP53 activator,MoA,Preclinical,Gene,Chemical_Compound
10228,30099,SIRT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14836,30099,SIRT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4097,30099,SIRT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14369,30102,pyruvate kinase isozyme activator,MoA,Preclinical,Gene,Chemical_Compound
30103,30104,lipoxygenase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
15211,30104,lipoxygenase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
12953,30108,histamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
5315,30108,histamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25839,30108,histamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25520,30112,Bruton's tyrosine kinase (BTK) inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26797,30113,prostanoid receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
8250,30114,insulin sensitizer|PPAR receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
10054,30114,insulin sensitizer|PPAR receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
7016,30115,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7905,30118,superoxide dismutase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
15961,30118,superoxide dismutase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
30120,30121,cytidine deaminase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25842,30123,calcium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
25536,30124,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
11055,30124,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
4116,30124,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
14073,30124,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
14881,30124,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
6933,30125,monoamine oxidase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
27730,30126,prostaglandin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3094,30127,CLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4358,30127,CLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8241,30127,CLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12918,30127,CLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15211,30128,CDK inhibitor|FLT3 inhibitor|JAK inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
8140,30128,CDK inhibitor|FLT3 inhibitor|JAK inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
5091,30128,CDK inhibitor|FLT3 inhibitor|JAK inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
11612,30128,CDK inhibitor|FLT3 inhibitor|JAK inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25516,30128,CDK inhibitor|FLT3 inhibitor|JAK inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
11513,30128,CDK inhibitor|FLT3 inhibitor|JAK inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25596,30129,SRC inhibitor|VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15699,30129,SRC inhibitor|VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4501,30130,SRC inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5125,30130,SRC inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26062,30130,SRC inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26063,30130,SRC inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25596,30130,SRC inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15699,30130,SRC inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11513,30131,JAK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5688,30131,JAK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6722,30132,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12010,30132,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9550,30133,PI3K inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
6722,30133,PI3K inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
12010,30133,PI3K inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25730,30133,PI3K inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
12596,30134,MTH1 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7954,30136,phosphodiesterase inhibitor,MoA,Launched,Gene,Chemical_Compound
25610,30136,phosphodiesterase inhibitor,MoA,Launched,Gene,Chemical_Compound
11220,30136,phosphodiesterase inhibitor,MoA,Launched,Gene,Chemical_Compound
30137,30138,GLCNAC phosphotransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25498,30147,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25845,30147,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25430,30149,dopamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25431,30149,dopamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25432,30149,dopamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25433,30149,dopamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25434,30149,dopamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
12953,30149,dopamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25435,30149,dopamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25438,30149,dopamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25439,30149,dopamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25846,30149,dopamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25847,30149,dopamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
15796,30150,membrane metalloendopeptidase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5091,30156,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5091,30157,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5091,30158,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11394,30166,AKT inhibitor|TRAIL modulator,MoA,Phase 2,Gene,Chemical_Compound
15278,30166,AKT inhibitor|TRAIL modulator,MoA,Phase 2,Gene,Chemical_Compound
7999,30167,glycogen synthase kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26939,30168,cytochrome P450 inhibitor|sodium/potassium/chloride transporter inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
4967,30168,cytochrome P450 inhibitor|sodium/potassium/chloride transporter inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25596,30169,TIE tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4362,30169,TIE tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25563,30170,ATP-sensitive potassium channel agonist,MoA,Phase 1,Gene,Chemical_Compound
25567,30170,ATP-sensitive potassium channel agonist,MoA,Phase 1,Gene,Chemical_Compound
7362,30172,cholesterol inhibitor|lipase clearing factor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25497,30174,histamine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25560,30176,carbonic anhydrase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3238,30177,farnesyltransferase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
9178,30177,farnesyltransferase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
4681,30178,plasminogen activator inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25544,30179,adrenergic receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25688,30179,adrenergic receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25802,30179,adrenergic receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25546,30180,sodium channel blocker,MoA,Withdrawn,Gene,Chemical_Compound
10658,30183,tyrosine kinase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
14818,30186,cyclophilin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11374,30187,methionine aminopeptidase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25544,30193,adrenergic receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25688,30193,adrenergic receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25802,30193,adrenergic receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
7541,30197,catechol O methyltransferase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
13693,30198,SRC activator,MoA,Phase 2,Gene,Chemical_Compound
15699,30198,SRC activator,MoA,Phase 2,Gene,Chemical_Compound
25425,30200,adrenergic receptor antagonist,MoA,Launched,Gene,Chemical_Compound
3897,30203,aldose reductase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
2655,30203,aldose reductase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
30204,30203,aldose reductase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
26728,30207,leukotriene receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25892,30212,cholesteryl ester transfer protein inhibitor,MoA,Phase 3,Gene,Chemical_Compound
14682,30213,DNA polymerase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9927,30213,DNA polymerase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7553,30215,mTOR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7553,30216,mTOR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9224,30217,peptidase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
14678,30217,peptidase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15533,30217,peptidase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6115,30218,serine/threonine kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25610,30219,adenosine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
13256,30220,Aurora kinase inhibitor|Bcr-Abl kinase inhibitor|FLT3 inhibitor|JAK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
8198,30220,Aurora kinase inhibitor|Bcr-Abl kinase inhibitor|FLT3 inhibitor|JAK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25800,30220,Aurora kinase inhibitor|Bcr-Abl kinase inhibitor|FLT3 inhibitor|JAK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26324,30220,Aurora kinase inhibitor|Bcr-Abl kinase inhibitor|FLT3 inhibitor|JAK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25482,30221,GABA receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
25524,30221,GABA receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
25525,30221,GABA receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
25526,30221,GABA receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
4206,30222,AXL kinase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
8369,30223,IKK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25482,30224,GABA receptor modulator,MoA,Phase 2,Gene,Chemical_Compound
12919,30225,potassium channel antagonist,MoA,Preclinical,Gene,Chemical_Compound
12919,30226,calcium-activated potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
7538,30228,beta amyloid protein neurotoxicity inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26178,30233,nociceptin/orphanin FQ receptor antagonist|opioid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
4116,30236,glutamate receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
11127,30241,phosphodiesterase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
15081,30242,DNA replication inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7763,30248,ribonucleotide reductase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26770,30248,ribonucleotide reductase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9483,30250,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26217,30250,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9854,30250,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5097,30250,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
11261,30250,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
10915,30250,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
15412,30250,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26219,30250,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
11559,30250,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
3712,30250,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
11394,30251,AKT inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
3526,30251,AKT inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
12280,30251,AKT inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
10808,30266,dihydrofolate reductase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25436,30270,serotonin receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25437,30270,serotonin receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
3757,30271,RNA polymerase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
28996,30273,cytokine production inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5939,30273,cytokine production inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25882,30273,cytokine production inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26938,30274,insulin sensitizer|PPAR receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
10054,30274,insulin sensitizer|PPAR receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
8982,30274,insulin sensitizer|PPAR receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25480,30276,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26076,30276,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7742,30277,cyclooxygenase inhibitor,MoA,Launched,Gene,Chemical_Compound
25549,30277,cyclooxygenase inhibitor,MoA,Launched,Gene,Chemical_Compound
12902,30281,bacterial DNA gyrase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25757,30282,opioid receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
27353,30283,cyclooxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6394,30285,retinoid receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
14114,30285,retinoid receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
6578,30285,retinoid receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
11449,30286,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15412,30287,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13503,30290,EGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25733,30291,free fatty acid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25669,30292,free fatty acid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
4988,30294,BCL inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15946,30294,BCL inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13177,30294,BCL inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7999,30295,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9986,30295,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5129,30295,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12229,30296,sphingosine 1-phosphate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25516,30297,FLT3 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12820,30298,EGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4362,30298,EGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12820,30299,EGFR inhibitor|tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12820,30300,EGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13503,30301,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12820,30302,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13503,30303,tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25596,30303,tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25850,30303,tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12820,30304,tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11394,30305,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7430,30305,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7999,30305,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26324,30305,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14630,30305,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15556,30305,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15694,30305,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15278,30305,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25792,30305,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15860,30305,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4362,30305,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9010,30305,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7160,30305,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5363,30305,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13539,30305,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8467,30305,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4670,30305,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7541,30306,catechol O methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10661,30307,carbonic anhydrase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
7468,30307,carbonic anhydrase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25560,30307,carbonic anhydrase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
26566,30307,carbonic anhydrase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25756,30308,opioid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25756,30309,opioid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25896,30310,growth hormone releasing factor agonist,MoA,Phase 1,Gene,Chemical_Compound
25432,30311,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7264,30312,dipeptidyl peptidase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3273,30312,dipeptidyl peptidase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25466,30313,acetylcholine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25468,30313,acetylcholine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25750,30313,acetylcholine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
8240,30315,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
8240,30316,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
8240,30317,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
28152,30317,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
8257,30318,XIAP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9483,30319,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9854,30319,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5097,30319,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11559,30319,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25431,30321,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25432,30321,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25433,30321,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25435,30321,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25943,30322,metalloproteinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3377,30322,metalloproteinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3434,30322,metalloproteinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11359,30322,metalloproteinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25486,30322,metalloproteinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11705,30323,procollagen C-endopeptidase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7236,30324,monocarboxylate transporter inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2701,30327,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5102,30327,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5102,30328,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5102,30329,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2701,30330,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5102,30330,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2701,30331,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5102,30331,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5102,30332,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2701,30333,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5102,30333,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8869,30334,L3MBTL antagonist,MoA,Preclinical,Gene,Chemical_Compound
11013,30335,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25516,30336,FLT3 inhibitor|MER tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26361,30336,FLT3 inhibitor|MER tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26361,30337,MER tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5154,30338,protein arginine N-methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6635,30339,phosphatidyl-inositol activator,MoA,Preclinical,Gene,Chemical_Compound
14981,30340,L3MBTL antagonist,MoA,Preclinical,Gene,Chemical_Compound
14981,30341,MBT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9912,30342,PARP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11394,30343,AKT inhibitor,MoA,Phase 2,Gene,Chemical_Compound
3526,30343,AKT inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12280,30343,AKT inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25769,30346,FAAH inhibitor,MoA,Phase 1,Gene,Chemical_Compound
30347,30346,FAAH inhibitor,MoA,Phase 1,Gene,Chemical_Compound
10521,30346,FAAH inhibitor,MoA,Phase 1,Gene,Chemical_Compound
14810,30351,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
12005,30351,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25624,30352,purinergic receptor activator,MoA,Launched,Gene,Chemical_Compound
25626,30352,purinergic receptor activator,MoA,Launched,Gene,Chemical_Compound
25627,30352,purinergic receptor activator,MoA,Launched,Gene,Chemical_Compound
28755,30352,purinergic receptor activator,MoA,Launched,Gene,Chemical_Compound
5305,30352,purinergic receptor activator,MoA,Launched,Gene,Chemical_Compound
30353,30354,mixed lineage kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3507,30354,mixed lineage kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25516,30354,mixed lineage kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4117,30354,mixed lineage kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7886,30354,mixed lineage kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6023,30354,mixed lineage kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3942,30354,mixed lineage kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27675,30354,mixed lineage kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10173,30354,mixed lineage kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7246,30356,ATPase inhibitor|NFkB pathway inhibitor|STAT inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
26688,30356,ATPase inhibitor|NFkB pathway inhibitor|STAT inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
4822,30356,ATPase inhibitor|NFkB pathway inhibitor|STAT inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
25603,30356,ATPase inhibitor|NFkB pathway inhibitor|STAT inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
4822,30357,MAP kinase activator,MoA,Preclinical,Gene,Chemical_Compound
7468,30358,cyclooxygenase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25549,30358,cyclooxygenase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25615,30367,P glycoprotein inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25842,30379,dopamine reuptake inhibitor,MoA,Phase 3,Gene,Chemical_Compound
27136,30382,secretory phospholipase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
12820,30384,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26062,30384,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26063,30384,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25596,30384,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
12215,30384,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
2657,30385,cathepsin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4410,30385,cathepsin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5789,30385,cathepsin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15729,30386,ATR kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12859,30387,ATR kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15729,30387,ATR kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7553,30387,ATR kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25730,30387,ATR kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25889,30390,leukotriene synthesis inhibitor,MoA,Phase 3,Gene,Chemical_Compound
13667,30391,PARP inhibitor,MoA,Phase 3,Gene,Chemical_Compound
9912,30391,PARP inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26641,30392,neuropeptide receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
13054,30396,HSP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4142,30397,HSP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
30399,30400,CC chemokine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
28326,30401,urate transporter inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7675,30403,tubulin polymerization inhibitor,MoA,Phase 2,Gene,Chemical_Compound
30404,30405,acetylcholinesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14361,30407,tumor necrosis factor receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25604,30408,CC chemokine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25476,30417,adrenergic receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25477,30417,adrenergic receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25478,30417,adrenergic receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25479,30417,adrenergic receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
7954,30422,adenosine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25610,30422,adenosine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
9723,30422,adenosine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25611,30422,adenosine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25679,30424,LDL oxidation inhibitor|PKC inhibitor,MoA,Launched,Gene,Chemical_Compound
12115,30424,LDL oxidation inhibitor|PKC inhibitor,MoA,Launched,Gene,Chemical_Compound
26803,30424,LDL oxidation inhibitor|PKC inhibitor,MoA,Launched,Gene,Chemical_Compound
9847,30424,LDL oxidation inhibitor|PKC inhibitor,MoA,Launched,Gene,Chemical_Compound
5968,30424,LDL oxidation inhibitor|PKC inhibitor,MoA,Launched,Gene,Chemical_Compound
7160,30424,LDL oxidation inhibitor|PKC inhibitor,MoA,Launched,Gene,Chemical_Compound
26636,30424,LDL oxidation inhibitor|PKC inhibitor,MoA,Launched,Gene,Chemical_Compound
6179,30424,LDL oxidation inhibitor|PKC inhibitor,MoA,Launched,Gene,Chemical_Compound
30425,30424,LDL oxidation inhibitor|PKC inhibitor,MoA,Launched,Gene,Chemical_Compound
30426,30424,LDL oxidation inhibitor|PKC inhibitor,MoA,Launched,Gene,Chemical_Compound
8459,30427,antitumor agent|ubiquitin C-terminal hydrolase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8214,30427,antitumor agent|ubiquitin C-terminal hydrolase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
14549,30429,PLK inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25438,30430,serotonin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
6992,30430,serotonin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25439,30430,serotonin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25839,30430,serotonin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
12902,30433,topoisomerase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7553,30437,mTOR inhibitor|PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9550,30437,mTOR inhibitor|PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25833,30438,beta amyloid antagonist,MoA,Phase 1,Gene,Chemical_Compound
8037,30438,beta amyloid antagonist,MoA,Phase 1,Gene,Chemical_Compound
25494,30439,cytochrome P450 inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25713,30440,renin inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25480,30441,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26076,30441,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25845,30442,histamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
5359,30443,CC chemokine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
8006,30444,phospholipase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9193,30445,acetylcholine receptor allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
26436,30446,potassium/chloride cotransporter inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25539,30447,glutamate receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
25539,30448,glutamate receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
27114,30449,glutamate receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
27114,30450,glutamate receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
3453,30451,phospholipase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27114,30452,glutamate receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
26745,30453,glutamate receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
25479,30454,acetylcholine receptor allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
25479,30455,acetylcholine receptor allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
25539,30456,glutamate receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
25539,30457,glutamate receptor potentiator,MoA,Preclinical,Gene,Chemical_Compound
25565,30458,potassium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
15278,30459,MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25904,30460,p38 MAPK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5939,30460,p38 MAPK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25792,30460,p38 MAPK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15860,30460,p38 MAPK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4362,30460,p38 MAPK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25882,30460,p38 MAPK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25792,30461,p38 MAPK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15860,30461,p38 MAPK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4362,30461,p38 MAPK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4728,30462,caspase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7525,30463,anaphylatoxin chemotactic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25435,30465,serotonin receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25439,30466,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25943,30467,metalloproteinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13503,30468,estrogen receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26130,30468,estrogen receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
11113,30468,estrogen receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25509,30468,estrogen receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25488,30469,gonadotropin releasing factor hormone receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25497,30469,gonadotropin releasing factor hormone receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25481,30469,gonadotropin releasing factor hormone receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25431,30470,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25438,30470,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25439,30470,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25846,30470,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25847,30470,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26756,30471,glutamate inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12410,30472,secreted frizzled related protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26652,30473,FXR agonist,MoA,Phase 1,Gene,Chemical_Compound
7553,30474,mTOR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25439,30475,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25457,30476,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
13904,30476,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25459,30476,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25425,30476,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25427,30476,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25428,30476,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25435,30476,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
12507,30477,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26324,30478,SRC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15699,30478,SRC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12820,30479,JAK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3018,30479,JAK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11513,30479,JAK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5688,30479,JAK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11344,30480,tankyrase inhibitor|WNT pathway inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7465,30481,aldehyde dehydrogenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6074,30482,bradykinin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
5118,30483,actin related protein inhibitor|neural Wiskott-Aldrich syndrome protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4832,30484,porcupine inhibitor,MoA,Preclinical,Gene,Chemical_Compound
30485,30486,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12373,30486,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9550,30486,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12010,30486,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25730,30486,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5090,30486,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14549,30486,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7366,30486,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8464,30487,STAT inhibitor,MoA,Phase 1,Gene,Chemical_Compound
11513,30488,deubiquitinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3040,30488,deubiquitinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8214,30488,deubiquitinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10968,30488,deubiquitinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
30490,30491,carboxylesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9828,30492,monoacylglycerol lipase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7553,30493,mTOR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7553,30494,mTOR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7553,30495,mTOR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12820,30496,EGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12820,30497,EGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13503,30497,EGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7446,30498,AMPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15191,30498,AMPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12820,30499,EGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25778,30500,CC chemokine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25435,30501,serotonin receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25544,30502,adrenergic receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25476,30503,acetylcholine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25477,30503,acetylcholine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25478,30503,acetylcholine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25479,30503,acetylcholine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
9193,30503,acetylcholine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25435,30503,acetylcholine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25436,30503,acetylcholine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25437,30503,acetylcholine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25737,30503,acetylcholine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25738,30503,acetylcholine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25438,30503,acetylcholine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
6992,30503,acetylcholine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25439,30503,acetylcholine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25846,30503,acetylcholine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25847,30503,acetylcholine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
7713,30504,tankyrase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11344,30504,tankyrase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9448,30505,benzodiazepine receptor ligand,MoA,Phase 2,Gene,Chemical_Compound
5912,30506,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13913,30506,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15441,30506,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28129,30506,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27022,30507,potassium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
25849,30507,potassium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
2670,30507,potassium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26258,30507,potassium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
5437,30507,potassium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
3018,30509,JAK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
11513,30509,JAK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5688,30509,JAK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9550,30510,PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12010,30510,PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25730,30510,PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11540,30511,Abl kinase inhibitor|insulin growth factor receptor inhibitor|SRC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
15699,30511,Abl kinase inhibitor|insulin growth factor receptor inhibitor|SRC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7553,30512,mTOR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12820,30513,EGFR inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
6296,30513,EGFR inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
13503,30513,EGFR inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26063,30513,EGFR inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25596,30513,EGFR inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
15404,30514,MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8762,30515,MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15404,30515,MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26064,30515,MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
30516,30515,MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8965,30519,focal adhesion kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11306,30520,estrogen receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25509,30520,estrogen receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
11368,30521,potassium channel activator,MoA,Phase 1,Gene,Chemical_Compound
11368,30522,potassium channel activator,MoA,Phase 1,Gene,Chemical_Compound
12829,30523,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14912,30523,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5683,30523,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25649,30523,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13539,30523,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9815,30523,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7345,30524,prolyl endopeptidase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
29736,30525,interleukin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13539,30526,rho associated kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9815,30526,rho associated kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
14623,30527,guanylyl cyclase activator,MoA,Preclinical,Gene,Chemical_Compound
26195,30527,guanylyl cyclase activator,MoA,Preclinical,Gene,Chemical_Compound
26197,30527,guanylyl cyclase activator,MoA,Preclinical,Gene,Chemical_Compound
7815,30527,guanylyl cyclase activator,MoA,Preclinical,Gene,Chemical_Compound
25896,30528,ghrelin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
30529,30530,apoptosis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3334,30530,apoptosis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26253,30531,CCK receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
30103,30532,survivin inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26880,30533,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26880,30534,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25824,30535,aromatase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
28156,30536,calcium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26676,30536,calcium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
10738,30536,calcium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
8276,30537,ACAT inhibitor,MoA,Phase 1,Gene,Chemical_Compound
30538,30539,IL5 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
30540,30539,IL5 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2917,30541,phosphodiesterase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
10907,30542,piezo channel activator,MoA,Preclinical,Gene,Chemical_Compound
9956,30544,phosphofructokinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4704,30544,phosphofructokinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7623,30545,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25480,30546,serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
26076,30546,serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25739,30546,serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25440,30546,serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
8430,30548,calmodulin antagonist,MoA,Phase 3,Gene,Chemical_Compound
25497,30549,histamine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25478,30550,acetylcholine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
26435,30552,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12559,30552,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7016,30552,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11127,30552,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26491,30552,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7016,30553,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
28096,30554,HCN channel blocker,MoA,Phase 3,Gene,Chemical_Compound
30555,30554,HCN channel blocker,MoA,Phase 3,Gene,Chemical_Compound
28098,30554,HCN channel blocker,MoA,Phase 3,Gene,Chemical_Compound
28099,30554,HCN channel blocker,MoA,Phase 3,Gene,Chemical_Compound
2425,30556,CDC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25802,30557,adrenergic receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25802,30558,adrenergic receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
5861,30559,angiotensin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
28096,30560,HCN channel blocker,MoA,Phase 2,Gene,Chemical_Compound
30555,30560,HCN channel blocker,MoA,Phase 2,Gene,Chemical_Compound
28098,30560,HCN channel blocker,MoA,Phase 2,Gene,Chemical_Compound
28099,30560,HCN channel blocker,MoA,Phase 2,Gene,Chemical_Compound
30120,30561,DNA methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14744,30561,DNA methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5086,30562,endothelin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
6933,30566,selective serotonin reuptake inhibitor (SSRI),MoA,Withdrawn,Gene,Chemical_Compound
7546,30566,selective serotonin reuptake inhibitor (SSRI),MoA,Withdrawn,Gene,Chemical_Compound
25684,30566,selective serotonin reuptake inhibitor (SSRI),MoA,Withdrawn,Gene,Chemical_Compound
11306,30568,estrogen receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25509,30568,estrogen receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25475,30569,CC chemokine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25482,30570,benzodiazepine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25524,30570,benzodiazepine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25525,30570,benzodiazepine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25526,30570,benzodiazepine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25529,30570,benzodiazepine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25532,30570,benzodiazepine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25482,30571,benzodiazepine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25524,30571,benzodiazepine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25525,30571,benzodiazepine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25526,30571,benzodiazepine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
13837,30572,AMPK activator,MoA,Preclinical,Gene,Chemical_Compound
7448,30572,AMPK activator,MoA,Preclinical,Gene,Chemical_Compound
13311,30572,AMPK activator,MoA,Preclinical,Gene,Chemical_Compound
7954,30573,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25610,30573,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
9723,30573,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25611,30573,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
12820,30574,Abl kinase inhibitor|SRC inhibitor|VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26062,30574,Abl kinase inhibitor|SRC inhibitor|VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26063,30574,Abl kinase inhibitor|SRC inhibitor|VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25596,30574,Abl kinase inhibitor|SRC inhibitor|VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25596,30575,VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8931,30576,RAF inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26324,30576,RAF inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4362,30576,RAF inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5363,30576,RAF inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3018,30577,JAK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5688,30577,JAK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13256,30578,Aurora kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8198,30578,Aurora kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26085,30582,prostaglandin synthesis inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
11901,30583,sodium/hydrogen exchanger inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25615,30589,P glycoprotein inhibitor,MoA,Phase 3,Gene,Chemical_Compound
30590,30589,P glycoprotein inhibitor,MoA,Phase 3,Gene,Chemical_Compound
6722,30593,PI3K inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
12010,30593,PI3K inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25730,30593,PI3K inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
7353,30595,N-type calcium channel blocker,MoA,Phase 2,Gene,Chemical_Compound
11513,30596,JAK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3736,30597,benzodiazepine receptor agonist|gamma hydroxybutyric acid agonist,MoA,Phase 1,Gene,Chemical_Compound
27136,30597,benzodiazepine receptor agonist|gamma hydroxybutyric acid agonist,MoA,Phase 1,Gene,Chemical_Compound
25833,30597,benzodiazepine receptor agonist|gamma hydroxybutyric acid agonist,MoA,Phase 1,Gene,Chemical_Compound
8783,30598,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15211,30598,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5957,30598,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7999,30598,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9845,30599,alpha mannosidase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26301,30600,potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
27059,30600,potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
27061,30600,potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
12919,30600,potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
14499,30601,sphingosine 1-phosphate receptor substrate,MoA,Preclinical,Gene,Chemical_Compound
27116,30601,sphingosine 1-phosphate receptor substrate,MoA,Preclinical,Gene,Chemical_Compound
15699,30602,SRC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25480,30604,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26076,30604,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
2589,30605,AKT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15859,30606,topoisomerase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10468,30607,PKC activator,MoA,Phase 2,Gene,Chemical_Compound
6052,30607,PKC activator,MoA,Phase 2,Gene,Chemical_Compound
26325,30608,nitric oxide synthase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25826,30608,nitric oxide synthase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26022,30608,nitric oxide synthase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26835,30609,prostanoid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
7954,30611,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
15946,30612,BCL-XL downregulator,MoA,Preclinical,Gene,Chemical_Compound
8988,30613,thioredoxin inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7538,30614,ATP synthase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27187,30615,hemoglobin modulator,MoA,Phase 2,Gene,Chemical_Compound
28233,30616,glutamate carboxypeptidase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25739,30617,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
7468,30618,carbonic anhydrase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25559,30618,carbonic anhydrase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25560,30618,carbonic anhydrase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26565,30618,carbonic anhydrase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26566,30618,carbonic anhydrase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9830,30619,"1,4,5-trisphosphate inhibitor",MoA,Preclinical,Gene,Chemical_Compound
28156,30619,"1,4,5-trisphosphate inhibitor",MoA,Preclinical,Gene,Chemical_Compound
9683,30619,"1,4,5-trisphosphate inhibitor",MoA,Preclinical,Gene,Chemical_Compound
26676,30619,"1,4,5-trisphosphate inhibitor",MoA,Preclinical,Gene,Chemical_Compound
7423,30619,"1,4,5-trisphosphate inhibitor",MoA,Preclinical,Gene,Chemical_Compound
25817,30619,"1,4,5-trisphosphate inhibitor",MoA,Preclinical,Gene,Chemical_Compound
25964,30619,"1,4,5-trisphosphate inhibitor",MoA,Preclinical,Gene,Chemical_Compound
8982,30619,"1,4,5-trisphosphate inhibitor",MoA,Preclinical,Gene,Chemical_Compound
30620,30619,"1,4,5-trisphosphate inhibitor",MoA,Preclinical,Gene,Chemical_Compound
6103,30619,"1,4,5-trisphosphate inhibitor",MoA,Preclinical,Gene,Chemical_Compound
30621,30619,"1,4,5-trisphosphate inhibitor",MoA,Preclinical,Gene,Chemical_Compound
25425,30622,imidazoline receptor ligand,MoA,Preclinical,Gene,Chemical_Compound
25427,30622,imidazoline receptor ligand,MoA,Preclinical,Gene,Chemical_Compound
25428,30622,imidazoline receptor ligand,MoA,Preclinical,Gene,Chemical_Compound
6933,30622,imidazoline receptor ligand,MoA,Preclinical,Gene,Chemical_Compound
7546,30622,imidazoline receptor ligand,MoA,Preclinical,Gene,Chemical_Compound
7954,30623,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25610,30623,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
9723,30623,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25611,30623,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
7954,30624,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25610,30624,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
9723,30624,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25431,30625,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25433,30625,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
14589,30626,glycolysis inhibitor,MoA,Phase 2,Gene,Chemical_Compound
30627,30626,glycolysis inhibitor,MoA,Phase 2,Gene,Chemical_Compound
30628,30626,glycolysis inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11643,30626,glycolysis inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7205,30630,androgen receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
13052,30631,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25444,30631,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26325,30632,nitric oxide synthase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25826,30632,nitric oxide synthase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25667,30633,melatonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25668,30633,melatonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
15081,30633,melatonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
7541,30634,hypoxia inducible factor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25824,30634,hypoxia inducible factor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26228,30634,hypoxia inducible factor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
3061,30634,hypoxia inducible factor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7815,30634,hypoxia inducible factor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7675,30634,hypoxia inducible factor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25436,30635,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25437,30635,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25737,30635,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25738,30635,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25480,30635,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26076,30635,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25846,30635,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25929,30636,glucose dependent insulinotropic receptor ligand,MoA,Phase 1,Gene,Chemical_Compound
2838,30639,pyruvate dehydrogenase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25667,30640,melatonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25668,30640,melatonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25457,30641,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
12953,30642,histamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
13635,30643,lipoxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25431,30644,dopamine receptor ligand,MoA,Preclinical,Gene,Chemical_Compound
25539,30645,glutamate receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
7205,30646,"CHK inhibitor|cytochrome P450 activator|indoleamine 2,3-dioxygenase inhibitor",MoA,Phase 3,Gene,Chemical_Compound
7815,30646,"CHK inhibitor|cytochrome P450 activator|indoleamine 2,3-dioxygenase inhibitor",MoA,Phase 3,Gene,Chemical_Compound
28996,30646,"CHK inhibitor|cytochrome P450 activator|indoleamine 2,3-dioxygenase inhibitor",MoA,Phase 3,Gene,Chemical_Compound
30647,30646,"CHK inhibitor|cytochrome P450 activator|indoleamine 2,3-dioxygenase inhibitor",MoA,Phase 3,Gene,Chemical_Compound
26747,30648,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26747,30649,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
15699,30650,SRC inhibitor|SYK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26201,30650,SRC inhibitor|SYK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26880,30651,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25476,30652,dopamine uptake inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25805,30652,dopamine uptake inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25842,30652,dopamine uptake inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25684,30652,dopamine uptake inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13667,30655,PARP inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25480,30656,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26325,30657,nitric oxide synthase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25826,30657,nitric oxide synthase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26022,30657,nitric oxide synthase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3070,30658,hexokinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25536,30659,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
11055,30659,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
4116,30659,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
14073,30659,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26880,30660,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25539,30660,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
15165,30661,adenosylhomocysteinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11013,30662,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26880,30666,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
2838,30667,GABA aminotransferase activator,MoA,Preclinical,Gene,Chemical_Compound
30647,30668,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25457,30669,adrenergic receptor ligand,MoA,Preclinical,Gene,Chemical_Compound
4704,30670,phosphofructokinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11394,30671,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7430,30671,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11449,30671,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7999,30671,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26324,30671,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14630,30671,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15278,30671,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25792,30671,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15860,30671,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4362,30671,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9010,30671,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7160,30671,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13539,30671,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8467,30671,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4670,30671,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25438,30672,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26880,30674,glutamate receptor agonist|glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26880,30675,glutamate receptor agonist|glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26309,30675,glutamate receptor agonist|glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
12260,30676,urokinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26976,30677,free fatty acid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25476,30678,cholinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25477,30678,cholinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25478,30678,cholinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25479,30678,cholinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
9193,30678,cholinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
13667,30679,PARP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14146,30680,sigma receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
9956,30682,macrophage migration inhibiting factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25824,30683,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2746,30683,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26998,30683,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25648,30683,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4190,30683,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25845,30684,histamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
6115,30685,IRE1 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25667,30686,melatonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25668,30686,melatonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
14146,30687,sigma receptor ligand,MoA,Preclinical,Gene,Chemical_Compound
25455,30688,nicotinic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
6734,30689,protein synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6734,30690,protein synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7633,30690,protein synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9483,30691,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7954,30692,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
2983,30693,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25536,30693,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
11055,30693,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
4116,30693,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
14073,30693,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
14881,30693,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
9139,30696,purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25435,30697,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25436,30697,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25437,30697,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25737,30697,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25738,30697,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25438,30697,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
6992,30697,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25439,30697,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25440,30697,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25846,30697,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25847,30697,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
14565,30699,thymidylate synthase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25478,30700,acetylcholine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25476,30703,acetylcholine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25477,30703,acetylcholine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25478,30703,acetylcholine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25479,30703,acetylcholine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25667,30704,melatonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25668,30704,melatonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
6103,30705,TRPV antagonist,MoA,Preclinical,Gene,Chemical_Compound
25536,30706,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
11055,30706,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
4116,30706,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
14073,30706,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25431,30707,dopamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25432,30707,dopamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25432,30708,dopamine receptor ligand,MoA,Preclinical,Gene,Chemical_Compound
15211,30709,CDK inhibitor|CHK inhibitor|PKC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7430,30709,CDK inhibitor|CHK inhibitor|PKC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
8245,30709,CDK inhibitor|CHK inhibitor|PKC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7999,30709,CDK inhibitor|CHK inhibitor|PKC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26324,30709,CDK inhibitor|CHK inhibitor|PKC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4362,30709,CDK inhibitor|CHK inhibitor|PKC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
10609,30709,CDK inhibitor|CHK inhibitor|PKC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4496,30709,CDK inhibitor|CHK inhibitor|PKC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5210,30709,CDK inhibitor|CHK inhibitor|PKC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7160,30709,CDK inhibitor|CHK inhibitor|PKC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26636,30709,CDK inhibitor|CHK inhibitor|PKC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15338,30709,CDK inhibitor|CHK inhibitor|PKC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25649,30709,CDK inhibitor|CHK inhibitor|PKC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
27350,30709,CDK inhibitor|CHK inhibitor|PKC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6772,30710,acetylcholinesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26325,30711,nitric oxide synthase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25826,30711,nitric oxide synthase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26022,30711,nitric oxide synthase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8109,30712,PKA activator,MoA,Preclinical,Gene,Chemical_Compound
25440,30713,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25847,30713,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25431,30714,dopamine receptor ligand,MoA,Preclinical,Gene,Chemical_Compound
25432,30714,dopamine receptor ligand,MoA,Preclinical,Gene,Chemical_Compound
25667,30715,melatonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25668,30715,melatonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
15859,30716,topoisomerase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
